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Abstract 
The calorie restriction (CR) and insulin/IGF-I-like signalling (IIS) are two 
pathways regulating the lifespan of C. elegans. Recent studies showed that glucose 
restriction extends the lifespan of C. elegans while excessive glucose shortens the 
lifespan of the worms. The first step of the glucose metabolism is the transport of 
glucose across the plasma membrane by the glucose transporters.  
The work described in this thesis aims to identify glucose transporters in C. elegans 
and to provide a primary investigation of the in vitro and in vivo function of the 
identified glucose transporter.  
Nine putative transporters have been cloned and expressed. Out of the nice cloned 
putative transporters in the C. elegans genome, H17B01.1 (H17) only is identified as 
a fully functional glucose transporter using an oocyte expression system in which 
glucose transport activity is directly measured. The two transcripts of H17 are both 
capable of transporting glucose with high affinity, as well as transporting trehalose. 
Heterologous expression of H17 in mammalian CHO-T cells suggests that the 
protein is localised both on the plasma membrane and in the cytosol. In vitro studies 
of H17 show that the protein does not respond to insulin stimulation when expressed 
in mammalian CHO-T cell and rat primary adipocyte systems.  
In vivo functional studies using H17 RNAi indicate that the worm’s lifespan is not 
affected by the H17 knockdown. However, glucose metabolism of C. elegans (as 
measured by glucose oxidation to CO2 and incorporation into fat reserves) is 
influenced by the decreased expression of H17, especially in the daf-2 mutant strain, 
e1370. However, the increase of glucose metabolism caused by H17 knockdown 
observed in daf-2 mutant is inhibited in the age-1 and akt-1 mutant strains.  
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The findings reported in this thesis suggest that the H17 glucose transporter may 
play an important role glucose metabolism in C. elegans and that this transport and 
metabolism is influenced by insulin receptor activity and serine kinase cascades.  
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Chapter 1 Introduction  
1.1  Regulation of lifespan 
Aging, or organismal senescence, is defined as gradual changes in an organism that 
“adversely affect its vitality and function, but most importantly, increase the mortality 
rate as a function of time” (Finch 1990). Viewed within the framework of evolutionary 
theory, natural selection does not influence post-reproductive animals, therefore, 
there is no selection for mechanisms to maintain an organism past reproductive age. 
Hence, the aging process can be regarded as the byproduct of such lack of 
maintenance (Golden and Melov 2007). Many theories have been proposed to 
explain the aging phenotype within this evolutionary context. Among these, two are 
the most influential, the “disposable soma” theory (Kirkwood 1977; Kirkwood and 
Holliday 1979) and the “antagonistic pleiotropy” theory (Williams 1957). The 
disposable soma theory proposes that the organism must allocate resources 
between maintenance of somatic tissues and reproduction, resulting in a trade-off 
between reproductive fitness and life span (Partridge, Gems et al. 2005; Golden and 
Melov 2007). While the antagonistic pleiotropy theory suggests that genes that are 
actively selected because they increase reproductive fitness may have detrimental 
effects later in life and contribute to aging (Golden and Melov 2007).  Consistent 
with the above theories, various types of damage have been proposed to accumulate 
with age, either because of an increased rate of production, or because of decreased 
repair or clearance of damage with time (Golden and Melov 2007). In humans, as a 
result, susceptibility to a wide variety of diseases increases with age, such as cancer, 
neuronal degeneration and type 2 diabetes. Therefore, understanding the 
mechanism of the regulation of lifespan will provide answers to the linkage between 
aging and age-related disease at a molecular level.  
Numerous theories of aging and parameters have been suggested to influence the 
- 16 - 
 
regulation of lifespan, including genetic instability, telomerase activity and oxidative 
stress. Recent findings in several model organisms suggest that three mechanisms 
(insulin-like signalling, calorie restriction, and mitochondrial respiration) share 
conserved roles not only in the regulation of lifespan, but also in the timing and 
control of diverse functions such as reproduction, stress resistance and metabolism 
(Katic and Kahn 2005; Kloting and Bluher 2005). This introduction mainly focuses on 
insulin-like signalling and calorie restriction dependent regulation of lifespan. 
1.1.1 Insulin/ IGF-1 signalling dependent regulation of aging 
The insulin/IGF-1 (insulin-like growth factor-1)-like signalling (IIS) pathway plays a 
very important role in the mechanisms governing the ingestion, distribution, 
metabolism, and storage of nutrients in organisms ranging from worms to humans. 
Mutations in IIS can affect growth, development, metabolic homoeostasis, fecundity 
and stress resistance, as well as lifespan (Porte, Baskin et al. 2005; Broughton and 
Partridge 2009). Although alterations in IIS can have severely detrimental effects, for 
instance diabetes in mammals, lowered IIS has been reported as an evolutionarily 
conserved means of extending lifespan in the nematode Caenorhabditis elegans, the 
fruit fly Drosophila melanogaster and the mouse Mus musculus (Klass 1983; 
Friedman and Johnson 1988; Clancy, Gems et al. 2001; Tatar, Kopelman et al. 2001; 
Holzenberger, Dupont et al. 2003).    
 IIS dependent regulation of aging in C. elegans 
The IIS pathway is the most well-studied aging pathway in the worm. Single-gene 
mutations were discovered to lead to great extension of the C. elegans lifespan 
(Friedman and Johnson 1988; Kenyon, Chang et al. 1993). The first two genes 
identified were the key component of the IIS pathway, daf-2 and age-1. DAF-2 
(Kimura, Tissenbaum et al. 1997) is the sole insulin/IGF-1 receptor in the worm, and 
AGE-1 (Morris, Tissenbaum et al. 1996) is a conserved phosphoinositide-3-kinase 
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(PI3K). Although the full picture of the IIS pathway in C. elegans is yet to be unveiled, 
in the past 15 years, many of the key components of the signalling network were 
identified and found to be highly conserved in higher eukaryotes, adding piece by 
piece of the IIS jigsaw puzzle of the worm.  
The life cycle of C. elegans comprises four larval stages (L1-L4), which are 
separated by moults (Figure 1.1). The embryonic development and hatching take 
about 1 day and the larva grows to a fertile adult in about 3 days. The adult worm can 
live on average 2-3 weeks when it is grown on a lawn of E. coli cells at 20-21°C. 
When encountering particular environmental stress, C. elegans larvae will enter a 
non-feeding, stress-resistant, dauer diapause larval stage to survive adverse 
conditions. After favourable environmental conditions arise, dauer larvae resume 
development and proceed to L4 larval stage and subsequently to adulthood. In the 
dauer state, worms can survive up to 6 months, which is much longer than the adult 
worm life span (2-3 weeks) (Braeckman, Houthoofd et al. 2001). 
 
 
 
 
 
Figure 1.1 The life cycle of C. elegans . Adapted from  (Braeckman, Houthoofd et  a l. 2001). 
After  embryonic developmen t  and ha tch ing, C. elegans  (the worms) exper ience a  ser ies of 
four  la rva l stages (L1-L4) before r each ing adulthood. When encounter ing par t icu la r  
environmenta l st ress, worms will en ter  the dauer  la rva l stage, which  a llows worms to 
survive adverse condit ions. After  favourable environmenta l condit ions a r ise, dauer  la rvae 
resume developm ent  and proceed to L4 la rva l stage and subsequent ly to adu lthood. In  the 
dauer  sta te, worms can  survive up to 6 months, which is much  longer  than  the adult  worm  
life span  (2-3 weeks) (Braeckman, Houthoofd et  a l. 2001). 
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The C. elegans genome encodes 38 insulin-like genes, several of which (INS-1, 
daf-28 and ins-7) can directly regulate the DAF-2 signalling and the function of the 
rest are unknown (Panowski and Dillin 2009) (Figure 1.2). Under normal conditions, 
in response to the taste and/or ingestion of food, one or more insulin-like ligands are 
secreted from neurosecretory cells in the worm central nervous system, activating 
DAF-2 and triggering the DAF-2 signalling (Porte, Baskin et al. 2005) (Figure 1.2). 
Active DAF-2 initiates a subsequent downstream cascade including the activation of 
AGE-1, production of second messenger phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) and the activation of the AKT family kinases (AKT-1,2 and SGK-1 (Paradis and 
Ruvkun 1998; Hertweck, Gobel et al. 2004)) through a PDK-1 kinase ortholog 
(Paradis, Ailion et al. 1999). The activated AKT family kinases subsequently 
phosphorylate the Forkhead Box O (FOXO) transcription factor, DAF-16 (orthologous 
to mammalian FOXO1, FOXO3a and FOXO4) (Henderson and Johnson 2001; Lee, 
Hench et al. 2001). The phosphorylated DAF-16 then binds with the 14-3-3 protein 
FTT-2 (Wang, Oh et al. 2006; Li, Tewari et al. 2007), which prevents the transcription 
factor from entering the nucleus and thus, stopping it promoting or repressing 
transcription of genes required for DAF-2 dependent functions (Lin, Dorman et al. 
1997; Ogg, Paradis et al. 1997). As a result, the worm will have a normal lifespan and 
normal reproduction rate. Inactivation of this pathway occurs in part via the activity of 
the PIP3 phosphatase, DAF-18 (Ogg, Paradis et al. 1997). The absence of the 
insulin-like ligands or inactivation of cascade components reduces the 
phosphorylation of DAF-16. This allows the non-phosphorylated transcription factor 
to enter the nucleus and promote longevity. The DAF-16 dependent DAF-2 signalling 
function not only alters the lifespan of the worm but also is involved in other 
processes, including the response to many stressors, such as oxidative damage, 
heavy metals and heat, as well as the dauer development (Wolff and Dillin 2006). 
Weak loss-of-function mutations in daf-2 lead to a dauer-constitutive phenotype 
(Daf-c) and allow the worms to enter dauer more readily (Gems, Sutton et al. 1998). 
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 IIS dependent regulation of aging in Drosophila 
Drosophila has endocrine tissues that resemble those of mammals. Three of the 
seven Drosophila insulin-like peptides (DILPs), DILP2, DILP3, and DILP5, are 
produced in large, specialized neurons of the central nervous system, the 
DILP-producing median neurosecretory cells (MNCs). The MNCs have been 
suggested to be functionally equivalent to pancreatic β-cells of mammals as 
producers of circulating insulin-like peptides for metabolic homoeostasis (Rulifson, 
Figure 1.2 The putative role of IIS pathway in the control of lifespan, reproduction in C. 
elegans. Adapted from (Por t e, Baskin  et  a l. 2005). In  response to the ta ste and/or  ingest ion  of 
food, secretory cells will produce one or  more insu lin -like ligands to act iva t e the insulin receptor  
or tholog, DAF-2. This in  tu rn will act iva te the insu lin -like signa lling pa thway. The act iva t ion  of 
DAF-2 will t r igger  in t racellu la r  signa lling via  the PI3-kinase or tholog AGE -1. This 
consequent ly inact iva tes th e forkh ead t ranscr ipt ion  factor , DAF-16, by phosphoryla t ion , which  
a llows normal growth , aging, reproduct ion , and fa t  storage. The cascade can  be in ter rupted by 
inadequa te nu t r ien t  availability, leading to reduced insu lin  signalling, act iva t ion  of DAF -16, 
and subsequent ly the worm en ters in to the dauer  phase of development  (Por te, Baskin  et  a l. 
2005). 
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Kim et al. 2002; Wang, Tulina et al. 2007). DILPs produced by the MNCs activate 
Drosophila insulin receptor (dINR), starting the IIS cascade. The dINR transduces 
the signal, either directly or through insulin receptor substrate (CHICO), to the 
PI3-kinase. The conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to PIP3 
leads to the activation of dPDK-1 and AKT kinase. The AKT kinase then 
phosphorylates dFOXO and prevents its nuclear translocation. Down-regulation of 
IIS by mutations in dINR or CHICO (or by over-expression of IIS antagonist dPTEN) 
results in increased nuclear localization of dFOXO which regulates transcription of 
genes that increase longevity and stress resistance (Toivonen and Partridge 2009). 
(Figure 1.3A) 
 IIS dependent regulation of aging in mammals  
The IIS regulation of aging in mammals is much more complicated. Unlike worms 
and flies which have only one insulin/IGF-1-like signalling pathway, mammals have 
separate insulin and IGF signalling pathways controlling blood glucose metabolism, 
growth, stress resistance, reproduction and aging. Although the number of ligands is 
reduced to three (these are insulin, IGF-1 and IGF-2), compared with 7 for the flies 
and 38 for the worms, there are multiple receptors (separate insulin and IGF-1 
receptors) with different ligand affinity and signalling output. Moreover, the 
mammalian IIS pathway is tightly linked with the actions of the growth hormone (GH) 
which has no counterpart in worms or flies (Bartke 2008). GH is the key regulator of 
IGF-1 biosynthesis and release and an important modulator of insulin actions in 
different organs (Bartke 2008). 
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Figure 1.3 Comparison of the insulin-like signalling in C. elegans, Drosophila, and mammals. 
(Adapted from (Por te, Baskin  et  a l. 2005; Broughton  and Par t r idge 2009)) The signa lling sta r t s with 
binding of insu lin -like pept ides to an  appropr ia te r eceptor . Mammals have th ree ligands to act iva te 
the signa lling pa thway (insulin , IGF -1 and IGF-2), whereas worms have 38 ligands and flies have 
seven  ligands iden t ified so fa r . On the cont ra ry, worms and flies have one receptor , whereas mice 
have th ree. In  worms and flies, the signa l can  be t ransduced to PI3K (or  AGE -1 in  worms) either  
direct ly or  indirect ly via  the on ly IRS. In  mice, the signa l is t ransduced indirect ly via  four  IRS 
(IRS1-IRS4). PI3K then  conver ts PIP
2
 in to the second messenger  PIP
3
. The phosph oryla t ion  can  be 
an tagonized by the PTEN phospha tase (DAF-18 in  worms). Eleva ted levels of PIP
3
 lead to the 
act iva t ion  of PKB and PDK. F lies have a  single PKB, whereas worms have AKT -1, AKT-2 and SGK-1 
and mice have Akt1, Akt2 and Akt3. The act iva ted PKB phosphoryla tes the forkhead t ranscr ipt ion  
factor  leading to it s exclusion  from the nucleus, and thus inact iva tes it . Worms and flies conta in  a  
single forkhead t ranscr ipt ion  factor , whereas mice con ta in  th ree. (Por t e, Baskin  et  a l. 2005; 
Broughton  and Par t r idge 2009). 
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The best-studied insulin-like signalling in mammals is the PI3-kinase pathway (Figure 
1.3C). The auto-phosphorylation of insulin receptor at several tyrosine residues upon 
binding with insulin results in the recruitment of the lipid kinase PI3-kinase to the 
plasma membrane of the cells. As the PI3-kinase becomes close to its physiological 
substrate PIP2, it phosphorylates the substrate to generate the second messenger 
PIP3. The binding of insulin to its receptor and the following events leads to a 
significant increase in the concentration of PIP3. This causes the binding of PIP3 to its 
key effector, AKT (also known as protein kinase B (PKB)), which subsequently 
causes the recruitment of AKT from cytosol to the plasma membrane. The 
recruitment of AKT makes it closer to another two enzymes that phosphorylate the 
protein and hence it is activated. The activated AKT will dissociate from plasma 
membrane and phosphorylate numerous substrates in both cytoplasm and nucleus, 
such as glycogen synthase kinase 3β (GSK3β) (hepatic glycogen synthesis) 
(Lizcano and Alessi 2002), AS160 (a rab GAP implicated in GLUT4 translocation) 
(Sakamoto and Holman 2008), the BAD·BCL2 heterodimer (antiapoptosis), and 
FOXO transcription factors (regulation of gene expression) (Taguchi and White 2008). 
AKT also phosphorylates tuberin (TSC2), which inhibits its GAP (GTPase Activating 
Protein) activity toward the small G protein RHEB. The inhibition causes the 
accumulation of the RHEB·GTP complex resulting in the activation of mammalian 
target of rapamycin (mTOR), which provides a direct link between insulin signalling 
and nutrient sensing (Watson and Pessin 2006).  
The evidence supporting the IIS regulation of lifespan in mammals is abundant but 
largely indirect. The first evidence suggesting a major increase in average and 
maximal lifespan in mutant mice with reduced plasma levels of IGF-1 and insulin was 
reported in 1996 (Brown-Borg, Borg et al. 1996). The Snell and Ames dwarf mice 
both have mutations that result in lack of GH and other pituitary hormones leading to 
similar phenotypes including small size and female sterility, and both phenotypes are 
consistently long-lived (Brown-Borg, Borg et al. 1996). Later, other mutant mice with 
defects in GH function were found to be long-lived (Bartke 2008). However, 
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identifying the specific role of insulin and separating it from the effects of reduced GH 
and IGF-1 signalling in these mutants is very difficult. Mice with severely reduced 
insulin or IGF-1 signalling have short lifespan owing to developmental and metabolic 
defects (Accili, Drago et al. 1996). However, heterozygous deletion of the IGF1 
receptor can extend the lifespan of female mice by up to 26% while no significant 
effect on male mice (Holzenberger, Dupont et al. 2003). In comparison of systemic 
deletion of the key components of the IIS pathway resulting in shortened lifespan, 
some tissue specific knockout mice were found to be long-lived. The fat-specific 
insulin receptor knockout (FIRKO) mice show 20% longer median and maximal 
lifespan than littermate controls (Bluher, Kahn et al. 2003). Mice with deletion of 
insulin receptor substrate-2 (IRS-2) only in the brain exhibit mild insulin resistance 
and show extended lifespan (Taguchi, Wartschow et al. 2007). Taken together, 
defining the role of IIS pathway in the control of mammalian aging is remaining a 
puzzle to be solved. 
1.1.2 Calorie restriction dependent regulation of lifespan 
The calorie restriction (CR) is usually defined as a dietary reduction in caloric intake 
(normally 20% ~ 40%) without compromising the maintenance of all essential 
nutrients (Piper and Bartke 2008). It is the most consistent non-pharmacological 
intervention increasing lifespan and protecting against the deterioration of biological 
functions. Since the first report of extending the lifespan in rats in 1935 (McCay, 
Crowell et al. 1989), evidence in multiple species (yeast, rotifers, spiders, worms, 
flies, fish, mice and rats) indicates that the effects of CR on lifespan extension are 
conserved all along the evolutionary scale (Koubova and Guarente 2003). 
Experiments with C. elegans and Drosophila show that CR extends their lifespan up 
to 50% or more (Clancy, Gems et al. 2002; Kenyon 2005). When subjected to CR, 
C57BL/6 or B6D2F1 mice postpone the accumulation of life-threatening tissue 
lesions and this extends the median and maximal lifespan by 35% (Forster, Morris et 
al. 2003). Studies on CR in Rhesus monkeys indicate that the CR monkeys are 
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protected from many age-associated pathophysiological changes, such as the 
development of insulin resistance and type 2 diabetes, atherosclerosis, and 
reductions in their basal metabolic rate, body temperature, oxidative damage and 
senescence of the immune system (Canto and Auwerx 2009).   
Although the evidence of CR extending lifespan has been well documented for ~70 
years the mechanism behind this remains largely unknown. The conventional 
mechanistic explanation of regulation of CR on lifespan was that reactive oxygen 
species produced during respiration would cause oxidative damage to DNA, RNA, 
protein, and lipids. And CR would decrease the load of reactive oxygen species, 
resulting in less damage and thus increased lifespan (Koubova and Guarente 2003). 
However, this theory was questioned by the findings of McCarter et al that, when 
normalized to body weight, metabolic rate was not slowed by calorie restriction 
(McCarter, Masoro et al. 1985).  
 
 
 
More recently the gene, silent information regulator 2 (Sir 2), has been implicated in 
the response to CR (Wood, Rogina et al. 2004).The family of proteins coded by the 
Sir2 gene function as histone deacetylases, removing the acetyl group from 
acetyllysine in histones, and require NAD+ as a cofactor, forming O-acetyl-ADP- 
Figure 1.4 The schematic diagram of SIR2 activity. SIR2 deacetyla tes the acetyllysine 
group on  h istone, with  NAD
+
 a s cofactor , forming the deacetyla ted h istone, n icot inamide 
and ADP-r ibose. Modified from (Wolf 2006) 
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ribose and nicotinamide (Figure 1.4) (Wolf 2006). The NAD+/NADH ratio is critical for 
the Sir2 activity, as NADH is an inhibitor of Sir2 (Lin, Ford et al. 2004). In yeast, CR 
increases oxidative metabolism, shifting the NAD+/NADH ratio in favour of NAD+ and 
at the expense of NADH, therefore, Sir2 is activated resulting in an increased 
lifespan (Lin, Ford et al. 2004). In Drosophila, CR increase Sir2 mRNA level. The 
lifespan increase resulted from overexpression of Sir2 was not further increased by 
CR (Rogina and Helfand 2004), while the activation of Sir2 by resveratrol could not 
increase the flies already subjected to CR, either (Wood, Rogina et al. 2004). 
Furthermore, neither CR nor resveratrol were able to extend lifespan in Sir2 ablated 
flies (Rogina and Helfand 2004).  
In C. elegans, however, the role of Sir2 ortholog, sir-2.1, in CR remains ambiguous. 
The effect of overexpression of sir-2.1 to induce extension of lifespan is dependent 
on daf-16, the master regulator of IIS in worms (Tissenbaum and Guarente 2001), 
while daf-16 is not required for the long lifespan of eat-2 mutant animals (a 
genetically modified mutant with slow pharynx pumping rate to mimic CR in worms) 
(Lakowski and Hekimi 1998). However, deletion of sir-2.1 suppresses the extended 
lifespan of eat-2 mutants but not daf-2 mutant (Wang and Tissenbaum 2006). 
Similarly in mammals, the effect of CR in extending lifespan is blunted in mice lacking 
the mammalian sir2 orthologue, SIRT1 (Boily, Seifert et al. 2008). Whereas the 
SIRT1 levels do not increase in all tissues in response to CR and it has been shown 
to be dispensable for proper adaptation to CR in liver (Chen, Bruno et al. 2008). 
1.1.3 Links between CR and IIS in the regulation of lifespan 
A possible explanation of CR increasing lifespan links it with the IIS pathway. Studies 
in rodents and humans show that CR consistently increases insulin sensitivity in the 
classic metabolic target tissues including liver, muscle, and adipose. As a result less 
insulin is needed to maintain glucose homeostasis leading to a dramatic decrease of 
circulating insulin concentrations. Therefore, all the tissues of the CR animal are 
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exposed to lower circulation insulin concentrations, which may lead to the increase of 
nuclear FOXO activity all over the body. In comparison, normal or excess nutrients 
increase the duration and concentration of circulating insulin. Thus, sustained 
activation of the insulin-like signalling cascades by high-calorie diet may expose 
animals to systemic stress due to reduced nuclear FOXO (Taguchi and White 2008).  
However, this theory is challenged by findings in C. elegans because CR can 
increase the worm lifespan independently of DAF-16 activity (Antebi 2007). PHA-4, a 
forkhead transcription factor with similarity to the mammalian FOXA orthologs, was 
reported to play a role in the extension of lifespan by CR in worms independently of 
the IIS pathway (Panowski, Wolff et al. 2007). PHA-4 expression is increased under 
conditions of CR and overexpression of PHA-4 can increase the lifespan of the 
worms in the absence of DAF-16 (Panowski, Wolff et al. 2007). Whereas, in 
mammalian cells the FOXA activity can be inhibited by insulin (Friedman and 
Kaestner 2006). 
On the other hand, work in both flies and worm suggests that IIS and CR share some 
of the mechanisms that can extend lifespan while different downstream effector 
mechanisms are involved (Taguchi and White 2008). As mentioned in 1.1.2, 
overexpression of sir2 leads to an increase in the lifespan in yeast, worms, and flies 
by mimicking the energy-depleted state (Longo and Kennedy 2006). However,  
sir2-induced lifespan extension is dependent upon daf-16, the master regulator of IIS 
(Tissenbaum and Guarente 2001); whereas, deletion of sir2 suppresses the 
extended lifespan of eat-2 mutants, but not daf-2 mutants (Wang and Tissenbaum 
2006). These evidences from the work in worms suggest that sir2 may work through 
two parallel pathways to bridge the interaction between the CR and IIS pathways for 
the regulation of longevity (Wolff and Dillin 2006).  
Studies in yeast, worms and flies also indicate the involvement of the TOR pathway 
in both CR and IIS regulated extension of lifespan (Wolff and Dillin 2006; Taguchi and 
White 2008). The TOR pathway is activated by nutrients and promotes protein 
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synthesis and growth (Wullschleger, Loewith et al. 2006). Mutations reducing TOR 
activity increase the lifespan of worms and flies (Giannakou and Partridge 2007). In 
mammalian cells, TOR inhibits signalling through the IRS protein and consequently 
inhibits the insulin signalling. Inhibition of TOR increases insulin sensitivity (Fisher 
and White 2004). In mammals, AMP-activated protein kinase (AMPK) is closely 
associated with IIS. It inhibits TOR activity and increases insulin sensitivity. The 
activator of AMPK, cellular AMP, increases during CR or energy depletion (Shaw, 
Lamia et al. 2005). In C. elegans, AMPK extends the lifespan of worm subjected to 
CR (Apfeld, O'Connor et al. 2004).         
 
 
 
 
 
Taken together, the failure to identify genetic components regulating CR that work 
independently of IIS suggests that IIS and CR increase lifespan via signalling 
Figure 1.5 Integrative view of the signalling pathways involved in regulating the aging process.  
Differen t  signa lling cascades in  the regula t ion  of lifespan  in  both  mammals and lower  an imals 
may act  in  a  ba lanced in terconnected n etwork ra ther  t han  in  an  independent  manner . For  
instance, CR is not  on ly sensed by SIR2 as a  change in  the NAD
+
/NADH ra t io bu t  a lso by AMPK 
as a  change in  the AMP/ATP ra t io. AMPK is involved in  the regula t ion  of mitochondr ia l 
respira t ion , which  in  tu rn  can  posit ively regula te SIRT2 act ivity. Both  AMPK and SIRT2 have 
effects on  the act ivity of FOXO t ranscr ipt ion  factors, which  have been  extensively linked to th e 
regu la t ion  of metabolism and longevity. In  addit ion , CR can  promote the downregu a lt ion  of 
insu lin -der ived signa ls, which  a lso in teract  with  FOXO t ranscr ipt ion  factors. (Adapted from 
(Canto and Auwerx 2009)) 
- 28 - 
 
mechanisms that are genetically regulated and autonomous of one another. Different 
signalling cascades in the regulation of lifespan in both mammals and lower animals 
may act in a balanced interconnected network rather than in an independent manner 
(Figure 1.5). 
1.2  Glucose homeostasis 
Glucose occupies a central position in the metabolism of plants, animals, and many 
microorganisms. It acts not only as an essential fuel to supply essential energy for 
living organisms, but also as a versatile precursor that provides a huge array of 
metabolic intermediates for biosynthetic reactions. In mammals, glucose 
homeostasis is maintained by the coordinated regulation of three processes. First, 
glucose absorption via the small intestine; second, glucose production in the liver; 
and third, consumption of glucose by nearly all tissues (Kahn 1992). These three 
processes are mainly regulated by two hormones: insulin and glucagon which are 
both secreted by islet cells within the pancreas in response to blood sugar levels.  
Insulin causes the glucose uptake from the blood by the cells in the liver, muscle and 
fat tissue and reduces the use of fat as an energy source. When insulin is low or 
absent, glucose uptake is stopped in the above cells and fat is used as an energy 
source (Chang, Chiang et al. 2004). On the contrary, glucagon, a 29-amino acid 
polypeptide, is synthesized and released by the alpha cells of the pancreas and acts 
as a counter-regulatory hormone of insulin. It can cause the liver to release stored 
glucose to raise the blood sugar level in response to insulin-induced hypoglycaemia 
(Jiang and Zhang 2003). 
The blood glucose level is tightly regulated and is limited and maintained in a very 
narrow range. Normally, in mammals the blood glucose level is maintained at the 
range between approx. 3.6 and 5.8 mmol/l. Abnormal blood glucose level can cause 
severe health problems. A lower blood glucose level than the normal status 
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(hypoglycaemia) can cause seizures, unconsciousness, and irreversible cell damage. 
On the other hand, a higher blood glucose level than the normal concentration 
(hyperglycaemia) has a adverse effect defined as “glucotoxicity”, which can lead to 
blindness, renal failure, cardiac and peripheral vascular disease, and neuropathy 
(Scheepers, Joost et al. 2004). Furthermore, excessive amounts of glucose over a 
prolonged period have negative effects on pancreatic-cell function, leading to the 
increased sensitivity to glucose, increased basal insulin release, reduced maximal 
secretory response, and a gradual depletion of insulin stores (Kaiser, Leibowitz et al. 
2003) 
Recent studies in C. elegans showed that increased glucose availability decreases 
lifespan while impaired glucose metabolism (resulting from exposure of the worms to 
2-deoxy-D-glucose (DOG) treatment) extends life expectancy by inducing 
mitochondrial respiration and increasing oxidative stress (Schulz, Zarse et al. 2007). 
A question that arises with this finding is: could this most important energy fuel and its 
catabolic pathway, glycolysis, be implicated in the aging process? A current 
explanation of the involvement of glucose in the aging process is that glucose can 
directly (through the glucose metabolism) or indirectly (by provoking insulin secretion 
from pancreatic β-cells) affect the main regulators of the aging process such as IIS 
pathway, sir2 and TOR signalling as well as increasing the oxidative stress (Kassi 
and Papavassiliou 2008).  
The first and limiting step of glucose metabolism is the transport of glucose across 
the plasma membrane. Hence, the key components of these transport systems may 
also play a role in the mechanisms of CR directed lifespan extension. In yeast, an 
increase in lifespan can be achieved by mutations that reduce the metabolism of 
glucose (such as deletion of hexokinase 2) (Lin, Defossez et al. 2000). However, in 
the long-lived klotho mouse which genetically lacks klotho gene (encoding a 
β-glucosidase-like protein) expression, an associated increased expression of 
glucose transporter 4 and increased insulin sensitivity have been demonstrated 
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(Utsugi, Ohno et al. 2000).  
1.3  The glucose transporter families 
Being a very important nutrient for many types of cells, not only in mammals and 
other higher organisms but also in microbes, glucose, in the polymeric form of 
cellulose, is probably the most abundant biological molecule on earth. In parallel with 
the widespread utilisation of glucose as nutrient source, a variety of mechanisms 
have evolved to catalyse the cellular uptake of the hydrophilic molecules across the 
hydrophobic core of the plasma membrane (Baldwin 1993). In eukaryotic cells, 
glucose is transported across the plasma membrane by membrane associated 
carrier proteins, glucose transporters. There are two different types of transporter 
proteins, which mediate the transfer of glucose and other sugars through the lipid 
bilayer, a Na+-coupled carrier system (SGLT) and the facilitative glucose transporters 
(GLUT) (Bell, Kayano et al. 1990; Carruthers 1990; Scheepers, Joost et al. 2004).  
1.3.1 The SGLT family 
The sodium dependent glucose transporter (SGLT) family comprises Na+-dependent 
glucose co-transporters (SGLT1 and SGLT2), the glucose sensor SGLT3, the widely 
distributed inositol and multivitamin transporters SGLT4 and SGLT6, and the thyroid 
iodide transporter SGLT5 (Scheepers, Joost et al.). SGLT1 and SGLT2 are also 
known as co-transporters or symporters. They are integral membrane proteins that 
mediate the transport of glucose and, with much lower affinity, galactose across the 
plasma membrane by an active transport mechanism (Wright 2001). The transport 
process is a co-transport of glucose molecules and sodium ions. Human SGLT3 
does not transport glucose when expressed in Xenopus laevis oocytes 
(Diez-Sampedro, Hirayama et al. 2003). It acts as a glucosensor by conveying 
information to the cell about external glucose concentration directly through the 
membrane potential or indirectly coupled through another molecule such as a G 
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protein (Scheepers, Joost et al. 2004) (Table 1.1). 
Table 1.1 Properties of Na+/glucose co-transporter family members (Zhao and Keating 2007) 
Protein 
Km
1
 
(mM) 
Major expression Tissue Function 
SGLT1 0.2 Kidney, intestine Glucose re-absorption in intestine and kidney 
SGLT2 10 Kidney Low affinity and high selectivity for glucose 
SGLT3 2 Small intestine, skeletal muscle Glucose activated Na
+ channel 
1 Net influx for 2-deoxyglucose or glucose. 
1.3.2 The GLUT family 
The facilitative glucose transporters (GLUTs) are also called passive carriers which 
are specific for the D-enantiomer of glucose and are not coupled to any 
energy-requiring components, such as ATP hydrolysis or an H+ gradient, and they 
can only transport their substrate down a concentration gradient (Gould and Holman 
1993). These passive transporters are most effective when the cell is exposed to a 
relatively constant level of the substrate. Therefore, the passive carriers are mainly 
restricted to multicellular organisms that regulate the composition of their internal 
medium (Carruthers 1990; Baldwin 1993; Mueckler 1994). The primary function of 
the facilitative glucose carriers is to mediate the exchange of glucose between the 
blood and the cytoplasm of the cell. This may involve a net uptake or output of 
glucose from the cell, depending on the type of cell in question, its metabolic state, 
and the metabolic state of the organism (Mueckler 1994). Thus, the glucose transport 
in these organisms is mediated by a family of highly related transporters which are 
the products of distinct genes and are expressed in a highly controlled tissue-specific 
fashion (Gould and Holman 1993). Moreover, these transporters are also different in 
their functional characteristics, such as the substrate specificity, the Km values, and 
their binding-affinities to the inhibitory ligands cytochalasin B and forskolin 
(Scheepers, Joost et al. 2004). The human genome contains 14 members of the 
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GLUT family (Figure 1.6). According to sequence similarities and characteristic 
elements, they are divided into three subfamilies (Table 1.2).  
 
 
 Class I facilitative transporters 
The class I facilitative transporters include the well characterized isoforms GLUT 1-4, 
plus the later identified isoform GLUT14. GLUT1 is the first identified protein in the 
mammalian glucose transporter family and is found to be responsible for the basic 
supply of cells with glucose (Baldwin, Baldwin et al. 1982; Mueckler, Caruso et al. 
1985). It is ubiquitously expressed while having the highest expression levels in 
erythrocytes and endothelial cells of the brain. GLUT2 (Fukumoto, Seino et al. 1988) 
is a low-affinity glucose transporter. It can also transport fructose (Wood and 
Trayhurn 2003) and, with higher affinity, glucosamine (Uldry, Ibberson et al. 2002).  
It is found to have predominant expression in pancreatic beta-cells, liver, kidney, and 
the basolateral surface of proximal renal tubules and enterocytes. In β-cells, GLUT2 
plays a role in the glucose-sensing mechanism, while in liver it allows for the 
Figure 1.6 Dendrogram of the family of human sugar transporter facilitators. The 
a lignment  was performed with  the CLUSTAL program. Numbers a t  the branches of the 
t ree indica te percen tage of iden t ity. Adapted from (Scheepers, J oost  et  a l. 2004). 
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bi-directional transport of glucose under hormonal control. It also forms part of the 
transcellular pathway for glucose and fructose transport (Wood and Trayhurn 2003). 
GLUT3 (Kayano, Fukumoto et al. 1988) is a high-affinity glucose transporter, which is 
expressed predominantly by neurons and other tissues with high glucose 
requirement (e.g. sperm, preimplantation embryo, and white blood cells ) (Simpson, 
Dwyer et al. 2008). The amino acid sequence of human GLUT14 shares 95% identity 
with GLUT3 (Wu and Freeze 2002) and it is exclusively expressed in testis; no 
ortholog of GLUT14 was found in mice (Scheepers, Joost et al. 2004).  
GLUT4 (Fukumoto, Kayano et al. 1989) is the only insulin responsive glucose 
transporter which transports glucose with high affinity. It is found to be expressed in 
major insulin-sensitive tissues (heart, skeletal muscle, adipose tissue) (Gould and 
Holman 1993). In response to insulin stimulation, GLUT4 translocates from 
intracellular GLUT4-containing vesicles to the plasma membrane, leading to an 
immediate 2-10 fold (depending on tissue) increase in glucose transport (Bryant, 
Govers et al. 2002). In addition to insulin stimulation, muscle contraction and hypoxia 
can also induce the translocation of GLUT4 in skeletal muscle (Lund, Holman et al. 
1995).  
 Class II facilitative transporters 
The fructose-specific transporter GLUT5 and 3 related proteins, GLUT7, GLUT9 and 
GLUT11 comprise the class II facilitative glucose transporters. Among the 7 
members of the GLUTs family that can transport fructose GLUT5 is the only fructose 
transporter with no ability to transport glucose and galactose, and is inhibitable by 
phloretin and cytochalasin B (Burant, Takeda et al. 1992). It is predominantly 
expressed in small intestine, testis, and kidney and is also found in fat, skeletal 
muscle, and brain with modest expression levels (Kayano, Burant et al. 1990; 
Douard and Ferraris 2008).  Being the closest family member of GLUT5, GLUT7 (Li, 
Manolescu et al. 2004) is a high affinity glucose and fructose transporter which is 
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primarily expressed in the apical membrane of the small intestine and colon. The 
mRNA of GLUT7 can also be detected in the testis and prostate (Cheeseman 2008). 
The highest expression level of GLUT9 (Phay, Hussain et al. 2000) is found in kidney 
and liver while expression in small intestine, placenta, lung, heart, skeletal muscle, 
and leukocytes is also detected (Doblado and Moley 2009). The mRNA of GLUT9 
has two alternative splice variants encoding two proteins which differ in the 
N-terminus (GLUT9a and GLUT9b). Although both forms of GLUT9 protein and 
mRNA are detected in the epithelia of the above tissues, in the polarized cells, 
GLUT9a was predominantly expressed on the basolateral surfaces while GLUT9b 
was expressed on apical surfaces (Augustin, Carayannopoulos et al. 2004). In 
addition to act as a high-affinity glucose and fructose transporter, GLUT9 is also a 
high-capacity uric acid transporter (Doblado and Moley 2009). The glucose transport 
of GLUT9 was not inhibited by cytochalasin B. The SLC2A11 gene of GLUT11 
generates 3 alternatively spliced isoforms that differ in the N-terminal sequence 
(Sasaki, Minoshima et al. 2001). GLUT11 is expressed predominantly in pancreas, 
kidney, and placenta and is also detected in heart and skeletal muscle with moderate 
expression level (Scheepers, Joost et al. 2004). GLUT11 is suggested to be a 
fructose transporter with low glucose affinity because its glucose transport activity 
can be inhibited by fructose (Doege, Bocianski et al. 2001).  
 Class III facilitative transporters 
The class III facilitative transporters (GLUT6, GLUT8, GLUT10, GLUT12 and HMIT), 
when comparing with the other two classes, are featured by the presence of the 
characteristic glycosylation motif on the larger extracellular loop 9, while having a 
shorter extracellular loop 1 (Joost and Thorens 2001). GLUT6 (Doege, Bocianski et 
al. 2000) is a low-affinity glucose transporter which is predominantly expressed in 
brain, spleen, and peripheral leukocytes. The high-affinity glucose transport activity 
of GLUT8 (Doege, Schurmann et al. 2000) is specifically inhibited by fructose and 
galactose, indicating that GLUT8 may be a multifunctional sugar transporter 
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(Scheepers, Joost et al. 2004). GLUT8 is predominantly expressed in testis, and 
lower expression level of GLUT8 is detected in most other tissues, including 
insulin-sensitive tissues like heart and skeletal muscle and adipocytes (Scheepers, 
Joost et al. 2004). The protein is also detected in preimplantation embryos, where it 
is reported to mediate insulin-stimulated glucose uptake (Carayannopoulos, Chi et al. 
2000). The subcellular localization of GLUT8 is found to be associated with 
endosomes and lysosomes but also with the endoplasmic reticulum membranes 
(Schmidt, Joost et al. 2009). GLUT8, as well as GLUT6, has a dileucine motif at the 
N-terminus that directs the protein to intracellular storage compartments when 
expressed in isolated adipocytes and COS-7 cells (Lisinski, Schurmann et al. 2001). 
GLUT10 (McVie-Wylie, Lamson et al. 2001) is predominantly expressed in the liver 
and pancreas. The SLC2A10 gene which codes for GLUT10 is localized on 
chromosome 20q13.1 which was previously linked to Type 2 diabetes. Recently, 
mutations in the SLC2A10 gene are also found to be related to the arterial tortuosity 
syndrome (Cheng, Kikuchi et al. 2009; Zaidi, Meyer et al. 2009). When expressed in 
Xenopus laevis oocytes, the glucose transport ability of GLUT12 (Macheda, Kelly et 
al. 2002) can be competitively inhibited by D-galactose and to a lesser extent by 
D-fructose (Rogers, Chandler et al. 2003). The protein is predominantly expressed in 
heart and prostate. In addition, GLUT12 seems to sustain the increased glucose 
consumption in prostate carcinoma (Chandler, Williams et al. 2003), breast cancer 
(Rogers, Docherty et al. 2003), and in the late diabetic nephropathy (Linden, DeHaan 
et al. 2006). The H+-coupled myo-inositol transporter (HMIT) (Uldry, Ibberson et al. 
2001) does not have any sugar transport activity but specifically transports 
myo-inositol and related stereoisomers. HMIT is predominantly expressed in the 
brain.   
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Table 1.2 Properties of glucose transporter family members1 
Protein 
Km
2 
(mM) 
Substrate 
Specificity 
Major expression Tissue Function 
GLUT1 5 Glucose/galactose Ubiquitous; red cells 
Basal glucose uptake, transport 
across blood tissue barriers 
GLUT4 5 Glucose Fat, muscle including heart 
Insulin-regulated transport in 
muscle and fat 
GLUT3 
(GLUT14) 
1 Glucose/galactose Neurons Neuronal transport 
GLUT2 11 
Glucose/galactose/ 
fructose 
Intestine, kidney, liver, 
beta-cell 
High-capacity low-affinity 
transport 
GLUT5 6 Fructose Intestine, kidney, sperm Transport of fructose 
GLUT7 0.3 
Glucose/fructose 
not galactose 
Intestine  Transport of fructose 
GLUT9 0.3 
Glucose/fructose 
not galactose 
Kidney, liver   
GLUT11 0.2 
Glucose/fructose 
not galactose 
Muscle, heart, fat, placenta, 
kidney, and pancreas 
Muscle-specific; fructose 
transporter 
GLUT6 
High 
Km 
Glucose  Brain and spleen  
GLUT8 
2.4 
(2DG) 
Glucose  
Testis, brain, fat, liver, and 
spleen 
Fuel supply of mature 
spermatozoa; insulin-responsive 
transport in blastocyst 
GLUT10 
0.3 
(2DG) 
Glucose/ galactose  
not fructose 
Liver and pancreas  
GLUT12 4-5 
Glucose, galactose, 
fructose 
Heart and prostate  
HMIT 0.1 Myoinositol Brain H
+/myo-inositol co-transpoter 
1 adapted from (Manolescu, Witkowska et al. 2007; Zhao and Keating 2007)   
2data collected when the proteins are expressed in Xenopus oocytes  
* blue background: Class I facilitate transporters; pink background: Class II facilitate transporters;  
  green background: Class III facilitate transporters. 
1.3.3 Glucose transport in other organisms 
The homologs of passive transporter family are found in Escherichia coli (E. coli), 
yeast, Drosophila and other insects (Baldwin 1993; Escher and 
Rasmuson-Lestander 1999; Kikawada, Saito et al. 2007). The H+-linked sugar 
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transporters in E. coli (D–galactose/H+ symporter (GalP), L–arabinose/H+ symporter 
(AraE) and the D–xylose/H+ symporter (XylE)) are found to be homologous to human 
GLUT1 (Baldwin 1993). However, xylose is the only substrate of XylE while AraE is 
more tolerant of variations in sugar substrate (Henderson and Maiden 1990) but 
does not transport D–glucose. GalP is able to transport both galactose and glucose 
and, like the mammalian transporter, is inhibited by forskolin (Baldwin 1993). 
Different from the mammalian glucose transport system, the glucose transporter of E. 
coli acts by a mechanism that couples translocation with phosphorylation of the 
substrate. It belongs to the family of structurally and functionally related transporters 
known as enzymes II of the bacterial phosphotransferase system (PTS) (Buhr, 
Daniels et al. 1992). In yeast, the glucose induction of its own transport is similar to 
the mammalian transport system. In both cases, glucose increases the number of 
glucose transporters in the plasma membrane. However, unlike the indirectly 
regulation of glucose transporter translocation by insulin, glucose increase the cell 
surface glucose transporter directly by increasing expression of the HXT (yeast 
hexose transporter) genes (Ozcan and Johnston 1999). However, the 
characterization of glucose transporters in C. elegans and Drosophila is largely 
unknown.    
1.4  Aims of the project 
Being an experimental model organism, C. elegans has great advantage in the 
studying of ageing and lifespan because of its small size (1mm in length), relatively 
short lifespan (~3 weeks), rapid reproduction rate, well-characterized genetics, its 
transparency and the known location and fate of its 959 cells. Moreover, the somatic 
cells of the adult animal are post-mitotic, making it an attractive model for studying 
the aging process of non-dividing cells. Besides, aging in C. elegans shares many 
characteristics with aging in humans, such as muscle atrophy, reduced skin elasticity 
and increased susceptibility to infection. In addition, the entire genome of C. elegans 
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has been sequenced. The inactivation of almost any gene can be accomplished 
through RNA interference (RNAi) by feeding the worm with bacteria, its laboratory 
food source, which are expressing double-stranded RNA of the gene of interest.  
Although aging research has strongly suggested that endocrine signalling has a key 
role in many of the pathways that alter the aging process in C. elegans, the biology of 
digestion and nutrient uptake in C. elegans remains largely unknown. The role of 
glucose transporters in C. elegans remains veiled. Identifying glucose transporters in 
the worm and studying of their function may lead to further understanding of the 
mechanisms of IIS and CR regulation of the lifespan. 
The work described in this thesis is aimed at identifying the glucose transporter(s) in 
C. elegans by cloning the putative glucose transporters from the C. elegans total 
cDNA and carrying functional characterization in in-vitro systems by heterologous 
expression in model cell systems. Further in-vivo study is also carried out to assess 
the role of identified glucose transporter in the IIS and CR regulated lifespan 
extending process. 
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Chapter 2 Materials and methods 
2.1. Materials 
2.1.1. Laboratory chemicals and materials 
Unless otherwise stated, all chemical reagents were purchased from Sigma or Fisher 
Scientific. All tissue culture medium and reagents were purchased from Cambrex or 
Gibco-Invitrogen. Plastic equipment for molecular biology was purchased from 
Eppendorf, Sterilin or Greiner Bio-One. Plastic equipment for tissue culture was 
purchased from Greiner Bio-One or Nunc.  
Table 2.1 Laboratory Reagents 
Reagents Resources 
Molecular biology grade agarose  Lonza 
DNA molecular weight markers Promega or Bioline 
SuperSignal West Dura Extended Duration Substrate Kit Thermo Fisher Scientific 
Monocomponent porcine insulin Calbiochem 
Bovine Serum Albumin Intergen Co. 
Protein Molecular markers Invitrogen 
Acrylamide stock (30% acrylamide, 0.8% bis-acrylamide) Flowgen 
d-[U-
14
C]Glucose (9.25 MBq, 250 µCi) Amersham 
 
2.1.2. Buffers  
The buffer compositions are stated in the context of their use. A compiled full 
description of the buffers is listed in appendix). 
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2.1.3. Molecular biology reagents 
General molecular biology reagents were purchased from Promega, Invitrogen or 
Novogen.  
1) Oligonucleotide primers 
DNA primers were synthesized by Sigma, MWG or Fisher Scientific. Primer 
sequences, where mentioned, are listed in the corresponding sections.  
2) Vectors and constructs 
Table 2.2 List of vectors and constructs 
Vectors Resources 
pT7Blue Novagen
®
 
pcDNA3.1 (+) Invitrogen 
pT7TS Gift from Dr. Adrian Wolstenholme  
L4440 Gift from Dr. Adrian Wolstenholme  
Constructs Resources 
pT7Blue-K09C4.1 Constructed by Anastasia Tsakmaki 
pCIS-HA-GLUT4 Gift from Dr. Samuel W. Cushman 
pUC19-GLUT1 Constructed by Edwards Lee 
L4440-unc22 Gift from Dr. Adrian Wolstenholme 
 
3) Restriction enzymes and ligase 
All restriction enzymes and ligase were purchased from Promega. Detailed 
restriction enzymes used, when mentioned, are listed in the corresponding sections. 
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2.1.4. Antibodies 
The source of antibodies and their appropriate dilutions for western blotting (section 
2.2.3) and immunochemistry (section 2.2.6) are shown in the table below. All 
antibodies were diluted in Phosphate buffered saline (PBS) (154 mM NaCl, 12.5 mM 
Na2HPO4, pH 7.2).  
Table 2.3 Sources and dilutions of antibodies used for Western Blot analysis and Immunochemistry 
 Antibody 
Polyclonal/Monoclonal  
Purified/Serum 
Source Dilution 
P
ri
m
a
ry
 
Sheep anti-GLUT4 
C-terminus 
Polyclonal 
Purified 
In House production 1:1000 
Mouse anti-HA.11 
(16B12) 
Monoclonal Covance 1:1000 
S
e
c
o
n
d
a
ry
 
Goat anti-sheep IgG 
HRP conjugate 
- Sigma 1:4000 
Goat anti-mouse IgG 
HRP conjugate 
- Sigma  1:4000 
Goat anti-mouse Alexa 
633- conjugated 
- 
Molecular Probes, 
Invitrogen 
1:1000 
 
2.1.5. Protein inhibitors 
Unless otherwise stated, protease inhibitors and the concentrations at which they 
were used are shown in table 2.4 below. 
Table 2.4 Protease inhibitors 
Inhibitor Inhibits Working 
concentration 
Protease 
inhibitor 
cocktail 
Antipain Ser and Cys proteases 1 μg/ml (1.65 μM) 
Aprotinin Ser proteases 1 μg/ml 
Pepstatin A Ser and Cys proteases 1 μg/ml (1.46 μM) 
Leupeptin Acid proteases 1 μg/ml (2.1 μM) 
AEBSF Ser proteases 100 μM 
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2.1.6. C. elegans strains 
A list of C. elegans strain used in this thesis is list in table 2.5 below.  
Table 2.5 List of C. elegans strains 
Strains Resources 
wild type N2  Gift from Dr. Adrian Wolstenholme 
CB1370 (daf-2) Purchased from CGC 
TJ1052 (age-1) Purchased from CGC 
GR1310 (akt-1) Purchased from CGC 
*CGC: Caenorhabditis Genetics Center  
2.1.7. Cell line 
The cell line used in the project was Chinese hamster ovary cells stably expressing 
insulin receptor (CHO-T cells). 
2.2. Methods  
2.2.1. C. elegans maintenance 
1) Preparation of bacterial food source and seeding of NGM petri plates 
A glycerol stock of E. coli OP50 (gift from Dr. Adrian Wolstenholme) was streaked on 
to the Luria Broth (LB) agar plate (1% [w/v] BactoTM Tryptone, 0.5% [w/v] BactoTM 
Yeast Extract, 0.5% NaCl, pH 7.5, 1.5% agar, autoclaved) using aseptic technique 
and incubated overnight at 37°C. On the next day, a single colony from the streak 
plate was inoculated aseptically in to 100 ml LB medium (1% [w/v] BactoTM Tryptone, 
0.5% [w/v] BactoTM Yeast Extract, 0.5% NaCl, pH 7.5, autoclaved). The inoculated 
culture was left to grow overnight at 37°C with 250 g shaking. The E. coli OP50 
solution was then stored at 4°C and ready for use in seeding.  
- 43 - 
 
When seeding, the appropriate amount of E. coli OP50 liquid culture (approximately 
50 μl to small or medium plates or 100 μl to large plates) was applied to Nematode 
Growth Medium (NGM) plates (composition and preparation see appendix 1).) using 
sterile technique. The bacteria lawn was allowed to grow overnight at room 
temperature (RT) or at 37°C for 8 h (the plates were cooled to RT before adding 
worms). 
2) Maintenance of C. elegans 
C. elegans was maintained on the NGM plates pre-seeded with E. coli OP50 bacteria 
as food source. The general stock of all C. elegans strains except for CB1370 was 
maintained at 20°C. CB1370 was maintained at 15°C. 
2.2.2. Molecular biology techniques 
1) Total RNA Extraction and First-strand cDNA synthesis 
C. elegans of mixed stages on a 9 cm NGM plate were washed 2 times with sterile 
M9 buffer (22 mM KH2PO4, 22 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4) and 
transferred into 50 ml Falcon tubes. The worm pellet was collected by spinning at 
1500 g for 5 min. The SV Total RNA Isolation System (Promega) was used for the 
total RNA extraction following the instructions in the technical manual supplied with 
the kit. The yield and quality of extracted RNA were determined using the Eppendorf® 
photometer.  
First-strand cDNA was synthesised using SuperScriptTM III First-Strand Synthesis for 
RT-PCR system (Invitrogen). The guideline provided with the kit was followed. 
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2) PCR amplification 
The target gene was amplified by Pfu Turbo DNA polymerase (Stratagene) with the 
corresponding forward primer and reverse primer in the presence of 1X cloned Pfu 
reaction buffer (2 mM MgCl2; Stratagene). The composition of each reaction is listed 
in Table 2.6 below. The final volume of each sample reaction is 50 μl.  
Table 2.6 Reaction mixture for a single PCR reaction 
Component Amount per reaction final concentration 
DNA template 2 μl or 50 ng
a
 - 
10 mM dNTP 1 μl 200 μM 
10 μM forward primer 1 μl or 1.25 μl
a 200 nM or 250 nMa 
10 μM reverse primer 1 μl or 1.25 μl
a
 200 nM or 250 nM
a
 
10X reaction buffer 5 μl 1X 
DNA polymerase 1 μl 2.5 U 
ddH2O Up to 50 μl - 
a When quick change site-directed mutagenesis is conducted, 50 ng of DNA template and 250 nM of the final 
concentration of primers were used. 
The appropriate PCR condition was adopted according to the experiment purpose 
(see Table 2.7 and Table 2.8). PCR amplification was performed using a PTC-100TM 
programmable thermal controller (MJ Research, Inc). 
Table 2.7 PCR cycling condition for general cloning  
Segment Number of cycles Temperature Duration 
1 1 95°C 2 min 
2 30 ~ 35 
95°C 30 sec 
Primer Tm - 5°C 30 sec 
72°C 
1 min for targets ≤ 1 kb 
1 min per kb for targets > 1 kb 
3 1 72°C 10min 
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Table 2.8 PCR cycling condition for quick change site-directed mutagenesis 
Segment Number of cycles Temperature Duration 
1 1 95°C 30 sec 
2 20 
95°C 1 min 
55°C 1 min 
72°C 1 min per kb 
 
3) Preparation of Competent XL-1 Blue Cells 
A glycerol stock of XL-1 Blue cells (Stratagene) was streaked onto the LB agar plate 
(1% [w/v] BactoTM Tryptone, 0.5% [w/v] BactoTM Yeast Extract, 0.5% NaCl, pH 7.5, 
1.5% agar, autoclaved) containing 12.5 μg/ml tetracycline and incubated overnight at 
37°C. On the next day, a single colony of XL-1 Blue was inoculated into 2.5 ml LB 
medium (1% [w/v] BactoTM Tryptone, 0.5% [w/v] BactoTM Yeast Extract, 0.5% NaCl, 
pH 7.5, autoclaved) containing 12.5 μg/ml tetracycline and incubated overnight at 
37°C with 250 g shaking. The entire overnight culture was inoculated into 250 ml LB 
medium (containing 20 mM MgSO4 and 12.5 μg/ml tetracycline) incubating at 37°C 
with 250 g shaking. The growth of the culture was monitored by taking OD readings. 
Incubation was stopped until the OD A600 of the culture reached 0.4~0.6. XL-1 Blue 
cells were then pelleted by centrifuging at 2000 g for 10 mins at 4°C. Supernatant 
was discarded and the pellets of the XL-1 Blue were suspended in 100 ml ice cold 
TFB1 buffer (100 mM RbCl, 50 mM MnCl2, 30 mM Potassium acetate, 10 mM CaCl2, 
15% glycerol [v/v], pH 5.8). The suspension was incubated at 4°C for 5 min. Cells 
were then pelleted at 2000 g for 10 min at 4°C. The supernatant was discarded. 
Pelleted cells were gently resuspended in 10 ml TFB2 (10 mM RbCl, 10 mM MOPS, 
75 mM CaCl2, 15% glycerol [v/v], pH 6.5) and incubate at 4°C for 15~60 mins. 100 μl 
of resuspended cells were then aliquoted into tubes on dry ice/isopropanol bath and 
stored at -80°C.   
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4) Transformation 
One aliquot of competent XL-1 Blue cells for each sample was thawed at 4°C for 5 
min. 10~100 pg of super-coiled DNA or 2 μl of ligation mixture (containing 100 ng of 
vector DNA) was added to the defrosted cells, mixed gently and then incubated at 
4°C for 5 min. The cells were heat-shocked at 42°C for 1 min and returned to 4°C 
immediately. The mixture was then added to 500 μl LB medium and incubated at 
37°C with 250 g shaking for 45 mins. The cells in LB medium were then scraped onto 
a LB agar plate containing the appropriate antibiotics. The plates were left to dry and 
then incubated overnight at 37°C. 
5) Colony PCR 
A single colony was picked by a fine yellow tip and suspended in 10.5 μl of dd H2O. 
The suspension was then heated at 95°C for 10 minutes. A PCR mixture was 
prepared on ice during the heating. GoTaq® Green Master Mix (Promega) was used 
for the colony PCR reaction. The PCR reaction mixture for each colony is listed in 
Table 2.9 below.  
Table 2.9 Reaction mixture for a single colony PCR reaction (25 μl reaction volume) 
Component Amount per reaction final concentration 
GoTaq
 ®
 Green Master Mix, 2X 12.5 μl  1X 
10 μM forward primer 1 μl  200 nM  
10 μM reverse primer 1 μl  200 nM  
Colony suspension 10.5 μl - 
 
PCR amplification was performed using a PTC-100TM programmable thermal 
controller (MJ Research, Inc). The colony PCR condition is listed in Table 2.10.  
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Table 2.10 PCR cycling condition for colony PCR  
Segment Number of cycles Temperature Duration 
1 1 95°C 2 min 
2 25 
95°C 30 sec 
Primer Tm - 5°C 30 sec 
72°C 
1 min for targets ≤ 1 kb 
1 min per kb for targets > 1 kb 
3 1 72°C 10min 
 
6) Plasmid DNA preparation 
One single E. coli colony was picked from LB agar plates with appropriate antibiotics, 
inoculated into 10 ml LB medium containing appropriate antibiotics and incubated 
overnight at 37°C with 250 g shaking. The overnight culture was pelleted at 2000 g 
for 5 mins. The DNA was prepared using the Wizard Plus SV Minipreps DNA 
purification system (Promega) Kit. The protocol provided with the kit was followed. 
7) Restriction digests 
Test digests were performed in a final volume of 7.5 μl and usually 1 μl of DNA was 
used. In cases that digested products were needed for further applications 2 μg of 
DNA were digested in final volume of 15 μl. The digest mixture was incubated at 
37°C for hours or overnight depending on the efficiency of the enzyme. 
Digest system: 10 × buffer 1.5 μl 
 10 × BSA 1.5 μl 
 Enzyme  1 μl 
 DNA 2 μg 
 double distilled H2O (dd H2O) up to 15 μl 
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8) Agarose gel electrophoresis  
Agarose solutions were prepared at a concentration appropriate for separating the at 
expected fragments in the DNA samples (Table 2.11) by melting the correct amount 
of powered agarose in certain volume of Tris-acetate EDTA (TAE) buffer (40 mM 
Tris-acetate, 1 mM EDTA, pH 8.5). The molten gel was cooled at RT to approx. 55°C. 
SYBR SafeTM DNA gel stain (Invitrogen) was added to the solution to a final 
concentration of 0.1% (v/v). The warm solution was then poured into a mold with 
appropriate comb for forming the sample slots in the gel. The gel was allowed to set 
completely at RT. The comb was then removed and the gel was mounted in the 
electrophoresis tank. TAE buffer was added to just cover the gel to a depth of approx. 
1mm. DNA samples was mixed with 0.2 volume of gel-loading buffers (30% [v/v] 
glycerol, 0.25% [w/v] bromophenol blue, 0.25% [w/v] xylene cyanol). 1kb DNA ladder 
(Promega) was used as DNA marker. DNA samples and markers were loaded into 
the slots. A voltage of 1 ~ 5 V/cm was applied to separate the DNA samples. When 
the dyes had migrated a sufficient distance through the gel, the gel was examined by 
UV transillumination and photographed.   
Table 2.11 Range of Separation in Different Amounts of Agarose 
Agarose Concentration in Gel  
(% [w/v]) 
Range of Separation of  
Linear DNA Molecules (kb) 
0.3 5-60 
0.6 1-20 
0.7 0.8-10 
0.9 0.5-7 
1.2 0.4-6 
1.5 0.2-3 
2.0 0.1-2 
 
 
 
- 49 - 
 
9) Gel band excision and purification 
The desired DNA fragments were quickly separated from the gel by using a razor 
blade to make an incision in the gel directly with illumination by UV light. Each 
excised gel band was then placed into a weighed 1.5 ml Eppendorff® tube. Then a 
DNA purification procedure was carried out using the Wizard® SV Gel and PCR 
Clean-Up System (Promega). After DNA purification, the concentration of the DNA 
solution was measured using the Eppendorf® photometer. 
10) Ligation 
A LigaFastTM Rapid ligation system (Promega) was used to ligate DNA fragments. 
The amount of vector and insert DNA needed in the ligation was calculated using the 
following formula: 
insertng
kbvector
kbinsert
vectorng 
1
2
)(
)(
100
 
A 10 μl system was used for the ligation reaction: plasmid   100 ng 
             insert DNA   X ng  
             2 × buffer   5 μl 
                T4 DNA ligase 1 μl 
            ddH2O   up to 15 μl  
The ligation reaction was carried out at RT for 5~10 min. A negative control was 
conducted every time in which the insert DNA was replaced by the same volume of 
ddH2O. 
11) Phosphorylation of double-stranded oligos 
In the presence of 1x Promega Buffer E, Plus and minus oligos were annealed in a 
100 μl system (10 μM of each primer, 6 mM Tris-HCl, 6 mM MgCl2, 100 mM NaCl, 
1mM Dithiothreitol (DTT)) by heated at 95°C for 5 min in water bath and left cool to 
RT in the water bath.  
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The annealed oligos were then added to the phosphorylation mixture listed below 
and incubated at 37°C for 1 h. After the phosphorylation, 0.5 μl 0.5 M EDTA was 
added to the mixture, and the T4 Polynecleotide Kinase (T4 PNK) (Promega) was 
heat inactivated at 68°C for 10 min. The phosphorylation mixture was then diluted to 
200 μl. 2 μl of the solution (100 nM phosphorylated oligos) was used in the ligation. 
Phosphorylation system: Annealed oligos 2 μl 
 10 mM ATP 1 μl 
 10 X T4 PNK buffer 0.5 μl 
 T4 PNK 1 μl 
 dd H2O up to 5 μl 
 
12) Dephosphorylation of the vector 
Linearized vector was gel-purified and freeze-dried to the appropriate concentration. 
1 μg of the purified vector was added to a 20 μl dephosphorylation mixture system 
containing Promega MULTI-CORETM Buffer (25 mM Tris-Acetate, pH 7.5 (at 37°C) 
100 mM potassium acetate, 10 mM magnesium acetate, 1 mM DTT) and 15 units of 
Thermosensitive Alkaline Phosphatase (TSAP) (Promega). The reaction mixture was 
incubated at 37°C for 15 min. The TSAP was then heat-inactivated at 74°C for 15 
min. 40 ng of the dephosphorylated vector was used in the ligation reaction.   
13) Sequencing 
All the DNA sequencing was carried out using the service provided by either MWG 
Biotech or GATC Biotech. 
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2.2.3. Protein biochemistry techniques 
1) Protein assay 
Total protein concentration of the cell lysate was estimated using the bicinchoninic 
acid (BCATM) Protein Assay Kit (PIERCE). The procedure in the manual was followed. 
Briefly, a standard curve of BSA using a 1 mg/ml BSA (in 0.1 M NaOH solution) was 
prepared by adding 20 μl of 1 – 10 μg BSA to the Microtitre plate (Sterilin) in duplicate. 
The appropriate amount of cell lysate was either diluted with 0.1 M NaOH or 
undiluted to make the total volume 20 μl. The BCA working reagent was prepared by 
mixing Reagent A (1% BCA-NO2, 2% Na2CO3·H2O, 0.16% Na2tartarate, 4% NaOH, 
0.95% NaHCO3) and Reagent B (4% [w/v] CuSO4·5H2O) at the ratio of 50:1. 200 μl 
working reagent was then added to each of the 20 μl cell lysate samples and the 
standards in Microtitre plate wells. The mixtures were incubated at 37°C for 30 min 
with lid in place and then allowed to cool to RT. The absorbance of the reaction 
solution was measured at 565 nm on a microplate spectrophotometer (Tecan).  
2) Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) 
A concentrated SDS sample buffer (187.5 mM Tris-HCl, pH 6.8, 300 mM DTT, 6% 
[w/v] SDS, 0.03% [w/v] bromophenol blue, 30% [v/v] glycerol) was prepared and 
stored at RT. 1 M DTT stock solution was prepared in small aliquotes and stored at 
–20°C. At the time of use, reducing agent DTT was added freshly. Protein samples 
were solubilized in sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% [w/v] SDS, 0.01% 
[w/v] bromophenol blue, 10% [v/v] glycerol) with 20 mM DTT added. The samples 
were then denatured at 95°C – 100°C for 5 - 10 min in a heating block.  
The Laemmli discontinuous buffer system was used for the electrophoresis. Slab 
gels were prepared using the mini-Protean 3 system (Bio-rad). All gels were made to 
a thickness of 1.5 mm. 10% resolving gels and 6% stacking gels were prepared 
using the buffer system listed in Table 2.12. Polymerisation was initiated by the 
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addition of N,N,N,N’-tetramethylethylenediamine (TEMED) and ammonium 
persulphate (APS), both to 0.05% (v/v) final concentration. Gels were run at a 
constant 200 V in electrophoresis running buffer (25 mM Tris-HCl, pH6.3, 0.1% [w/v] 
SDS, 0.2 M Glycine) for approximately 1 h until the bromophenol blue dye just ran off 
the bottom of the gel. Novex® Sharp Protein Standard (3.5 – 260 kDa) (Invitrogen) 
was used as marker (Figure 2.1 A). 
Table 2.12 SDS-PAGE gel solution composition 
A. 10% Running gel solution (for 15 ml) 
H2O 6.15 ml 
Resolving gel Buffer (1.5 M Tris-HCl, pH 8.9, 0.4 % [w/v] SDS) 3.8 ml 
Proto Gel® (30%[w/v] Acrylamide:0.8%[w/v] Bis-acrylamide 37.5:1)   5 ml 
10% APS 56 μl 
TEMED 12.6 μl 
B. 6% Stacking gel solution (4% Acrylamide) (for 20 ml) 
H2O 10.87 ml 
Stacking gel Buffer (0.5 M Tris-HCl, pH6.8, 0.4% [w/v] SDS) 5 ml 
Proto Gel® (30% [w/v] Acrylamide:0.8% [w/v] Bis-acrylamide 37.5:1) 3.99 ml 
10% APS 73.3 μl 
TEMED 16.8 Μl 
 
 
 
 
 
 
 
 
A. B. 
Figure 2.1 A. The molecular weights of the protein bands in the Novex® Sharp Proein Standard  
B. Transfer schematic diagram 
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3) Electrophoretic transfer to nitrocellulose membrane 
Proteins resolved in the SDS-gel were transferred onto nitrocellulose membrane 
using the Multiphor II Novablot electrophoretic transfer apparatus (Pharmacia) by the 
semi-dry transfer method. 18 pieces of 3mm Whatman filter paper and one piece of 
nitrocellulose were cut to the same size as the running gel and soaked in transfer 
buffer (48 mM Tris, 39 mM glycine, 0.0375% SDS [w/v], 20% [v/v] methanol, pH8.8 
without adjusting) for 10 min. The stacking gel was removed from the running gel. 
The running gel was immersed in transfer buffer for 10 min. Nine sheets of filter 
paper were placed onto the anode electrode of the transfer apparatus, then the 
nitrocellulose membrane, the gel, and the other nine sheets of filter paper on the top 
(Fig. 2.1 B). Air bubbles were removed by rolling a 15 ml falcon tube over the blot. 
The cathode was dampened with transfer buffer and was placed above the blot on 
the anode. The transfer process was run for 1 h and 50 min at a constant current of 
0.8 mA × the surface area of the gel in cm2. After transfer, the nitrocellulose 
membrane was washed with double-distilled water and stained with Ponceau dye 
solution (0.1% [w/v] Ponceau, 3% [w/v] trichloroacetic acid (TCA)) for 2-3 min. 
Excess stain was washed off with distilled water so that the protein bands could be 
visualized. Markers were marked with a pencil after the membrane was dried.  
4) Western blot analysis 
The nitrocellulose membrane was washed with Tris-buffered Saline (TBS) - Tween 
washing buffer (9% [w/v] NaCl, 100 mM Tris, 0.1% [v/v] tween-20) to be re-hydrated 
and to remove the Ponceau S stain. The membrane was then blocked in blocking 
buffer (5% [w/v] dried skimmed milk (Marvel), 1 × TBS, 0.1% [v/v] tween-20) with 
gentle rocking either at RT for 30-60 min or at 4°C overnight to block non-specific 
protein binding sites. Blocking buffer was discarded. The membrane was washed 
with TBS-Tween washing buffer for couple of times followed by incubation with the 
primary antibody, at the required dilution (section 2.1.4) in TBS-Tween buffer 
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containing 1% (w/v) BSA, for 2 h at RT or overnight at 4°C with gentle rocking. The 
membrane was then washed with washing buffer for several quick wash and four 
long wash for 15 min with shaking. After washing, the membrane was immersed into 
the secondary antibody, at required dilution (section 2.1.4) in blocking buffer for 45 
min to 2 h at RT with shaking. After the secondary binding, the membrane was 
washed with washing buffer by repeating the same wash after the primary binding.  
The membrane was developed using SuperSignal® West Dura Extended Duration 
Substrate (Pierce) or AmershamTM ECL Advance (GE Healthcare) following the 
manufacturer’s guideline. In brief the two reagents were mixed at a 1:1 ratio and the 
membrane was incubated the mixture for 5 min at RT. The chemiluminescent signals 
were detected with an EPI Chemi II darkroom imaging system (UVP). For 
experiments where protein bands were quantified by densitometry, multiple 
exposures of the blots were performed to ensure that the analysis was performed in 
the linear range of signal densities. 
2.2.4. Maintenance of CHO-T cells 
All the cell culture work was carried out in a class 2 Laminar flow cabinet, using 
aseptic techniques. CHO-T cells were maintained in Ham’s F-12 medium with 
L-glutamine with 10% (v/v) fetal bovine serum (FBS) and 450 μg/ml G-418 in 9 cm 
cell culture dishes. Unless otherwise stated, this medium composition was used 
throughout.  
Cells were passaged at 90% confluency. Spent medium was removed. Dead cells 
were washed off by rinsing the cells with PBS (OXOID) (half volume of the culture 
medium). The cell monolayer was detached by trypsinising with Trypsin EDTA. Cells 
were examined under the microscope to make sure that all of the cells were 
detached. Detached cells were then transferred into 20 ml of fresh medium and spun 
at 1000 g for 2 min at 18°C. The cell pellet was resuspended in 2 ml fresh medium. 
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One tenth of the cell suspension was then seeded into a new labelled dish with the 
addition of fresh medium. The cells in new dish were incubated at 37°C/5% CO2. 
Cells were observed under microscope to detect any changes in the cells or 
contamination everyday. Medium was changed every 48 h.  
2.2.5. Transfection of CHO-T cells 
CHO-T cells were passaged into 3.5 cm cell culture dishes one day before 
transfection to make sure that they could reach 60~70% confluency on the next day. 
Lipofectamins (Invitrogen) was used as transfection reagent. The ratio of transfection 
reagent to DNA was 8:1. On the day of transfection, solution A and solution B were 
prepared as follows: 
- Solution A : 1 μg DNA + 100 μl serum free Ham’s F-12 medium 
- Solution B: 8 μl lipofectamins + 92 μl serum free Ham’s F-12 medium 
The two solutions were thoroughly mixed and incubated at RT for 35 min. During the 
period, medium for CHO-T cells was replaced by serum free Ham’s F-12 medium for 
several times (approx. once/10 min). A and B solution mixtures were then mixed with 
800 μl serum free Ham’s F-12 medium and added onto the cells. Cells covered with 
DNA and lipofectamins mixture were then incubated at 37°C/5% CO2 for approx. 5 h. 
Afterwards, the transfection mixture was replaced by fresh Ham’s F-12 medium with 
L-glutamine with 10% (v/v) FBS and 450 μg/ml G-418. Cells were incubated at 37°C / 
5% CO2. 
2.2.6. Immunochemistry and confocal microscopy 
Cells seeded on cover slips one day prior to the experiment were washed with PBS 
and fixed with 4% paraformaldehyde (PFA) in PBS for 30 min at RT. Cells were 
washed with PBS three times. The fixed cells were incubated in blocking solution 
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(3% goat serum, 1% BSA in PBS, pH7.2) for 2 h at RT. The cells were then incubated 
in blocking solution in the presence of appropriately diluted primary antibody (Table 
2.3) overnight at 4C with shaking. On the next day, cells were washed 3 times (10 
min each time) with wash solution (1% BSA in PBS). Cells were then incubated in 
blocking solution with the appropriately diluted secondary antibody (Table 2.3). Cells 
were then washed with wash solution and mounted in Vector shield (Vector 
Laboratories). Fluorescent signals were detected using confocal laser scanning 
microscope Zeiss LSM510META (Zeiss) at the appropriate wavelength. Pictures 
were taken using a 63× oil immersion lens. 
2.2.7. Heterologous expression of the putative glucose transporters of the C. 
elegans in Xenopus oocytes  
1) Preparation of Xenopus oocytes 
Adult Xenopus laevis females (European Xenopus Resource Centre, Portsmouth) 
was anesthetized by immersion in 0.2% benzocaine in tap water for 15 min. Lobes of 
the ovary were surgically removed and rinsed with Ca2+ free OR-2 buffer (82.5 mM 
NaCl, 2.5 mM KCl, 1 mM NaHPO4, 1 mM MgCl2,
 5 mM HEPES, pH 7.5). The ovary 
lobes were then placed in sterile petri-dish and teased into small pieces (~ 0.5 cm in 
diameter). Teased ovary lobe pieces were washed 3 times with Ca2+ free OR-2 buffer. 
5 ml of the lobe pieces were transferred in a new sterile 50 ml conical tube. The 
oocytes were separated by adding 10 ml of collagenase type II (Sigma) (1.5 mg/ml, 
in Ca2+ free OR-2) to approximately equal volume of teased ovary pieces and 
incubating for 1.5 h with gentle agitation at 18°C. Oocytes were then washed 3 times 
with Ca2+ free OR-2 and once with complete ND96 buffer (96 mM NaCl, 2 mM KCl, 1 
mM MgCl2, 1.8 mM CaCl2,
 5 mM HEPES pH 7.5, 2.5 pyruvic acid, 1% FBS). Healthy 
stage V and VI oocytes were selected and maintained in complete ND96 with gentle 
agitation at 4°C for subsequent procedures.  
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2) Preparation of linearized DNA template 
Test digests were performed prior to the experiment to determine the complete 
digest time for each DNA template by agarose gel electrophoresis. The following 
work was carried out in an RNAase free environment. 10 μg of template DNA were 
linearized by the appropriate restriction enzyme in a 100 μl system at 37°C for the 
appropriate amount of time. The digest mixture was then purified using the Wizard® 
SV Gel and PCR Clean-Up System (Promega). The concentration of purified DNA 
solution was adjusted to 200 ng/μl by freeze-drying.  
3) In vitro cRNA transcription and purification of cRNA 
The linearized plasmids were transcribed using T7 RNA polymerase in the presence 
of cap analog (mMESSAGE mMACHINE; Ambion, Austin, TX) following the 
instructions in the manual. The transcribed RNA was purified by phenol:chloroform 
extraction and isopropanol precipitation. Briefly, the transcription reaction was 
stopped by adding 115 μl nuclease-free water and 15 μl Ammonium Acetate Stop 
Solution (provided by the kit). The complementary RNA (cRNA) was extracted with 
same volume of phenol/chloroform (5:1 [v:v], for molecular biology, Sigma). The 
aqueous phase was recovered to new nuclease-free tube and cRNA was then 
extracted with same volume of chloroform (for molecular biology, Sigma). The 
extracted cRNA in the aqueous phase was then precipitated with the same volume of 
isopropanol. The mixture was stored at -20°C overnight. On the next day, cRNA was 
pelleted by centrifuging at 14000 g, 4°C for 15 min. Supernatant was then removed 
carefully. The cRNA was resuspended in nuclease-free water. The amount of purified 
cRNA was determined using an eppendorf photometer and the concentration of the 
solution was adjusted to 1 μg/μl by adding the appropriate amount of nuclease-free 
water. The cRNA solution was stored frozen at -80°C for subsequent procedure. All 
the above work was carried out in an RNAase free environment. 
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4) Microinjection of Xenopus oocytes 
Capillary glass (Anachem) was pulled to micropipette on a P-30 vertical micropipette 
puller (Sutter instrument), using conditions of a high heat 990, pull force 580. The 
capillary was then filled with mineral oil (for molecular biology, Sigma) using a 1 ml 
syringe with 100 μl flat tip HPLC needle and attached to the injector. Excessive 
mineral oil was emptied. 2 μl of sample cRNA solution (1 μg/μl) or 2 μl of 
nuclease-free water was pipetted into the capillary for subsequent microinjection. 
Healthy stage V and VI Xenopus oocytes were selected for the microinjection 
procedure. 50 ng of cRNA or the same volume (50 nl) of diethyl pyrocarbonate 
(DEPC)-treated water (as blank control) was injected into the oocytes under 
dissection microscope using the Nanoject Auto-Nanoliter injector (Drummond 
scientific company). Oocytes were maintained at 18°C in complete ND96 with the 
medium changed every day. 72 h after injection, healthy oocytes were selected for 
subsequent experiments. 
2.2.8. Transport assays in the Xenopus oocytes 
1) Glucose transport assay 
Healthy Xenopus oocytes injected with appropriate cRNA or H2O were washed 3 
times with incomplete ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM 
CaCl2,
 5 mM HEPES, pH 7.5) and incubated in incomplete ND96 for 1h at 18°C. 
Oocytes were then transferred in groups of 5 to each well of a 12-well plate (Nunc) in 
triplicate. Glucose transport activity of the oocytes was determined by incubating 
groups of 5 oocytes in incomplete ND96 with or without the appropriate amount of 
D-glucose for 30 sec before the addition of U-[14C]-glucose (Amersham, GE 
Healthcare) (0.3 µCi per assay). The reaction was stopped after 60 min by rapidly 
washing the oocytes 3 times with ice-cold incomplete ND96 containing 300 μM 
phloretin. Each group of oocytes was solubilized in 500 μl solubilization buffer (1% 
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SDS [w/v]) for 3~4 h at RT. 450 μl of the lysate of each group was transferred into 
individual scintillation vial and used for determination of radioactivity in addition of 
scintillation liquid on a scintillation counter. 
2) Trehalose transport assay 
 Trehalose uptake 
Healthy Xenopus oocytes injected with appropriate cRNA or H2O were washed 3 
times with incomplete ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM 
CaCl2,
 5 mM HEPES, pH 7.5) and incubated in incomplete ND96 buffer for 1h at 
18°C. Oocytes were then transferred in groups of 60 oocytes to each well of 12-well 
plate. The trehalose uptake was then carried out by incubating the oocytes in 
incomplete ND96 buffer with or without 100 mM trehalose at RT for 3 h. After the 
incubation, each group of oocytes was transfer to 4 ml polypropylene tube and 
washed 3 times with ice cold ddH2O. The oocytes were then homogenized with 5 
strokes in a 2 ml homogenized (Thomas Scientific) and resuspended in 1 ml ddH2O. 
The suspension was centrifuged twice at 14,000 g for 10 min at 4°C. 800 μl of the 
supernatant was kept and stored at 4°C for subsequent procedure. 
 Trehalase treatment 
Citric acid stock buffer (1.35 M, pH 5.7 at 37°C) and Tris-HCl buffer (5 M, pH 7.5 at 
37°C) were prepared in advance and store at RT. Trehalase enzyme solution was 
prepared on ice just before use by diluting the appropriate amount of trehalase 
(Sigma) in ice cold 135 mM citric acid buffer. A positive control solution was prepared 
by adding 100 mM trehalose stock solution to 135 mM citric acid buffer to the final 
concentration of 4 mM. A pre-experiment was carried out to determine the maximum 
time for 0.01 unit of trehalase completely digesting the amount of trehalose in 400 μl 
positive control solution. 400 μl supernatant from trahalose uptake experiment was 
mixed with 50 μl citric acid stock buffer and incubated in 37°C water bath. The digest 
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was initiated by adding the trehalase enzyme solution (0.01 unit per assay) to the 
sample solution, whereas in the negative control samples the trehalase enzyme 
solution was replaced by the same volume of 135 mM citric acid solution (pH 5.7 at 
37°C). The mixture was incubated at 37°C for the time tested in the pre-experiment. 
The reaction was stopped by adding 25 μl of the Tris-HCl buffer (5 M, pH7.5 at 37°C). 
The mixture was then removed from the 37°C water bath and cooled to RT for 
subsequent glucose concentration analysis. 
 Glucse concentration analysis 
A Glucose (GO) Assay kit (Sigma) was used to determine the amount of glucose in 
the sample solution after the trehalase treatment (section 2.2.8 – 2). The instructions 
in the manual were followed. In brief, a standard curve of glucose using a 1 mg/ml 
glucose stock solution was prepared by adding 20 μl of 1 – 10 μg glucose solution (in 
135 mM citric acid) to the Microtitre plate (Sterilin) in duplicate. The assay reagent 
was prepared by dissolving the contents of the Glucose Oxidase/Peroxidase 
Reagent capsule in 39.2 ml ddH2O and then mixing with 800 μl o-Dianisidine 
Reagent. The assay reagent was stored in 2-8°C for one month. 150 μl of the sample 
solution was added to the Microtitre plate in triplicate. 200 μl of the assay reagent 
was mixed with sample solution and the mixture was then incubated at 37°C for 30 
min. The absorbance of the reaction solution was measured at 540 nm on a 
microplate spectrophotometer (Tecan). 
2.2.9. HA-antibody surface binding assay 
1) HA-antibody surface binding assay in Xenopus oocytes 
Healthy Xenopus oocytes injected with ddH2O or sample cRNA were selected 72 h 
after injection. The oocytes were washed with incomplete ND96 buffer (96 mM NaCl, 
2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2,
 5 mM HEPES, pH 7.5). Anti-HA mouse 
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monoclonal antibody was diluted in 1:1000 (1 μg/ml) in incomplete ND96 buffer with 
1% BSA. Groups of 6 oocytes were incubated in 100 μl primary antibody solution for 
2 h at RT with inverting. The oocytes were then washed with incomplete ND96 buffer 
with 1% BSA 3 times (10 min each time). The secondary antibody solution was 
prepared by diluting anti-mouse IgG β-Galactosidase conjugate (SouthernBoitech) at 
1:1000 (1 μg/ml) in incomplete ND96 buffer with 1% BSA. The oocytes were then 
incubated in secondary antibody solution for 1 h at RT. The oocytes were washed 
once with incomplete ND96 buffer with 1% BSA and 3 times with incomplete ND96 
buffer. Groups of two oocytes were transferred to each well of the 96 well black 
plates (Greiner) containing 100 μl of incomplete ND96 buffer. A working solution was 
prepared just before use by adding the 40 mM Fluorescein di-β-D- galactopyranoside 
(FDG) stock solution in dimethylsulfoxide (DMSO) to incomplete ND96 to the final 
concentration of 0.2 mM. The surface binding was initiated by adding 100 μl of the 
working solution to each well. The fluorescence (emission 512 nm/excitation 488 nm) 
was measured in bottom reading mode using a flouresecent microtiter plate reader 
(FLUOstar Galaxy; BMG labtechnologies).  
2) HA-antibody surface binding assay in primary rat adipocytes 
 Preparation of rat adipocytes 
Isolated rat adipocytes were prepared from the whole epididymal pads of male 
Wistar rats (180 – 200 g) as described (Taylor and Holman 1981; Simpson, Yver et al. 
1983; Quon, Zarnowski et al. 1993). The rats were stunned and the necks were 
dislocated. The epididymal fat tissue was quickly removed and kept in 37°C 
pre-warmed Krebs-Ringer HEPES (KRH) buffer (140 mM NaCl, 4.7 mM KCl, 2.5 mM 
CaCl2, 1.25 mM MgSO4, 0.2 mM NaH2PO4, 10 mM HEPES, 200 nM adenosine, pH 
7.4) with 1% (w/v) BSA added. The rinsed fat tissue was transferred in adipocyte 
digestion buffer (3.5% [w/v] BSA in KRH supplemented with 5 mM glucose and 500 
μg/ml Collagenase type 1 from Clostridium histolyticum) in a 23 ml polystyrene 
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flat-bottomed tube (Sarstedt), and minced finely with scissors. The minced tissue 
suspension was shaken rapidly in a shaking water bath at 37°C for approx. 20 – 25 
min until most of the tissue lumps were digested. The cell suspension was then 
filtered through a nylon mesh (250 μm mesh size, Lockertex), into a fresh 23 ml 
polystyrene flat-bottomed tube. The filtered cells were washed with KRH with 1% 
(w/v) BSA, and returned to 37°C water bath allowing the cells to float. The infranatant 
buffer was removed using a needle (2mm diameter X 100 mm) attached to a 20 ml 
plastic syringe. 15 – 20 ml KRH with 1% (w/v) BSA was added and the cells were 
gently resuspended and allowed to float. The above wash procedure was repeated 
twice. The cells were then washed twice with 37°C Dulbecco’s modified Eagle’s 
medium (DMEM) containing 25 mM glucose, 25 mM HEPES, 4 mM L-glutamine, 200 
nM adenosine, and 75 μg/ml gentamycin. The cell suspension was adjusted to a 
cytocrit of 40% (≈ 5-6 x 106 cells/ml) by using a capillary tube which was centrifuged 
at 1000 g for 1 min and expressed as the ratio of the length of the packed cell fraction 
in the tube to the total length of the suspension in the tube. The cells were then 
incubated at 37°C and ready for further use. 
 Transfection of the rat primary adipocytes by electroporation 
The electroporation procedure was performed as described previously (Quon, 
Zarnowski et al. 1993; Al-Hasani, Hinck et al. 1998). 200 μl of DMEM medium 
containing 200 nM adenosine was mixed with 100 μg of carrier DNA (sheared herring 
sperm DNA, Invitrogen) and the appropriate amount of expression plasmids as 
indicated. The total concentration of plasmid DNA in each cuvette was adjusted to 5 
μg/cuvette with empty pCIS2 vector. The mixture was added to a 0.4-cm gap-width 
cuvettes (Bio-rad). The isolated adipose cells incubated at 37°C were gently 
resuspended and 200 μl of the cells was added to the cuvette and gently mixed with 
the DNA mixture. The cuvette was quickly placed in the cuvette holder of the Gene 
Pluser Electroporator (Bio-rad) and slid into place such that the cuvette was in 
contact with the electrodes. The electroporation was carried out by applying one 
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pulse (12 ms, 400V) to the cells. 4 cuvettes of cells were pooled into a 15 ml conical 
tube. The cuvettes were washed once with 37°C DMEM medium containing 200 nM 
adenosine and the washed solution was also collected into the same conical tube. 
The cells were washed once with 37°C DMEM medium containing 200 nM 
adenosine and allowed to float. The infranatant was removed and the adipose cells 
were resuspended in 3 ml DMEM containing 3.5% BSA, 200 nM adenosine, and 75 
μg/ml gentamycin. The cells were then transferred to 3 cm petri dish and incubated 
at 37°C, 5% CO2 for 5 h.    
 Cell surface antibody binding assay 
The dishes containing transfected adipose cells were removed from the incubator. 
Half of the medium was removed by 17 g blunt needle attached to 5 ml syringe. The 
cells were gently swirled to mix and transferred to 4 ml tubes which were marked with 
1 ml and 2 ml on the side. The cells were washed twice with KRH buffer containing 
200 nM adenosine by filling the buffer to at least 2 ml, allowing cells to float up and 
removing the infranatant each time. The cell suspension was then filled to 1 ml with 
KRH buffer containing 200 nM adenosine and 20 μl of the suspension was saved for 
protein gel analysis. The remaining cells were washed twice by repeating the same 
washing procedure as described above. The cell suspension was then filled to 2 ml 
with KRH buffer containing 200 nM adenosine and 1% BSA. The cells were 
stimulated by 60 nM (1 X 104 microunits/ml) insulin for 20 min at 37°C. After the 
stimulation, the subcellular trafficking was stopped by the addition of 2 mM KCN 
(freshly made just before use) and incubation at 37°C for 3 min. The cells were 
allowed to float up and infranatant was removed. The cells were then washed twice 
with KRH buffer containing 200 nM adenosine, 5% BSA and 2 mM KCN and 
resuspended in 1 ml of the same buffer. The primary antibody binding was carried 
out by the addition of 1 μg/ml of primary antibody and incubation at RT for 1 h. The 
cells were mixed gently every 10 – 15 min during the binding. After the primary 
binding, the cells were allowed to float up and infranatant was removed. The cells 
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were then washed twice with KRH buffer containing 200 nM adenosine, 5% BSA and 
filled to 1 ml. The secondary antibody was added to the cell suspension to the final 
concentration of 1 μg/ml. The suspension was incubated at RT for 1 h. The cells 
were mixed gently every 10 – 15 min during the binding. The cells were then washed 
once with KRH buffer containing 200 nM adenosine, 5% BSA and 2 mM KCN and 3 
times with KRH buffer containing 200 nM adenosine and 2 mM KCN. The volume of 
the cell suspension was adjusted to 1 ml and 15 μl of the cells were saved for protein 
concentration assay.  
A working solution was prepared just before use by adding the 40 mM Fluorescein 
di-β-D- galactopyranoside (FDG) stock solution in dimethylsulfoxide (DMSO) to KRH 
buffer containing 2 mM KCN to the final concentration of 0.2 mM. 90 μl of KRH buffer 
was added to wells of the 96 well black plates (Greiner). 10 μl of the cell suspension 
was added to each well of the plate by ends cut tips. Each sample was analyzed in 
triplicate. The surface binding was initiated by adding 100 μl of the working solution 
to each well. The fluorescence (emission 512 nm/excitation 488 nm) was measured 
in bottom reading mode using a flouresecent microtiter plate reader (FLUOstar 
Galaxy; BMG labtechnologies). 
2.2.10. RNA-interference (RNAi) in C. elegans 
RNAi in the C. elegans was performed by feeding the worms with RNAi bacteria on 
agar plates following the methods described in Wormbook (Ahringer (ed.) 2006). 
NGM agar plates containing 50 μg/ml ampicillin and 1 mM isopropyl 
β-D-1-thiogalacto-pyranoside (IPTG) were prepared 4-7 days before seeding. RNAi 
bacterial stains were streaked on the LB plates containing 50 μg/ml ampicillin and 10 
μg/ml tetracycline and allowed to grow at 37°C overnight. Single colonies were 
inoculated into LB medium containing 50 μg/ml ampicillin. The culture was allowed to 
grow at 37°C, 250 g shaking for 8 h. The NGM plates were then seeded with the 
bacterial culture, allowed to dry and the expression of double stranded RNA (dsRNA) 
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was induced overnight at RT. 
Desired worm strains were grown on standard NGM plates seeded with OP50 
bacteria untill most of the hermaphrodites became gravid and the bacteria were just 
consumed. The standard bleaching/washing protocol to obtain embryo were carried 
out as described (Stiernagle 2006). Worms from 2 9 cm NGM plates were washed off 
the plates with sterile dH2O. The liquid was collected into a sterile 15 ml conical 
centrifuge tube. The tube was centrifuged 30 sec at 1000 g to pellet the gravid 
hermaphrodites, and the volume of the liquid was adjusted to 7 ml. The worms were 
bleached by the addition of 500 mM NaOH and 1% household bleach (5% solution of 
sodium hypochlorite). The worms were incubated in the bleaching solution for 10 min 
with vortexing every 2 min. The released eggs were pelleted by centrifugation in a 
table top centrifuge (Beckman) for 30 sec at 1300 g. The supernatant was removed 
to the volume of 0.3 ml. The pelleted eggs were washed twice with sterile dH2O and 
once with M9 buffer (22 mM KH2HPO4, 22 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4, 
1 mM CaCl2) by adding the washing solution to the volume of 6 ml, vortexing for a 
few sec and spinning for 30 sec at 1300 g. The embryos were incubated in M9 buffer 
to hatch overnight at RT with shaking at 250 g.  
The synchronized starved L1 larvae were pelleted by centrifuging at 800 g for 45 sec. 
Supernatant was removed to the appropriate volume allowing 100 μl of the L1 larvae 
suspension being transferred to the NGM plates seeded with RNAi bacteria. The 
worms were grown to the desired stage on the RNAi plates and transferred to new 
NGM plates seeded with RNAi bacteria before the RNAi food source was consumed.   
2.2.11. Quantitative realtime PCR (QPCR) 
Synchronized or asynchronous worms growing on the RNAi plates were washed off 
the plates with ice cold sterile M9 buffer and pelleted by centrifuging at 1000 g for 1 
min. The worm pellet was then washed once with ice cold sterile M9 buffer and twice 
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with ice cold DEPC treated ddH2O to completely remove the bacteria food source. 
Total RNA isolation was carried out as described in section 2.2.2-1). RNA 
quantification was assessed by UV-spectrophotometer (Eppendorf). cDNAs were 
synthesized with random hexamers using SuperScriptTM III First-Strand Synthesis for 
RT-PCR system (Invitrogen) according to the manufacturer’s protocol. The 
concentration of the cDNA was adjusted to 1 ng/μl with nuclease-free H2O. Real-time 
PCR was performed using iTaqTM SYBR® Green Supermix with ROX kit in 96-well 
unskirted PCR white plates (Bio-rad). Each sample was analyzed in triplicates. 
The QPCR primers are listed in Table 2.13A. The PCR mixture for each reaction was 
set up following the composition listed in Table 2.13B. The reaction was carried out in 
a real-time thermal cycler (Mx3000P QPCR system, Stratagene) using the cycling 
conditions listed in Table 2.13C. The data was analyzed using MxProTM QPCR 
Software supplied with the Mx3000P QPCR system. 
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Table 2.13 Primers, reaction system and cycling conditions for the QPCR 
A. Primers  
Primer Name Sequence  
H17qPCR1left GGCCAGCTACTCAGCCATC 
H17qPCR1right ATTTCGGAGACGAAGAACCA 
H17qPCR2left TGCTCCTTTTCGTCATCTCC 
H17qPCR2right TGGAGTTCGCGTTTCCAC 
B. Reaction system 
Component Amount per reaction (total 15 μl) 
cDNA 5 ng (5 μl) 
Forward Primer (15 pM stock) 0.5 μl 
Reverse Primer (15 pM stock) 0.5 μl 
2X SYBR
®
 Green Supermix 7.5 μl 
nuclease-free H2O 1.5μl 
C. Cycling conditions 
Segment Number of cycles Temperature Duration 
1 1 95°C 1 minutes 30 seconds 
2 20 
95°C 15 seconds 
55°C 30 seconds 
95°C 30 seconds 
  
2.2.12. Lifespan assay 
Lifespan assays were performed at 20°C. Young adult worms were allowed to lay 
eggs overnight on NGM plates seeded with either E. coli OP50 or RNAi bacteria. The 
progeny were allowed to grow on the corresponding plates until the L4 larvae stage 
at 18°C. The L4 larvae were then transferred onto NGM plates containing 50 μM 
5-fluoro-2′- deoxyuridine (FUDR) seeded with appropriated bacteria to prevent the 
growth of progeny and maintained at 20°C until all the worms on the plate died. For 
worms growing on the RNAi NGM plates, they were transferred to new plates before 
the bacteria food source was consumed. The adult population was scored every day 
or every other day. Animals that crawled off the plates or exploded were censored. 
Animals that failed to respond to a gentle prodding with a platinum wire were scored 
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as dead. Day 0 of lifespan was the day that the eggs were laid. Statistical analysis 
was performed with Kaplan-Meier method. The assays were repeated two times and 
similar results were observed in both experiments.  
2.2.13. Glucose uptake assay in C. elegans 
Synchronized worms were grown on NGM plates seeded with appropriate bacteria 
until L4 larvae. The worms were washed off the plates with M9 buffer and collected in 
a 15 ml centrifuge tube. The worms were pelleted by centrifugation at 800 g for 1 min 
and washed three times with M9 buffer to completely remove the bacteria. The 
worms were resuspended in 300 μl M9 buffer and transferred to new agarose plates 
containing 50 μg/ml ampicillin, 50 μM FUDR and without bacteria seeded. The 
worms were starved on the plate for 18 h at 18°C. The starved worms were then 
washed off the plates and pelleted by centrifuging. The worm pellets were 
resuspended in 350 μl of M9 buffer. 100 μl of the worm suspension was added to a 5 
ml bijou tube with 350 μl M9 buffer added. Each sample was analyzed in triplicates. 
The glucose uptake was initiated by the addition of D-glucose stock solution 
containing U-[14C]-D-glucose to the final concentration of 50 μM and 1 μCi per assay. 
The worms were incubated at 18°C for 1 h. The uptake was stopped by flash freezing 
the worm suspension in liquid nitrogen. The frozen worms were then thawed and 250 
μl of M9 buffer was added to the worm suspension. The mixture was sonicated on ice 
with a tip sonicator. The mixture was sonicated at amplitude of 27 microns for 5 times 
15 sec with intervals of 60 sec on ice. The suspension was then centrifuged at 
14,000 g at 4°C for 15 min. 450 μl of the supernatant was transferred to a 1.5 ml tube. 
50 μl of the supernatant was saved for protein assay. The fat content was extracted 
by the addition of 500 μl of heptane to the tube and votexing. The organic phase and 
aqueous phase were allowed to separate. 450 μl of the organic phase was then 
transferred to scintillation vials and mixed with 5 ml scintillation liquid (Fisher). The 
radioactivity was determined using a scintillation counter.   
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2.2.14. Glucose oxidation in C. elegans 
Uniformly labeled [14C]-D-glucose oxidation was 
determined as described (Schulz, Zarse et al. 2007) 
with some modification. Each sample was analyzed 
in triplicate. Synchronized starved worms were 
prepared as described in section 2.2.13. 100 μl of 
worm suspension was added to the bottom of a bijou 
tube containing 350 μl M9 buffer. A lid-removed 1.5 
ml tube containing 1 ml 0.1 M KOH was placed in the 
bijou tube to trap the produced CO2 as shown in 
Figure 2.2. The reaction was initiated by the addition 
of 50 μM D-glucose with 0.6 μCi/100 μl U-[14C]-D-glucose per assay. The lid of the 
bijou tube was then sealed with parafilm. The reaction was stopped by removing the 
1.5 ml tube from the bijou tube. The worm suspension was transferred to new 1.5 ml 
tube and flash frozen in liquid nitrogen. The suspension was then thawed and 
sonicated as described in section 2.2.13. 50 μl of the supernatant after centrifugation 
was saved for protein assay. 950 μl of the KOH solution was transferred to 
scintillation vials and mixed with 5 ml scintillation liquid. The radioactivity was 
determined using a scintillation counter.   
2.2.15. Data analysis 
Densitometric analysis of western blots was performed using Labwork version 4 
(UVP). Graphical analysis was performed using GraphPad PRISM version 5.0 
(Graphpad Software, Inc) and Microsoft office Excel (Microsoft). Statistical analysis 
was carried out using the PRISM programme with unpaired and paired two-tailed t 
tests as indicated in the figure legend. 
 
 
Figure 2.2 Schematic diagram of 
the CO2 trapping system. 
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Chapter 3 A search for putative glucose transporters in C. 
elegans and their subsequent cloning 
3.1  Introduction 
3.1.1 Structure of the GLUT family  
Although the substrate specificity and the affinity to the substrate differ in the GLUT 
family members (see section 1.3.2), analysis of the predicted amino acid sequences 
of the mammalian glucose transporters (GLUTs) shows that these members are 
highly homologous with one another and share similar protein structures. Orthologs 
found in other species including cyanobacteria (Zhang, Durand et al. 1989), E. coli 
(Maiden, Jones-Mortimer et al. 1988), Zymomonas mobilis (Barnell, Yi et al. 1990), 
yeast (Celenza, Marshall-Carlson et al. 1988; Szkutnicka, Tschopp et al. 1989), 
algae (Sauer and Tanner 1989), protozoa (Cairns, Collard et al. 1989; Bringaud and 
Baltz 1992) and plants (Sauer, Friedlander et al. 1990) were also found to possess 
high levels of sequence similarity with the mammalian GLUTs. 
Among the mammalian GLUTs that have been cloned, the structure of GLUT1 has 
been best characterized. Hydropathy analysis of the predicted amino acid sequence 
of GLUT1 indicated a protein containing 12 membrane-spanning α-helical domains 
with both the amino and carboxyl termini oriented intracellularly (Mueckler, Caruso et 
al. 1985). The 12 transmembrane helices combine to form a central aqueous pore or 
channel through which the substrate crosses the lipid bilayer (Hruz and Mueckler 
2001; Manolescu, Witkowska et al. 2007). This model was supported by a 
comprehensive series of studies using cysteine scanning mutagenesis with up to 8 of 
the 12 helices contributing to parts of the surface lining of the pore (Mueckler and 
Makepeace 2006) (Figure 3.1). The model was further supported by recent X-ray 
crystal structure analysis of two related bacterial proteins, the proton coupled lactose 
transporter LacY and the glycerol-3-phosphate transporter GlpT. The analysis 
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indicated a barrel structure in which two clusters of six transmembrane helices 
surrounded the aqueous pore in the centre (Abramson, Smirnova et al. 2003; Huang, 
Lemieux et al. 2003). Computer analysis of the structure of GLUT1, using the 
coordinates for GlpT, generated a very similar model (Salas-Burgos, Iserovich et al. 
2004). Large loops between helices 1 and 2 and between helices 6 and 7 were also 
predicted (Hruz and Mueckler 2001). The large loop between helices 6 and 7 divides 
the structure into two halves, the N-terminal domain and the C-terminal domain 
(Gould and Holman 1993). The cytoplasmic orientation of the carboxyl terminus and 
large sequence connecting transmembrane segments 6 and 7 has been confirmed 
by proteolytic cleavage and immunological epitope mapping experiments (Hruz and 
Mueckler 2001). In addition, a single extracellular N-linked glycosylation site was 
also predicted to be located between transmembrane helices 1 and 2. Sequence 
alignment and analysis of other GLUT isoforms showed a similar size of these 
proteins (~500 amino acid), and characterized by a topology identical to that 
proposed for GLUT1, including the conservation of the N-linked glycosylation site 
(Baldwin 1993; Gould and Holman 1993; Olson and Pessin 1996). 
 
Figure 3.1 The characteristic structure of the GLUTs family. The st ructure of the GLUTs 
family is character ized by twelve t ransmembrane regions, cytoplasmic N - and C- terminus 
and la rge loop between  helices 6 and 7, and N -linked glycosyla t ion  site on  the first  la rge 
exofacia l loop (Gould and Holman 1993). 
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Despite the overall similarity in the structural organization, there is a considerable 
divergence in the specific amino acid sequences through out the GLUTs family. For 
example, only 38% of all the amino acids are conserved between the GLUT1-4 
isoforms (Olson and Pessin 1996). However, the greatest degree of amino acid 
sequence identity was found in the transmembrane domains whereas the most 
divergence was found in the large cytoplasmic loop between helices 6 and 7 and in 
the N- and C- terminus of these proteins (Baldwin 1993; Olson and Pessin 1996). 
According to the sequence alignment, several motifs were found to be conserved in 
the glucose transporters including GRR/K between helices 2 and 3 in the N-terminal 
half and correspondingly between helices 7 and 8 in the C-terminal half, and 
EXXXXXXR between helices 4 and 5 in the N-terminal half and correspondingly 
between helices 10 and 11 in the C-terminal half (Baldwin 1993; Gould and Holman 
1993). Other characteristic glucose transporter motifs include PMY in helix 4, 
PESPRY/FLL in loop 6, GPGPIP/TW in helix 10, and VPETKG in the C-terminal tail 
(Zhao and Keating 2007). Moreover, the motif QQXSG- NXXXYY in helix 7 is also 
found to be present in all the mammalian transporters and is highly conserved in all 
members of the wider glucose transporter superfamily (Figure 3.2) (Baldwin 1993; 
Gould and Holman 1993; Manolescu, Witkowska et al. 2007). Molecular modelling 
and mutational experiments suggest that the highly conserved residues in helical 
regions line on the faces of the helices that are directed to the centre of the protein 
and away from the membrane lipid and may be involved in the ligand recognition 
(Gould and Holman 1993; Manolescu, Witkowska et al. 2007).    
 Figure 3.2 The conserved motifs of the GLUTs family. The conserved motifs of the GLUTs superfamily 
include GRR/K between helices 2 and 3 in the N-terminal half and correspondingly between helices 7 and 8 
in the C-terminal half, EXXXXXXR between helices 4 and 5 in the N-terminal half and correspondingly 
between helices 10 and 11 in the C-terminal half, PMY in helix 4, PESPRY/FLL in loop 6, 
QQXSG-NXXYY in helix 7, GPGPIP/TW in helices 10, and VPETKG in the C-terminal tail (Gould and 
Holman 1993; Zhao and Keating 2007). 
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3.1.2 Research objectives and experimental approach 
The fully sequenced C. elegans genome and highly conserved motifs and structures 
in the glucose transporter superfamily provide the possibility of analyzing the 
sequence of the putative C. elegans glucose transporters and further cloning and 
functional study of proteins of interest. Therefore, the aims of this chapter are: 1) to 
analyze the sequence of the predicted worm sugar transporters listed in Wormbase 
(http://www.wormbase.org/) to determine the possible worm glucose transporter 
proteins; 2) to clone the putative worm glucose transporters into pT7Blue vector 
allowing subsequent gene manipulation; 3) to introduce the human influenza 
hemagglutinin (HA) epitope tag sequence into the predicted first exofacial loop by 
site-directed mutagenesis for antibody detection of the target proteins; 4) to clone the 
target proteins into pT7-TS vector for heterologous expression of the proteins in 
Xenopus oocytes (Figure 3.3).   
 
Figure 3.3 The schematic diagram of the cloning procedure for the genes of interest. After  
amplifica t ion  from the cDNA libra ry the ta rget  gene would be liga ted in to pT7Blue vector  for  
subsequent  gene manipula t ion . HA-tag would be inser ted in to the first  exofacia l loop of the 
pu ta t ive prot eins. Both  the tagged and non -tagged version  of prot ein  would be clon ed in to 
pT7TS vector  for  heterologou s expression  of the prot eins in  Xenopus  oocytes. 
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3.2  Results 
3.2.1 Searching for candidate glucose transporters in C. elegans 
Putative glucose transporters were first searched in NCBI protein database 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed) with 156 results (protein 
sequences were predicted from cDNA sequences). These putative proteins were 
then cross-compared with the motif report list of the major facilitator superfamily 
(PFAM:PF07690) (189 proteins) and the motif report list of the sugar transporter 
(PFAM:PF00083) (65 proteins). The “best BLAST hits from selected species” listed in 
the protein description in Wormbase for each protein was considered. The RNAi 
phenotype in the function section of the gene summary in Wormbase for each protein 
was also taken into consideration. The putative proteins which had mammalian 
GLUTs orthologs and/or had the metabolic- and/or lifespan-related RNAi phenotypes 
were then subjected to the alignment with mammalian GLUT1 and GLUT4. T-coffee 
(http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffeecgi/index.cgi?stage1=1&daction=TCO
FFEE::Advanced) was used for the alignment of protein sequences (Notredame, 
Higgins et al. 2000; Moretti, Armougom et al. 2007).  
In mammals, GLUT4 is the major insulin responsive glucose transporter. It can 
increase glucose uptake in mammals by translocating from intracellular storage 
vesicles to the plasma membrane via the PI3-kinase and PKB pathway (Holman and 
Sandoval 2001). The insulin signaling pathway is also well conserved in the worm 
(see section 1.1.1). It was considered interesting to determine whether there was 
similar insulin responsive glucose transporter translocation system in worms. Worm 
gene K09C4.1 (K09) encodes a putative 521-amino-acid protein which is predicted 
to be the ortholog of human GLUT4 (BLAST E value: 4e-21). The gene was cloned 
from worm total cDNA library into pT7Blue vector by a previous MRes student 
Anastasia Tsakmaki and Dr. Scott Lawrence, and this construct was used for 
subsequent cloning.  
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Worm gene H17B01.1 (H17) has two transcripts, H17B01.1a (H17a, 492 aa) and 
H17B01.1b (H17b, 510 aa). There are about 21-amino-acid difference in the 
N-terminus between the two transcripts (Figure 3.4A). Both of the two putative 
proteins were predicted to be orthologs of human GLUT3 (Blast e-value: 1e-97, 43% 
identity). Worm gene R09B5.11 (R09) encodes a putative membrane protein which is 
predicted to be the ortholog of human GLUT1 (Blast e-value: 5.3e-90, 36% identity). 
Although there is no obvious metabolic or life-span related RNAi phenotype for H17 
and R09, the protein sequence alignments with human GLUT1 and GLUT4 of the 
two proteins showed very high similarity and the characteristic glucose transporter 
motifs were all found to be present in the two putative proteins (Figure 3.4B).   
 
 
 
Both of the worm genes F14E5.1 (F14) and K09C4.5 (K4.5) were found to have the 
RNAi phenotype of fat content increased. F14 encodes a 472 aa protein and K4.5 
encodes a 515 aa protein, both of which are predicted to be orthologs of human 
GLUT14. The proteins encoded by worm genes C35A11.4 (C35), Y39E4B.5 (Y39), 
and F48E5.2 (F48) are predicted to be the orthologs of human GLUT3, GLUT9 and 
Figure 3.4 A. Difference between the two transcripts of H17B01.1 in protein sequence. There a re 
18 amino acids more in  the N-terminus of H17b than in  H17a . B. Sequence alignment of 
H17B01.1 and R09b5.11 with human GLUT1 and GLUT4. The character ist ic mot ifs descr ibed in  
sect ion  3.1.1 were h igh ly con served in  the two worm puta t ive prot eins.  
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GLUT1 respectively. The ortholog of yeast glucose transporter encoded by worm 
gene T08B1.1 (T08) was also selected because of the slow growth RNAi phenotype. 
The membrane topology of the selected proteins was predicted using three different 
protein topology prediction tools, including SOSUI (Hirokawa, Boon-Chieng et al. 
1998), Predictprotein (Rost, Yachdav et al. 2004), and HMMTOP (Tusnady and 
Simon 1998) (Figure 3.5). All the putative proteins were predicted to have similar 
membrane topology with the GLUTs family which was characterized by the 10 ~ 12 
transmembrane regions with cytoplasmic N- and C- terminus, large exofacial loop 
between helices 1 and 2 and large cytoplasmic loop between helices 6 and 7 (Gould 
and Holman 1993; Olson and Pessin 1996).    
 
 
 
 
 
To sum up, nine worm genes were selected for subsequent cloning according to the 
sequence alignment and/or metabolic- or life-span- related RNAi phenotyes (Table 
3.1) (See appendix 2) for the complete sequence alignments with human GLUT1 and 
GLUT4). The membrane topology prediction of each protein provided the possibility 
of inserting HA epitope tag into the first exofacial loop of the target proteins for 
antibody detection of the proteins. 
Figure 3.5 Predicted membrane topology of H17B01.1a as determined using SOSUI. Despite 
of minor  difference in  the posit ions of the helices, the selected pu ta t ive glucose t ranspor t ers 
were a ll predicted to have the character ist ic 10 ~ 12 t ransmembrane regions by the protein  
membrane topology predict ion  tools. 
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Table 3.1 Selected putative glucose transporters 
Putative GT* 
(Gene Name) 
Amino 
acids 
Human 
ortholog 
Identity to 
ortholog 
RNAi Phenotype 
H17B01.1 
A: 492 aa 
B: 510 aa 
GLUT3 43%  
R09B5.11 516 aa GLUT1 36%  
C35A11.4 515 aa GLUT3 29% Larval lethal, embryonic lethal 
F14E5.1 472 aa GLUT14 27% Fat content increase 
Y39E4B.5 505 aa GLUT9 24% Larval rest 
F48E5.2 488 aa GLUT1 23% Embryonic lethal 
K09C4.5 524 aa GLUT14 22% Fat content increase 
K09C4.1 521 aa GLUT4 20%  
T08B1.1 591 aa 
Yeast glucose 
transporter 
23% 
Larval arrest, embryonic lethal, 
reduced brood size 
*GT: glucose transporter 
3.2.2 Cloning of the putative glucose transporters from C. elegans total cDNA 
library 
A C. elegans cDNA library was first synthesized using total RNA extraction from 
worms of all stages. The sequence information of the target genes was obtained from 
WormBase. The target genes were amplified from the cDNA library using primers 
which were designed according to the predicted spliced form of the gene sequences 
(Figure 3.6). The primers were designed to bind several bases upstream of the start 
codon and downstream of the stop codon. A full list of primers used in the cloning of 
interest genes from the cDNA library is specified in Table 3.2.  
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Table 3.2 List of Primers used for cloning the putative glucose transporter genes from cDNA library 
Gene 
Name 
Gene Size 
Primer 
Name 
Primer Sequence 
H17B01.1 
a: 1479 bp 
H17aFOR AAATGGGTGTCAACGACC 
H17aREV GCATTACTTCCTCTTCTCG 
b: 1533 bp 
H17bFOR ATGTCGGAAAAATCAAGAAGTG 
H17bREV TTACTTCCTCTTCTCGAATTCG 
H17int GGCCACTGATCTTTGCC 
R09B5.11 1551 bp 
R09FOR ATGAACGCC GTTGTTGCC 
R09REV CCGACTATGAACATATCCG 
R09intFOR GGTGCCAA TGTTTCTTACCG 
R09intREV CGGTAAGAAACATTGGCACC 
C35A11.4 1548 bp 
C35FOR ATGGTGGAAGCACCCAGTTTTCGG 
C35REV CTAGAGTCGATAAGATAAGG 
C35intFOR CTGTGAGATTGATGAAGCC 
C35intREV GGCTTCATCAATCTCACAG 
F14E5.1 1419 bp 
F14FOR ATGTCAAATAGATTGTGGCC 
F14REV TCATTTTTTTTTAAGTTCATTC 
F14intFOR GGAGATGGTACAGATGC 
F14intREV GCATCTGTACCATCTCC 
Y39E4B.5 1518 bp 
Y39FOR ATGCGGTGGCAAACGATTCG 
Y39REV TTAGTAAATTCGAAGATGTCC 
Y39intFOR CATGAGCGAATATCAAGCC 
Y39intREV GGCTTGATATTCGCTCATG 
F48E5.2 1467 bp 
F48FOR CCAGTGACAACATGCAAAAACTCAATTGG 
F48REV GGCTGTCATTATAATTTATTCATTCC 
F48intFOR CGTCGTGGGTTTTTGTTGGG 
F48intREV CCCAACAAAAACCCACGACG 
K09C4.5 1575 bp 
K4.5FOR CCATTAGCAATCATGTTATTCAATGCGCC 
K4.5REV GGCAATGAAGCAAGCAAACATCGCAGG 
K4.5intFOR GGAGAAGAATTTGACACAGG 
K4.5intREV CCTGTGTCAAATTCTTCTCC 
T08B1.1 1776 bp 
T08FOR ATGTCAGAATTTGAAGAAG 
T08REV CAGTCTTCCTTCACATTTGG 
T08intFOR CGTCCTGACCTACGCTATGG 
T08intREV CCATAGCGTAGGTCAGGACG 
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Figure 3.6 Amplification of the putative glucose transporter genes from worm total cDNA 
library. The genes of in terest  were amplified from the tota l cDNA libra ry of worms a t  a ll stages 
with  the pr imers listed in  t able 3.2 and ana lyzed on  1% (w/v) agarose gel with  1 kb DNA ladder  
(Promega) (A-B, D-H). C: Test digestion of R09 after the amplification. (1.2% Agarose gel, 2 Kb 
DNA ladder) R09 gene is about  ~1.6 kb and can  be digested in to 2 fragments by BamHI 
(fragment  size: 977bp, and 574bp) or  digested in to 4 fr agments by HindIII (fragment  size: 
715bp, 491bp, 306bp and 39bp, the smallest  fragment  cannot  be seen  on  th e gel).  
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The amplified DNA fragments were then ligated into pT7Blue vector for subsequent 
manipulation using Perfectly Blunt® Cloning Kits (Novagen, UK) respectively. The 
multiple cloning site of pT7Blue vector (Figure 3.7) is located in middle of the lacZ 
gene allowing blue-white screening for the positive colonies. Transformed competent 
cells were inoculated on to the LB agar plates containing 0.1 mM of IPTG and 40 
μg/ml X-gal. At least 15 white colonies were picked for colony PCR using the 
corresponding primers listed in table 3.2 (gel pictures not shown). Two of the colony 
PCR positive colonies were selected for DNA miniprep. 30 μg of the sample plasmid 
DNA was sequenced by MWG. The sequencing results were aligned with the target 
gene sequences in wormbase using multiple sequence alignment software by 
Florence Corpet (http://bioinfo.genopole-toulouse.prd.fr/multalin/multalin.html). 
Sequencing results were consistent with the sequences of the eight target genes 
recorded in the Wormbase.  
 
 
 
Figure 3.7 The map of pT7Blue vector and the cloning/expression region of the vector. The 
ta rget  genes were liga ted in to the EcoR V blun t  clon ing site. 
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3.2.3 HA insertion to the first exofacial loop 
In order to allow further functional study of the putative proteins, it is necessary to 
make the target proteins to be detectable by the antibody techniques. However, there 
were no specific antibodies available for the putative proteins; therefore, inserting a 
universal epitope tag into the appropriate position of the protein would provide the 
possibility of further functional study of the proteins of interest. The influenza 
hemagglutinin epitope (HA) was chosen to insert into the first exofacial loop of the 
target proteins as previously described (Quon, Guerre-Millo et al. 1994).  
The membrane topology prediction for each target protein was used to determine the 
insertion site of the HA-tag (Table 3.3). The Bsu36I restriction site (recognition site: 
CCTNAGG) was introduced into the pT7Blue constructs using Quickchange® 
site-directed mutagenesis kit (Stratagene, UK). The mutation site was confirmed by 
sequencing and alignment with the original sequence. The mutated plasmid was 
then digested with Bsu36I and dephosphorylated by TSAP enzyme to prevent the 
linearized DNA from re-ligation.  
Table 3.3 Insertion site of the HA-tag in the putative glucose transporter proteins 
Gene Name Position of the HA insertion Mutated Amino Acid 
H17B01.1 
a T57 – E58 -- 
b P70 – G71 -- 
R09B5.11 P71 – G72 -- 
C35A11.4 M42 – N43 M42 → P, N43 → D 
F14E5.1 T55 – E56  
Y39E4B.5 L45 – R46 R46 →A, Q47 → E, P48 → A 
F48E5.2 N42 – E43 -- 
K09C4.5 P51 – T52 T52 → A 
K09C4.1 T54 – E55 T54 → E 
T08B1.1 D76 – W77 D76 → E, W77 → G 
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The double-stranded DNA oligonucleotide coding for the HA tag was annealed from 
two single-stranded oligonucleotides. The annealed double-stranded DNA oligo was 
phosphorylated as described in section 2.2.2-11). The phosphorylated oligo was 
ligated with the dephosphorylated linearized vector. The sense oligonucleotide was 
5'-TGA GAT CGA TTA TCC TTA TGA TGT TCC TGA TTA TGC-3'. The antisense 
oligonucleotide was 5'-TCA GCA TAA TCA GGA ACA TCA TAA GGA TAA TCG 
ATC-3'. This encoded for a peptide, IDYPYDVPDYAE, which was inserted into the 
position listed in table 3.3 in each gene sequence. There is a unique ClaI site 
(recognition site: ATCGAT) in the HA sequence allowing the test digestion after the 
ligation. The ClaI site was first screened in the sequence of the amplification region in 
the target gene so that the size of the fragments (after test digestion) could be 
estimated. The insertion was verified first by ClaI digestion after the colony PCR 
(Table 3.4, Figure 3.8), and then by direct sequencing of the regions including the 
oligonucleotide insert. 
Table 3.4 The size of the fragments after ClaI digestion for verifying the presence of HA insertion into the 
putative glucose transporter genes. 
Gene Name 
The size of the fragments after ClaI digestion 
+ HA - HA 
H17B01.1 
a 1301bp, 181bp, 44bp 1482bp, 44bp 
b 1316bp, 215bp, 41bp 1531bp,41bp 
R09B5.11 1327bp, 218bp 1560bp 
C35A11.4 1456bp, 131bp 1551bp 
F14E5.1 1288bp, 173bp 1425bp 
Y39E4B.5 865bp, 546bp, 143bp 1008bp, 546bp 
F48E5.2 1375bp, 134bp 1503bp 
K09C4.5 1423bp, 164 bp 1551bp 
K09C4.1 1438bp, 164bp 1602bp 
T08B1.1 906bp, 676bp, 230bp 1100bp, 676bp 
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Figure 3.8 ClaI test digest for the verification of HA-tag insertion into the putative glucose 
transporter genes. UC: uncu t , PCR product  with  n o Cla I added to th e digest ion  mixtu re. The 
genes of in terest  were amplified using pr imers listed in  table 3.2 in  colony PCR. The PCR 
products were then  digested with  Cla I for  1 hour  a t  37°C. The digest ion  mixtures were 
ana lyzed on  1.5% (w/v) agarose gel with  1 kb DNA ladder  (Promega). Posit ive colony were then  
determined according to the size of the fragments compar ing with  the predict ion  in  table 3.4.    
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3.2.4 Cloning of the putative glucose transporters into a heterologous 
expression vector 
The oocytes of South-African clawed frog Xenopus laevis have been widely used for 
the expression of mammalian channels and transporters, as well as for the in vitro 
study of channels function and regulation of C. elegans (Nishimura, Pallardo et al. 
1993; Bianchi and Driscoll 2006; Mueckler and Makepeace 2006). The most 
common approach for expression of exogenous proteins in Xenopus oocytes is to 
inject in vitro transcribed cRNA into the oocyte cytoplasm (Bianchi and Driscoll 2006). 
In order to ensure the stability of the transcribed sequence and efficient translation 
into Xenopus oocytes, the cloned cDNA of the putative glucose transproters was 
inserted into the pT7TS vector. The pT7TS plasmid contains the 5’ and 3’ 
untranslated regions (UTRs) of Xenopus β-globin mRNA (Figure 3.9), which was 
isolated from a modified version of the translation vector pSP64T (Krieg and Melton 
1984) and then was cloned into pGEM4Z (Promega). Sense strand transcription is 
driven by T7 promoter. 
 
 
 
Figure 3.9 The Xenopus  β-globin UTRs flanked multiple cloning region of pT7TS vector. The 5’ 
and 3’ UTRs of Xenopus β-globin  mRNA was inser ted in to pGEM4Z vector . The sense st rand 
t ranscr ipt ion  was dr iven  by T7 promoter  and the an t isense st rand t ranscr ipt ion  was dr iven  by 
SP6 promoter . Th e vector  ha s stop codons in  a ll 3 reading frames downst ream of the mult iple 
clon ing site.     
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The cloned cDNA of the target genes was inserted between the BglII and SpeI sites 
so that the transcription was driven by T7 promoter. The sequences of the target 
genes were first screened to remove the two restriction sites (BglII and SpeI) with 
silent mutation. Both of the cDNA fragments with or without HA-tag were then 
amplified with primers containing BglII and SpeI sites and binding with pT7blue 
sequence upstream and downstream of the target genes respectively. Both the 
vector plasmid and the amplified fragments were then digested with BglII and SpeI 
(Figure 3.10). The digested fragments were ligated with T4 DNA ligase and 
transformed into XL-1 Blue competent cells. The presence of the target genes in the 
pT7TS vector was first verified with colony PCR with the primers listed in table 3.2, 
then verified by sequencing. 
In order to set up a positive control in the transport activity study, a pT7TS-GLUT1 
was constructed. The rabbit GLUT1 gene fragment was amplified from 
pUC19-GLUT1 construct (constructed by Dr. Edwards Lee, a previous PhD student 
in this laboratory) with primers containing BglII and SpeI sites respectively. The 
fragment was then ligated into the pT7TS vector after the double digestion. The 
successful ligation was verified first by colony PCR with primers binding with the 
beginning and the end of the GLUT1 sequence, and then by sequencing. A 
HA-tagged version of pT7TS-GLUT1 was also constructed. The HA tag was inserted 
into the first exofacial loop of GLUT1 between I40 and E41 (Figure 3.11) 
 
 
 
Figure 3.11 The sequence alignment of GLUT1 and HA-GLUT1. The Bsu36I site inser ted 
GLUT1 sequence was a ligned with  the sequencing resu lt  of pT7TS -HA-GLUT1. The HA tag 
was inser ted between  I40 and E41.      
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Figure 3.10 Bgl II and Spe I double digest of the cloned cDNAs of the 10 putative glucose 
transporters and the pT7TS vector. The cDNAs of the cloned pu ta t ive proteins in  pT7-Blue 
vector  were first  amplified with  pr imers conta in ing BglII and SpeI rest r ict ion  sites a t  5 ’ and 3’ 
ends respect ively. The PCR products were then  digested with  BglII and SpeI enzymes in  
Promega  r est r ict ion  enzym e buffer  D a t  37°C for  4-5 hours. The pT7TS was a lso digested with  
the two enzymes to produce a  ~3100 bp linea r ized fragment . Digested fragments were a na lyzed 
on  1% agarose gel and then  cleaned for  subsequent  liga t ion  p rocedure. In  figure F . pT7TS-R09, 
instead of the pT7TS plasmid, was digested to produce the ~3100 bp vector  and ~ 1500bp R09 
fragment  so tha t  the vector  backbone was able to be separa ted more easily.  
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3.3  Discussion and conclusion  
In this chapter, nine putative worm glucose transporter genes (H17B01.1, R09B5.11, 
C35A11.4, F14E5.1, Y39E4B.5, F48E5.2, K09C4.5, K09C4.1, and T08B1.1) were 
selected and cloned according to the sequence alignment and/or metabolic- or 
life-span- related RNAi phenotypes (Table 3.1). Membrane topology prediction for 
these putative proteins showed the characterized 10-12 transmembrane regions with 
cytoplasimc N- and C- terminus as well as large cytoplasmic loop between helices 6 
and 7. Except for the yeast glucose transporter ortholog T08B1.1, all the rest of the 
putative glucose transporters showed high alignment score with human GLUT1 and 
GLUT4 in the T-coffee protein alignment program indicating high sequence similarity 
between the putative proteins and the mammalian glucose transporters. However, 
only H17B01.1 and R09B5.11 have almost all the characteristic motifs of the glucose 
transporters. The metabolic and growth related RNAi phenotypes of the other 
putative proteins make them interesting target to study the role of the glucose 
transporter in the life-span regulation. However, the first step would be to confirm the 
glucose transport activity of these proteins. The insertion of HA-tag into the first 
exofacial loop of the putative proteins would allow antibody detection of the 
expression of the putative proteins; thus, allow the visualization of the subcellular 
localization of the putative proteins, as well as the comparison of the expression 
levels of different putative proteins in the study of the transport activity.  
The Xenopus oocytes contain accumulated stores of enzymes, organelles and 
proteins that are normally used after fertilization which can be recruited for the 
expression of heterologous proteins after the injection of the corresponding mRNA 
(Bianchi and Driscoll 2006). Moreover, the frog oocytes are built to survive for long 
periods of time outside the body; therefore, the low exogenous nutrient uptake 
makes the oocytes particularly suitable for the study of the sugar uptake activity of 
the sugar transporters. Thus, the Xenopus oocytes expression system was chosen 
for the expression of the putative worm glucose transporters. The HA-tagged and 
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non-tagged cDNA of the ten putative proteins were inserted into the Xenopus 
translation plasmid pT7TS respectively. Successful cloning of the cDNAs into the 
translation plasmid pT7TS allows the subsequent in vitro study of the glucose 
transport activity of the cloned putative glucose transporters. 
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Chapter 4 An in vitro functional study of the putative C. 
elegans glucose transporters 
4.1  Introduction 
The carbohydrate energy sources in C. elegans are primarily stored as cellular 
glycogen, however, significant amounts of trehalose and glucose are also present 
(Braeckman, Houthoofd et al. 2009). Trehalose has been shown to have important 
physiological functions in nematodes, including C. elegans (Pellerone, Archer et al. 
2003). Moreover, trehalose is assumed to be the major transported sugar during the 
dauer stage of the worms (McElwee, Schuster et al. 2004). Hence, the identification 
of glucose and trehalose transporters may provide important information for the 
understanding of the carbohydrate metabolism in the worms. C. elegans orthologs of 
the GLUT superfamily, as well as most of the enzymes involved in the main pathways 
of intermediary metabolism, have been predicted according to the worm cDNA(s) in 
Wormbase. However, this can only provide the information that the sugar transport 
system and standard metabolic pathways are conserved in the worms. The activities 
of these predicted proteins can only be determined by gene expression and 
functional studies. Therefore, the current studies (described below) of the 
mammalian GLUTs, and trehalose transporters in other species, will provide helpful 
references in the investigation of glucose and trehalose transporters in the C. 
elegans. 
4.1.1 The characteristics of two representative mammalian GLUT proteins  
The proteins of mammalian GLUT superfamily are the products of distinct genes and 
are expressed in a highly controlled tissue-specific fashion (Gould and Holman 1993). 
These transporters are also different in their functional characteristics, such as the 
substrate specificity, the Km values, and their binding-affinities to the inhibitory 
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ligands cytochalasin B and forskolin (Scheepers, Joost et al. 2004) (detailed in 
section 1.3.2). Despite little being known for the glucose transporters in C. elegans, 
the structural similarity of the transporters suggests that many features of the 
mammalian GLUTs family could turn out to be shared by the homologues.  
Among the mammalian GLUTs superfamily proteins, GLUT1 and GLUT4 are the 
most extensively studied (also discussed in section 1.3.2). GLUT1 is widely 
distributed in tissues with the highest expression levels in erythrocytes and 
endothelial cells of the brain. It is responsible for the basic supply of cells with 
glucose. The glucose transporter GLUT4 is the major insulin-responsive transporter 
that is predominantly restricted to striated muscle and adipose tissue. In the basal 
state, the majority of GLUT4 locates in intracellular compartments, GLUT4 vesicles, 
while only a very small amount of the transport cycles to and from the cell surface. 
When the insulin signalling cascade is stimulated upon the binding of insulin to 
insulin receptor, the exocytic rate of GLUT4 is significantly increased while the 
endocytosis of GLUT4 is reduced (Figure.4.1) (Bryant, Govers et al. 2002; Watson, 
Kanzaki et al. 2004; Dugani and Klip 2005). Thus the glucose uptake is increased. 
Once the blood glucose concentration is brought down, circulating insulin returns to 
basal level. GLUT4 molecules on the cell surface are internalized through 
clathrin-coated pits and are recycled back to intracellular compartments (Bryant, 
Govers et al. 2002; Watson, Kanzaki et al. 2004; Dugani and Klip 2005). During its 
cycling to and from the cell surface, GLUT4 traffics through several intracellular 
compartments, including endosomes and the trans-Golgi network (Holman and 
Sandoval 2001). 
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4.1.2 The role of trehalose in C. elegans physiology 
Trehalose is a soluble, non-reducing disaccharide of glucose which is naturally 
present in a wide range of organisms, including bacteria, yeasts, fungi, insects, 
invertebrates, and plants (Elbein, Pan et al. 2003). In the model nematode C. 
elegans, trehalose is also present in its all life cycle stages in significant quantities 
(up to 2.3% dry weight), with the highest concentrations found in eggs and dauer 
larvae (Pellerone, Archer et al. 2003), the two stages that are highly resistant to 
environmental stresses. Only α,α-trehalose (1-O-(α-D-glucopyranosyl)-α-D- 
glucopyranoside, structure in Figure 4.2) is found in biological material among the 
three isomers: α,α-trehalose, α,β-trehalose and β,β-trehalose (Elbein 1974). The 
disaccharide is synthesized in cells from metabolites of glucose and is readily 
hydrolysed to glucose. Therefore, it can function in cells as a less chemically reactive 
store of the reactive form glucose (Behm 1997). Trehalose is a multifunctional 
compound with a variety of functions in the worms’ physiology (Behm 1997), 
including: 1) serving as an energy and carbon reserve; 2) acting as a stabilizer and 
protectant of proteins and membranes; 3) providing protection from stress such as 
heat, damage of oxygen radicals, and cold (Behm 1997; Elbein, Pan et al. 2003).  
Figure 4.1 Insulin stimulation results in the translocation of GLUT4 from intracellular storage sites 
to the plasma membrane (Watson, Kanzaki et al. 2004). Glut4 labelled with enhanced green fluorescent 
protein (EGFP) fusion construct was transfected into differentiated 3T3L1 adipocytes. The cells were 
incubated with (A) or without (B) of insulin for 30 min. The cells were then fixed and pictures were taken 
using confocal fluorescent microscopy.  
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While playing an important role in the worms’ physiology, trehalose is an uncharged 
and osmotically active small molecule that cannot pass freely across biological 
membranes (Elbein, Pan et al. 2003). Hence, the trehalose transport system will be 
essential for trehalose to transport in and out of the cells to achieve its physiological 
function. However, there is hardly any report about the trehalose transport system in 
C. elegans. Certain transporters have been found to promote the permeation of 
trehalose across the plasma membrane in archaea and bacteria (MalEFGK2) (Boos 
and Shuman 1998) and yeast (MAL11/AGT1) (Han, Cotty et al. 1995; Stambuk, De 
Araujo et al. 1996; Stambuk, da Silva et al. 1999). However, the substrate selectivity 
of the two transporters also includes α-glucopyranoside, sucrose, and maltose (Boos 
and Shuman 1998; Stambuk, da Silva et al. 1999). Moreover the direction of 
trehalose transport of these transporters is only inward (Stambuk, De Araujo et al. 
1996; Boos and Shuman 1998). Okuda et al. reported the first trehalose-specific 
transporter, trehalose transporter 1 (TRET1), in the larvae of the sleeping chironomid, 
Polyedilun vanderplanki (Kikawada, Saito et al. 2007). TRET1 was reported to be a 
trehalose-specific facilitated transporter. The direction of the transportation was 
suggested to be reversible depending on the concentration gradient of trehalose. 
Protein sequence analysis showed that TRET1 also has a domain for sugar transport, 
of which the family contains the GLUT/SLC2A family and belongs to the major 
facilitator superfamily (MFS). The membrane topology prediction of TRET1 shows a 
Figure 4.2 The chemical structure of the naturally occurring isomer of trehalose, α,α-trehalose. 
(Adapted from (Behm 1997)) 
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12-transmembrane structure, which is the characteristic structure for the MFS 
(Kikawada, Saito et al. 2007). Therefore, while studying the glucose transport 
activities of the putative glucose transporters, it is also worth to test the trehalose 
transport activities of these proteins.  
4.1.3 Research objectives and experimental approach 
The cloning of nine putative C. elegans glucose transporters allowed the possibility of 
studying the characteristics of these proteins including the substrate specificity, 
cellular localization and so on. The aims of this chapter include: 1) to examine the 
glucose and trehalose affinity of the putative transporters using the Xenopus oocytes 
expression system; 2) to examine the cellular localization of the target protein upon 
identifying the glucose transporter within the nine candidates; 3) to test the possible 
insulin response of the identified glucose transporter protein in the insulin sensitive 
system.     
4.2  Results 
4.2.1 Expression of the candidate proteins in Xenopus oocytes 
The nine putative glucose transporter proteins with or without HA insertion were 
cloned into pT7TS vector (described in section 3.2.4). These constructs were then 
linearized by restriction enzyme (listed in table 4.1) at the downstream of the putative 
proteins’ coding region. The linearization of the plasmids was checked by agarose 
gel electrophoresis. The linearized plasmids were purified and then transcribed using 
the T7 RNA polymerase in the presence of cap analog (described in section 2.2.7). 
The transcribed RNA was purified by phenol/chloroform method and was adjusted to 
the concentration of 1 μg/μl for the injection into Xenopus oocytes.  
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Table 4.1 The restriction enzymes used in the linearization of the pT7TS constructs  
Construct Restriction Enzyme Construct Restriction Enzyme 
pT7TS-(HA)–C35 PstI pT7TS-(HA)–H17a SalI 
pT7TS-(HA)–F14 PstI pT7TS-(HA)–H17b PstI 
pT7TS-(HA)–F48 SalI pT7TS-(HA)–T08 SalI 
pT7TS-(HA)–K09 PstI pT7TS-(HA)–Y39 PstI 
pT7TS-(HA)–K4.5 PstI pT7TS-(HA)–GLUT1 SalI 
pT7TS-(HA)–R09 XbaI   
Both of the constructs with (HA) or without HA insertion was linearized by the listed restriction enzyme at 37°C 
for 5 hours and then purified and the concentration of the linearized plasmid was adusted to 200 ng/μl. 
Xenopus oocytes were prepared as described in section 2.2.7. After an overnight 
incubation period, healthy oocytes were selected for injection with 50 ng of capped 
RNA of the putative proteins or GLUT1. A group of negative control was prepared by 
injecting the oocyte with the same volume (50 nl) of DEPC-treated water. Injected 
oocytes were maintained at 18°C in complete ND96 with the medium changed every 
day. In the intact cells, antibody can bind to the HA –tagged putative transporters only 
when the transporters are located in the plasma membrane since the HA tag was 
inserted to the first exofacial loop of these proteins. Two days after the injection, the 
surface expression of the HA-tagged putative proteins was determined by 
HA-antibody surface binding assay (described in section 2.2.9, Figure 4.3). All of the 
putative proteins were expressed on the cell surface. The two transcripts of H17, 
H17a and H17b, exhibited the highest expression level on the cell surface, while K09 
showed the lowest expression level on the cell surface.  
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4.2.2 Glucose transport activities of the putative glucose transporters in 
Xenopus oocytes 
Healthy Xenopus oocytes injected with cRNA of non-HA-tagged putative glucose 
transporters and GLUT1 were selected for the glucose transport assay. The oocytes 
were first starved in non-nutrient buffer for 1 h. A group of 5 oocytes for each sample 
was incubated in the incomplete-ND96 buffer with 50 μM D-glucose for 30 sec. The 
assay was initiated by the addition of 0.3 μCi of the U-[14C]-glucose to each assay. 
After 1 h of incubation, each group of oocytes was homogenized and the radioactivity 
of each sample was determined by the scintillation counter in addition of scintillation 
liquid. The same procedure was also carried out on the oocytes injected with 
DPEC-treated water as the negative control. Among all the tested putative glucose 
transporters, only H17a and H17b showed significant glucose transport activity 
comparing with the negative control (Figure 4.4A). The rest of the putative 
transporters all showed no significant difference in the transport levels comparing 
with the negative control (Figure 4.4B), suggesting that glucose was not the 
favourable substrate of these putative transporters. Thus, H17a and H17b were 
identified as the glucose transporter in C. elegans. However, whether K09 has the 
Figure 4.3 The expression levels of the HA-tagged putative proteins and GLUT1 in Xenopus oocytes. 
50 ng of the cRNA of the HA-tagged putative transporters or HA-GLUT1 was injected into healthy 
Xenopus oocytes. Two days after the injection, healthy oocytes were selected for HA-antiody surface 
binding assay. All the putative glucose transporters were expressed on the cell surface at different level. 
The two transcript of H17 showed the highest expression level on the cell surface. The experiment was 
repeated three times. Each value is the mean ± SEM. 
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glucose affinity or not is not clear due to the low expression of the protein on the 
plasma membrane (Figure 4.3).   
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Figure 4.4 The glucose transport activity of the putative transporters in Xenopus oocytes. 50 ng of the 
cRNA of the putative transporter or GLUT1 was injected into healthy Xenopus oocytes. Oocytes were also 
injected with 50 nl of the DEPC-treated water as the negative control in the following assay. Two days after 
the injection, healthy oocytes were selected for glucose transport assay. A. Among the ten cloned putative 
transporters, only the protein of H17a and H17b exhibited significant glucose transport activity comparing 
with the negative control and similar transport activity to the rabbit GLUT1 in Xenopus oocytes. B. The rest 
of the eight putative transporter showed no glucose affinity (the transport levels were not significantly higher 
than the level of water injected oocytes) comparing with the glucose affinity of the positive control, rabbit 
GLUT1. The experiment was repeated three times. Each value is the mean ± SEM. 
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In order to normalize the transport activities of H17a and H17b to their expression 
levels on the cell surface, the glucose transport activities of HA-tagged H17a and b 
and HA-GLUT1 (as the positive control) were also examined using the same 
conditions as used for the non-tagged proteins (1h starvation, incomplete-ND96 with 
50 μΜ D-glucose, 0.3 μCi U-[14C]-Glucose for each assay). HA-antibody surface 
binding assays were also conducted on each group of the oocytes. Although 
expressed on the cell surface (Figure 4.5B), all the three transporters showed low 
level of transport activity (the amount of transported glucose of the three transporter 
were not significantly different from that of the water control, P > 0.05) (Figure 4.5A). 
Both of the HA-tagged and non-HA-tagged version of the three proteins were then 
tested in the same experiment. The result showed that the glucose transport 
activities of the three transporters were almost completely disrupted by the insertion 
of HA tag in the first exofacial loop (Figure 4.5C) 
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Figure 4.5 The glucose transport activity was disrupted by the insertion of HA tag into the first 
exofacial loop of the three transporters, H17a, H17b, and GLUT1. Oocytes were injected with cRNA 
of either HA-tagged or non-HA-tagged H17a, H17b and GLUT1 respectively. The injected oocytes were 
then subjected to glucose transport assay (1 h uptake, 50 μM glucose, 0.3 μCi of U-[14C]-Glucose). The 
experiment was repeated three times. Each value is the mean ± SEM. A. All of the three HA-tagged 
transporters showed low glucose transport activity (PH17a vs H2O = 0.08, PH17b vs H2O = 0.18, PGLUT1 vs H2O = 
0.67).  
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Figure 4.5 The glucose transport activity was disrupted by the insertion of HA tag into the first 
exofacial loop of the three transporters, H17a, H17b, and GLUT1. Oocytes were injected with cRNA of 
either HA-tagged or non-HA-tagged H17a, H17b and GLUT1 respectively. The injected oocytes were then 
subjected to glucose transport assay (1 h uptake, 50 μM glucose, 0.3 μCi of U-[14C]-Glucose). The 
experiment was repeated three times. Each value is the mean ± SEM. B. The expression levels of H17a, 
H17b and GLUT1 on the cell surface. C. Comparing with the amount of glucose uptake of the 
non-HA-tagged proteins, the glucose transport activities of the three HA-tagged proteins were almost 
complete disrupted.  
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4.2.3 Trehalose transport activities of the putative glucose transporters 
The trehalose transporter in insect, TRET1, was suggested to have the domain for 
sugar transport and belong to the MSF (Kikawada, Saito et al. 2007), moreover, 
trehalose plays an important role in the physiology of C. elegans (described in 
section 4.1.2) (Pellerone, Archer et al. 2003). Sequence alignment showed that 
TRET1 had high similarity to the ten selected putative glucose transporters (Table 
4.2). Therefore, we decided to test the trehalose transport activities for the putative 
transporters.   
Table 4.2 TCoffee scores for the alignment of the putative transporters with TRET1 
Protein TCoffee score Construct Enzyme 
C35 76 R09 71 
F14 77 H17a 81 
F48 67 T08 57 
K09 58 Y39 65 
K4.5 62   
The value of TCoffee score > 50 suggests a good similarity between the two aligned sequences. The higher the 
score is, the higher similarity is shared between the two sequences (Notredame, Higgins et al. 2000). All of the 
TCoffee values of the putative transporters aligned with TRET1 were higher than 50, suggesting that these 
proteins shared high similarity to TRET1.   
Trehalose can be hydrolyzed to glucose by trehalase (Dahlqvist 1968). Glucose is 
oxidized to gluconic acid and hydrogen peroxide by glucose oxidase. Hydrogen 
peroxide reacts with o-dianisidine in the presence of peroxidase to form a colored 
product. Oxidized o-dianisidine reacts with sulphuric acid to form a more stable pink 
colored product. The intensity of the pink color measured at 540 nm is proportional to 
the original glucose concentration (Bergmeyer 1974) (Figure 4.6). The amount of the 
trehalose uptake by the oocytes can, thus, be determined. Based on the above 
principle, the following experiment was designed: Xenopus oocytes expressing the 
non-HA-tagged putative transporters were prepared as described in section 2.2.7. 
The oocytes were starved for 1 h before the uptake. A group of 60 oocytes for each 
sample were then incubated in incomplete-ND96 buffer (nutrient free) containing 
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100mM trehalose for 3 h at 18°C. The uptake reaction was stopped by washing the 
oocytes quickly for 3 times in large amount of ice cold ddH2O. The oocytes were then 
homogenized and the yolk protein was collected by centrifuging and discarded. The 
supernatant of each sample was then treated with trehalase. The concentration of 
glucose was analyzed using the Glucose (GO) assay kit (described in section 2.2.8). 
The amount of the trehalose uptake by the oocytes was then calculated according to 
the glucose concentration.  
 
 
 
All of the ten putative transporters were tested for trehalose transport activity (Figure 
4.7). Except from H17a and H17b, the rest of the eight proteins showed no trehalose 
transport activity (the P values of there trehalose uptake of these proteins vs. water 
control were all larger than 0.05). The transport levels of H17a and H17b were 
significantly different from that of the water injected negative control (PH17a = 0.0017, 
PH17b = 0.0272). The amount of trehalose uptake in H17a samples was about 3 fold 
higher than in the negative control, while the uptake amount in H17b was about 2 fold 
higher than in the negative control. This result suggests that the two proteins, H17a 
and H17b, are also capable of transporting trehalose. 
Figure 4.6 The principle of trehalose assay. Trehalose can be hydrolyzed into two D-glucose by trehalase 
in acidic environment. Glucose is oxidized to gluconic acid and hydrogen peroxide by glucose oxidase. 
Hydrogen peroxide reacts with o-dianisidine in the presence of peroxidise to form a coloured product. 
Oxidized o-dianisidine reacts with sulphuric acid to form a more stable pink coloured product. The intensity 
of the pink colour measured at 540 nm is proportional to the original glucose concentration.  
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4.2.4 Kinetics of the glucose transport for H17a and H17b 
Among the ten cloned putative glucose transporters in C. elegans, only the two 
transcripts of H17 exhibited both glucose and trehalose transport activity, therefore, 
we decided to mainly focus on the study of the two proteins, H17a (492 aa) and H17b, 
(510 aa). There are about 21-amino-acid difference in the N-terminus between the 
two transcripts (Figure 3.4A). Both of the two putative proteins were predicted to be 
orthologs of human GLUT3 (Blast e-value: 1e-97, 43% identity), which belongs to the 
class I facilitative transporters. The glucose transport of the facilitative transporters 
exhibits simple, hyperbolic Michaelis-Menten kinetics (Baldwin 1993). Kinetic 
analysis was conducted on both H17a and H17b.  
 
Figure 4.7 The trehalose uptake in the ten putative C. elegans transporters. Healthy ooctyes injected 
with the cRNAs of the putative transporter were incubated in incomplete-ND96 buffer with 100 mM 
trehalose for 3 h. The cell lysates were diluted and treated with trehalase first and then subjected to Glucose 
Oxidase (GO) assay to determine the concentration of the hydrolyzed glucose. The amount of trehalose 
uptake was then calculated according to the glucose concentration in the cell lysates. Except from H17a and 
H17b, the rest of the eight proteins showed no trehalose transport activity (the results of the transport level 
were not significant to that of the negative control, P > 0.05). The transport levels of H17a and H17b were 
significantly different from that of the water injected negative control (**PH17a = 0.0017, *PH17b = 0.0272). 
The experiment was repeated three times. Each value is the mean ± SEM. 
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Xenopus oocytes injected with cRNA of H17a and H17b were used in the kinetic 
analysis. A group of five oocytes was incubated 1 h in incomplete-ND96 buffers 
containing D-glucose with a concentration gradient (2 mM, 5 mM, 12.5 mM, 20 mM, 
and 25 mM respectively). The reaction was initiated by the addition of 0.3 μCi of 
U-[14C]-Glucose to each assay. The glucose uptake was measured by the 
radioactivity in the cells lysates after the reaction. The procedure was repeated three 
times. The results were then analyzed by GraphPad to fit the equation: [S]/V = 
(Km/Vmax) + ([S] / Vmax) ([S]: substrate concentration, V: initial reaction rate). The 
results showed that the Km and Vmax values of H17a activity for glucose were 
6.52±1.85 mM and 2.93±0.25 pmole/min/oocyte (Figure 4.8A); while the Km and Vmax 
values of H17b activity for glucose were 9.57±2.55 mM and 3.47±0.37 
pmole/min/oocyte (Figure 4.8B). The Km value of H17a is lower than that of H17b 
suggesting that H17a has a higher affinity to glucose than H17b in the glucose 
transport.   
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Figure 4.8 Kinetics analysis of glucose transport activities of H17a (A) and H17B (B). Xenopus 
oocytes expressing H17a and H17b were incubated in the indicated concentrations of glucose for 1 h. 
Uptake data were fitted to the Michealis-Menten equations. Km and Vmax were calculated by nonlinear 
regression analysis. The experiment was repeated three times. Each value is the mean ± SEM. 
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4.2.5 Cellular localization of H17a and H17b 
The expression pattern for H17 stated in the Wormbase demonstrates that the gene 
is very broadly expressed in all life stages of C. elegans. Green fluorescent protein 
(GFP) fused reporter gene assay showed that the expression of H17 was observed 
in neurons, pharynx, hypodermis, and muscles (WormBase 2009) (Figure 4.9).  
 
 
 
In order to visualize the cellular localization of H17, H17a and H17b were expressed 
in the CHO-T cells. Firstly, the HA-tagged H17a and H17b genes were fused with 
enhanced green fluorescent protein (EGFP) at the C-terminus and then cloned into 
mammalian expression vector pcDNA3.1(+) (Figure 4.10A). The stop codon of H17a 
and H17b was removed by silent mutation using site-directed mutagenesis, an AgeI 
restriction site was added at the downstream of the two H17 genes so that the EGFP 
fragment cut from pEGFP-N1 vector could be ligated in frame. The primers used for 
deleting the stop codon of the two genes are as follows (the mutated base and Age I 
recognition site are in red): 
H17astopdelFor: CGAGAAGAGGAAGTCACCGTTCCATATGACTAGTAGATCC 
H17astopdelRev: GGATCTACTAGTCATATGGAACGGTGACTTCCTCTTCTCG 
H17bstopdelFor: CGAGAAGAGGAAGTCACCGGTTATGACTAGTAGATCC 
H17bstopdelRev: GGATCTACTAGTCATAACCGGTGACTTCCTCTTCTCG 
After the mutagenesis, the mutated HA-H17a and -b (~1500bp) were cut out from 
pT7Blue vector by Acc65I and AgeI. The EGFP fragment (~720bp) was cut put from 
pEGFP-N1 vector by AgeI and NotI. The vector pcDNA3.1 was digested with Acc65I 
Figure 4.9 The schematic diagram of the expression pattern of H17 in C. elegans. GFP reporter gene 
data (Wormbase Expr1684 [http://www.wormbase.org/db/gene/expression?name=Expr1684;class=Expr 
_pattern]) showed that the expression of H17 was observed in neurons, pharynx, hypodermis, and 
muscles (the pink area in the picture). The picture was adapted from (WormBase 2009) 
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and NotI (Figure 4.10B). The three fragments were then ligated to form the new 
construct: pcDNA-HA-H17a/b- EGFP. The sequence of the two constructs were 
sequenced and aligned with the original sequence for any sequence alterations 
occurred during the cloning procedure. The clones which did not have any alterations 
were selected and used in the following expression in CHO-T cells. When expressed 
in cells, the HA tag in the first exofacial loop would allow the detection of the target 
proteins on the cell surface, while the EGFP fused at the C-terminus of the two 
proteins was able to indicate the localization of the proteins inside the cells.  
 
 
 
 
 
Figure 4.10 The construction of pcDNA-HA-H17a/b-EGFP. A. The map of pcDNA3.1(+). B. The 
agarose gel picture of the three fragments constructing pcDNA-HA-H17a/b-EGFP. The stop codon of 
HA-H17a/b was removed by silent mutation while an AgeI site was added to the downstream of the two 
genes. The EGFP fragment was cut out by AgeI and NotI so that the fragment could be ligated in frame 
with the HA-H17a/b fragment. 
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The pcDNA-HA-H17a/b-EGFP construct was then transfected into CHO-T cells using 
the transfection reagent, Lipofectamins (described in section 2.2.5) and allowed to 
express for 24 h. The cells were then fixed with PFA and blocked with the blocking 
reagent. The cells were then first incubated with the primary mouse HA-antibody at 
the dilution of 1:1000 and second incubated with goat anti mouse Alexa-633 
conjugated antibody at the dilution of 1:1000. Finally the cells were mounted on 
slides and examined using the confocal laser scanning microscope. The cellular 
expression of H17a/b showed similar patterns. Both of the proteins were expressed 
on the plasma membrane while grainy expression around the perinulear region in the 
cytosol was also observed (Figure 4.11Basal panels). 
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Figure 4.11 The cellular localization of H17a/b. The pcDNA-HA-H17a/b-EGFP was transfected into 
CHO-T cells respectively using the transfection reagent and allowed to express for 24 h. The cells were 
than incubated with HA antibody and stained with Alexa-633 conjugated antibody. The pictures were 
taken by confocal laser microscope at the wavelength of 488 nm (for EGFP) and 633 nm (for Alexa 
633). Insulin panels: The cells were first stimulated with 100 nM insulin for 30 min at 37°C and then 
preceded to the same fixation and immunostaining procedure as the basal cells. The experiment was 
repeated three times and similar expression pattern were observed. 
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4.2.6  Insulin response of H17a and H17b 
One of the most important signalling pathways related to glucose transport is the 
insulin signalling pathway. There is about 21-amino-acid difference in the N-terminus 
between the two transcripts of H17 (Figure 3.4A). Eleven serines are presented in 
the N- terminus of H17b, which is indicating that the protein may be phosphorylated 
and, thus, may be involved in the signal transduction pathways. Because of such 
considerations, we decided to test the insulin response on H17a and H17b 
localisation. 
 The intracellular translocation and glucose transport activity of H17 in response to 
insulin stimulation in CHO-T cells 
The CHO-T cells are a cell line that stably expresses the insulin receptor. These cells 
provided platform in which the insulin response (e.g. the intracellular translocation or 
glucose transport activity in response to insulin stimulation) of a target protein can be 
tested. The HA tag in the first exofacial loop of H17a/b allows the detection of the 
protein on the cell surface without permeabilizing the cells. If any of the two proteins 
was responsive to insulin stimulation, we would expect to have certain levels of 
translocation from the intracellular compartment to the cell surface, which would be 
reflected on the increase of HA:EGFP signal ratio. Therefore, the insulin 
responsiveness of H17a/b can be determined by comparing the strength of the HA 
signals on the cell surface and the EGFP signals inside the cells between the basal 
and insulin stimulated status.  
The pcDNA-HA-H17a/b-EGFP construct was transfected into CHO-T cells, 
respectively, and allowed to express for 24 h. A group of the transfected cells was 
then stimulated with 100 nM insulin for 30 min at 37°C. The HA and EGFP signals 
were then examined using a confocal laser microscope after the immunostaining 
procedure. There were no significant signal difference in HA signals nor in EGFP 
signals between the insulin and basal state of the cells. Cells with strong HA signals 
(indicating that large amount of H17a/b proteins were on the cell surface) were found 
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in both basal and insulin state with similar number of cells. The cells with strong 
EGFP signal but weak HA signal (indicating that most of the proteins were in the 
intracellular compartment) were also observed with a similar cell numbers in both 
state (Figure 4.11). Thus, examining the insulin response by comparing the 
HA:EGFP signal ratio was not successful.  
A possible insulin signalling response leading to transporter activation was then 
examined in glucose transport assays in CHO-T cells. Because the variation in the 
radioactivity signals is much more sensitive than the fluorescent signals. The 
expression construct of pcDNA-H17a/b was constructed by inserting either H17a or 
H17b gene between the Acc65 I and Xba I sites in the pcDNA3.1 vector. CHO-T cells 
transfected with pcDNA-H17a/b were incubated at 37°C for 24 h to allow the 
expression of H17a/b. The cells were starved in Ham’s F-12 medium with 
L-glutamine without FBS for 1 h. The cells were treated with or without insulin (100 
nM) for 30 min at 37°C. The cells were then subjected to glucose transport assays 
(described in section 2.2.8) (50 μM glucose in Ham’s F-12 medium with L-glutamine, 
0.2 μCi of U- [14C]-glucose for each assay).  
The endogenous glucose uptake level of CHO-T cells is rather high (Figure 4.12A). 
When stimulated by insulin, the level of glucose uptake in H17a expressing cells was 
1.3 fold higher than the level of the cell transfected with empty vector, while that of 
the H17b expressing cells was 1.2 fold higher. In the basal state, the levels of 
glucose uptake in H17a and H17b expressing cells were 1.2 and 1.5 fold higher than 
the levels of basal cells transfected with empty vector respectively (Figure 4.12A). 
For comparisons of the glucose uptake levels between the cells expressing H17a/b 
in insulin and basal state, the endogenous uptake was substracted. However, the 
glucose uptake levels of H17a and –b between insulin and basal state were not 
significantly different (PH17a = 0.3591 > 0.05, PH17b = 0.2016 > 0.05) (Figure 4.12 B). 
Thus, the glucose transport activity of neither of H17a nor –b was responsive to 
insulin stimulation when expressed in CHO-T cells.   
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Figure 4.12 The glucose transport of H17a/b in CHO-T cells. Either pcDNA -H17a/b or the empty 
pcDNA3.1 vector was transfected into CHO-T cells respectively using the transfection reagent and 
allowed to express for 24 h. The cells were treated with or without insulin (100 nM) at 37°C for 30 min 
before being subjected to glucose transport assay. The transport assays were carried out under the 
condition of 50 μM glucose in Ham’ F12 medium in addition of 0.2 μCi U-[14C]-glucose per assay. A. 
The glucose transport levels at insulin and basal state including the negative control transfected with 
empty vector. B. The glucose transport levels of H17a/b at insulin and basal state with background value 
substracted. The experiment was repeated three times. Each value is the mean ± SEM. 
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 Intracellular translocation of H17 in response to insulin stimulation in primary rat 
adipocytes 
In the typical insulin responsive system such as primary rat adipocytes, stimulation 
by insulin leads to HA-GLUT4 translocation to the plasma membrane, where the HA 
tag in the first exofacial loop can be detected by anti-HA primary antibody. The 
primary antibody then binds with the IgG β-galactosidase conjugate secondary 
antibody. β-galactosidase catalyzes the hydrolysis of its fluorogenic substrate FDG. 
The process is first to fluorescein monogalactoside (FMG) and then to highly 
fluorescent fluorescein (Okada and Rechsteiner 1982; Lin, Yang et al. 1994). The 
fluorescence (emission 512 nm/excitation 488 nm) can then be measured with a 
fluorescent microtiter plate reader. Thus the amount of HA-GLUT4 translocated to 
the plasma membrane is able to be described (Quon, Zarnowski et al. 1993; Quon, 
Guerre-Millo et al. 1994). The responses of H17a and –b to insulin were also tested 
using this assay. 
Both H17a and –b were expressed on the cell plasma membrane in basal state. 
Therefore, it was very important that the two transporters were not over expressed in 
the adipocytes. Because over expression might lead to accumulation of the proteins 
on the plasma membrane. This would compromise the accuracy of the fluorescent 
signal detection. Therefore, the high copy number expression vector pcDNA was not 
suitable for the expression in primary rat adipocytes. Under such consideration, 
HA-H17a and –b fragments were ligated into a low copy number expression vector 
pCIS2 between the BglII and ApaI sites to form the expression constructs: 
pCIS-HA-H17a and pCIS-HA-H17b. The two constructs and pCIS-HA-GLUT4 (as 
positive control) were transfected into primary rat adipocytes by electroporation. The 
basal level of cell surface HA-GLUT4 was proportional to the amount of DNA 
transfected. As the amount of transfected DNA was increased, the basal levels of cell 
surface HA-GLUT4 also increased accompanied by a decrease in the fold 
stimulation by insulin (Quon, Guerre-Millo et al. 1994). The transfection condition for 
HA-GLUT4 was already optimized to 100 ng DNA per cuvette by Dr. Francoise 
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Koumanov. This gave the best insulin stimulation effect under the experimental 
conditions used in the lab as an optimum level of expressed GLUT4 was achieved. 
The transfection condition of HA-H17a and –b was optimized to 1.5 μg and 1 μg DNA 
per cuvette respectively, so that the total HA-H17a and -b expression level was 
similar to that of the HA-GLUT4 (Figure 4.13B).  
The cells were incubated at 37°C for 5 h to allow expression before being subjected 
to the cell surface HA-antibody binding assay (described in section 2.2.9). The cells 
were treated with or without insulin (60 nm) in KRH buffer at 20°C for 20 min. The 
anit-GLUT4 antibody and anti-HA antibody were used in the western blot respectively 
to indicate the total protein and total HA-H17a and –b or total HA-GLUT4 levels in 
each sample (Figure 4.13A and B). The density of each band of the western blots 
was analyzed using Labworks software (version 4, UVP). The data of the cell surface 
fluorescent increase for each sample were then normalized to the total protein level 
as well as the total H17a and –b level expressed in the adipocytes. The data were 
also corrected for nonspecific binding. As shown in Figure 4.13C, an 8.6-fold 
increase in the cell surface HA-GLUT4 was observed with insulin stimulation. 
Whereas, the HA-H17a level on cell surface in the insulin state versus in the basal 
state was not significantly different (P > 0.05), while the HA-H17b level on cell 
surface in the basal state was even higher than in the basal state. Thus, no increase 
in the cell surface HA-H17a or –b was observed with insulin stimulation. This result 
suggests that H17a and –b are not insulin responsive when expressed in the primary 
rat adipocytes, either. 
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Figure 4.13 The insulin response of H17a and –b in the primary rat adipocytes. The primary rat 
adipocytes were transfected with HA-GLUT4 (100 ng/cuvette), HA-H17a (1.5 μg/cuvette), and HA-H17b (1 
μg/cuvette) by electroporation. After incubated in DMEM containing 3.5% BSA, 200 nM adenosine, and 75 
μg/ml gentamycin, at 37°C for 5 h, the cells were subjected to HA-antibody surface binding assay. A. GLUT4 
immunoblot of the transfected cells. Cell lysates from 5 μl of the resuspended cells were loaded on each lane. 
B. HA immunoblot of the transfected cells. Cell lysates from 15μl of the resuspended cells were loaded on 
each lane. C. Cell surface HA binding assay for HA-GLUT4, HA-H17a and –b. Cells expressing the above 
three proteins were treated with or without insulin (60 nM) at 20°C for 20 min, followed by KCN (4mM) 
treatment for 3 min to stop the translocation. Cells were then incubated for 1 h with anti-HA mouse antibody. 
After washing, cells were incubated with a secondary anti-mouse IgG β-galactosidase conjugate antibody for 1 
h. The fluorescent signal was measured using a fluorescent microtiter plate reader (emission 512 nm/excitation 
488 nm).*Results from each experiment were normalized for total protein level and total HA level. ΔF: the 
increase of the fluorescent signals, B: basal, In: insulin. The experiment was repeated three times. Each value is 
the mean ± SEM. 
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4.3  Discussion and conclusion 
This chapter is mainly focused on the description of in vitro functional studies of the 
ten putative glucose transporters in C. elegans whose cloning was reported in 
Chapter 3. Both the glucose transport activity and trehalose transport activity were 
examined for the ten proteins when being expressed in Xenopus oocytes. Among all 
the cloned putative glucose transporters, only the two transcripts of the gene 
H17B01.1, H17a (worm protein ID: CE27184, 492 aa) and H17b (worm protein ID: 
CE27184, 510 aa), showed both glucose and trehalose transport activities. This is, 
for the first time, a glucose transporter identified in the worm C. elegans.  
The two proteins, H17a and –b, have both been reported as the orthologs of human 
GLUT3 (Blast e-value: 1e-97, 43% identity), which is a high affinity glucose 
transporter in the class I facilitative transporter family. Protein sequence analysis 
suggests that all the key motifs of the GLUT superfamily are found in H17 protein 
sequence (Figure 3.4B). Protein membrane topology prediction suggests that both of 
the proteins have the typical GLUT family membrane topology which is characterized 
by the 12 transmembrane-region structure with cytoplasmic N- and C- terminus, 
large exofacial loop between helices 1 and 2 and large cytoplasmic loop between 
helices 6 and 7 (Gould and Holman 1993; Olson and Pessin 1996) (detailed in 
section 3.1.1). Class I and II mammalian glucose transporter proteins bear an 
N-linked glycosylation site in loop 1 (Baldwin 1993; Gould and Holman 1993; Olson 
and Pessin 1996). This N-glycosylation site is proved to be essential in the targeting 
and stability of GLUT1, as well as maintaining the high-affinity transport of glucose 
for these proteins (Asano, Katagiri et al. 1991; Asano, Takata et al. 1993). When 
HA-H17a and –b are expressed in the Xenopus oocytes, the glucose transport 
activities of the two proteins are almost completely disrupted by the insertion of HA 
tag in the first exofacial loop (Figure 4.14). This suggests that the first exofacial loop 
plays an essential role in the binding of glucose. Moreover, an N-glycosylation site 
may also exist in the first exofacial loop of H17. The insertion of HA tag may alter the 
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conformational structure of loop1 which would result in the un-availability of the 
glycosylation site and, therefore, cause the protein to fail to transport glucose across 
the cell membrane.   
      
 
Mammalian GLUT1 is ubiquitously expressed and GLUT3 is mainly expressed in 
neurons (Manolescu, Witkowska et al. 2007; Zhao and Keating 2007). However, the 
expression of H17 is observed through-out all the life stages to be very broadly 
expressed in tissues including neurons, pharynx, hypodermis, muscle which all are 
the sites with high glucose demands. The Km of H17a and –b for glucose uptake is 
~6.5 mM and ~ 9.6 mM respectively when expressed in the Xenopus oocytes. These 
Km values are comparable with those of GLUT1, 5 mM, GLUT4, 5 mM, and GLUT3, 1 
mM, indicating that H17 is a high-affinity glucose transporter in C. elegans. All of the 
above findings suggest that H17 may act as a major glucose transporter in C. 
elegans. Moreover, H17 also shows trehalose transport activity when expressed in 
Xenopus oocytes. The disaccharide trehalose plays important role in the C. elegans 
physiology (discussed in section 4.1.2). Recently, trehalose is also found to be able 
to extend the lifespan of the worm (Honda, Tanaka et al. 2010). However, trehalose 
cannot pass freely across biological membranes (Elbein, Pan et al. 2003). Therefore, 
Figure 4.14 The position of HA insertion in the two H17 proteins. The HA tag was inserted between 
T57 and E58 for H17a and between P70 and G71 for H17b. 
- 117 - 
 
H17 may also play a role in the mechanism of trehalose extending the longevity in C. 
elegans.  
H17a and –b were also expressed in CHO-T cells and primary rat adipocyte to test 
the possibility of insulin response. The presence of multiple serines in the N-terminus 
of H17b suggests that the protein can be phosphorylated and involved in signal 
transduction. However, the two proteins are not responsive for insulin stimulation in 
either of the mammalian expression systems studied. The insulin responsive test in 
rat primary adipocytes is based on the increased number of the transporter on the 
plasma membrane in response to insulin stimulation. The FQQI or LL motif at the 
C-terminus of mammalian GLUT4 is required for the translocation of GLUT4 from 
intracellular compartment to the plasma membrane in response to insulin stimulation 
(Melvin, Marsh et al. 1999). Sequence alignment shows that H17 is lacking a similar 
motif at the C-terminus. Furthermore, the expression of HA-H17-EGFP shows that 
the cellular localization of H17 is mainly on plasma membrane (Figure 4.11) which is 
similar to the expression pattern of GLUT1 (Shanmugam, McBrayer et al. 2009). 
Therefore H17 translocation between cell membrane and intracellular compartments 
may not be responsive to the insulin (or insulin-like ligands in C. elegans) stimulation. 
However, whether H17 is involved as a downstream target of the insulin signalling 
pathway or any other signal transduction in C. elegans remains to be unveiled.   
Although the rest of the eight putative transporters (C35, F14, F48, K09, K4.5, R09, 
T08, and Y39) are all predicted to be the orthologs of the human GLUT superfamily 
(Table 3.1) and all the corresponding human orthologs of the GLUT superfamily are 
capable of transporting glucose with high affinity, none of these putative transporters 
show either glucose or trehalose transport activity when expressed in Xenopus 
oocytes. For the mammalian GLUT superfamily, several studies on GLUT1-5 
suggest that, within helix 7, there are a number of residues that are very important for 
functional activity of the transporters. The motif “QLS” in this region is a site involved 
in substrate recognition. GLUT1, 3, and 4, which transport glucose but not fructose, 
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have the QLS sequence in helix 7, whereas GLUT2 and 5, that both transport 
fructose have HVA or MGG, respectively in the corresponding position (Manolescu, 
Witkowska et al. 2007). Sequence alignments of the nine putative transporters with 
human GLUT1 and GLUT4 show that only H17 has the “QLS” motif in helix 7 among 
these proteins. This finding is consistent with the above conclusion and indicates that 
the key motifs of glucose transport are also conserved in the worms. In C. elegans, 
glucose and glycogen, followed by trehalose, fructose and sucrose can be utilized as 
energy sources (Lu 1993). Moreover, long-chain fatty acids, ethanol, n-propanol and 
acetate can also be utilized as energy sources (Lu, Hugenberg et al. 1978). In the 
wormbase gene profile, all of the eight putative transporters are reported to have the 
protein domains of general substrate transporter (INTERPRO:IPR005828). The 
general substrate transporter protein domain is composed of the protein domain of 
sugar/inositol transporter, citrate-proton symport, phosphate permease, and organic 
cation transport protein (INTERPRO 2009). Therefore glucose may not be the 
favourable substrate for these putative transporters and the substrate specificity of 
these proteins are yet to be discovered. 
To sum up, a high-affinity glucose transporter, H17B01.1, for the worm C. elegans is 
identified in this chapter. There are two transcripts of H17B01.1, H17a (492 aa) and 
H17b (510 aa), both of which are capable of transporting glucose with high affinity, as 
well as trehalose, when expressed in Xenopus oocytes. The cellular localization of 
H17 is mainly on the plasma membrane while expression around the perinuclear 
region is also observed. Both of the two transcripts are not insulin responsive when 
expressed in the CHO-T cells and rat primary adipocytes. The rest of eight putative 
transporters cloned in Chapter 3 do not transport either glucose or trehalose when 
expressed in Xenopus oocytes. 
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Chapter 5 An in vivo functional study of H17a/b in C. 
elegans 
5.1  Introduction 
5.1.1 The role of glucose in the regulation of lifespan 
Calorie restriction (CR) and insulin/IGF-I-like signalling (IIS) are two pathways 
affecting lifespan in a variety of species. Genetic studies in C. elegans suggest that 
CR and IIS regulate the worm lifespan through distinct cellular signalling pathways 
(detailed in section 1.1). For example, the FOXO transcription factor, DAF-16, is 
essential for longevity in IIS mutants, but is dispensable for the lifespan extension 
through CR. Moreover, CR is able to further lengthen lifespan of long-lived worms 
lacking IIS due to a mutation in the kinase domain of the DAF-2 (Lakowski and 
Hekimi 1998; Houthoofd, Braeckman et al. 2003; Hansen, Hsu et al. 2005). However, 
there is also evidence suggesting that CR and IIS converge on downstream targets 
that act to promote longevity. In C. elegans, certain superoxide dismutase (sod) 
genes are specific targets of either CR or IIS, while other sod genes are targets of 
both pathways (Panowski, Wolff et al. 2007). In Drosophila, CR sensitivity was 
altered in chico (insulin receptor substrate in Drosophila) mutants, which have 
extended lifespan from disrupted IIS (Clancy, Gems et al. 2002). However, much 
work is still needed to fully understand the interactions between the two pathways. 
Glucose is the major source of energy in eukaryotic organisms. In mammals, glucose 
homeostasis is maintained by processes regulated by the two hormones, insulin and 
glucagon (discussed in section 1.2). Therefore, glucose lack may not be only related 
to the CR mediated lifespan extension but also connected to the IIS mediated 
lifespan extension. However, the role of glucose metabolism in the multicellular 
eukaryote in regards to life expectancy is largely unknown. The worm, C. elegans, is 
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a suitable model organism for studying the role of glucose in the life span regulation 
because of its short life span, the relative ease in modifying its genome, and its 
simple insulin receptor system (the daf-2 signalling pathway) (Schulz, Zarse et al. 
2007; Lee, Murphy et al. 2009; Schlotterer, Kukudov et al. 2009).  
Several recent studies indicate that glucose does play a role in the regulation of 
lifespan of C. elegans. Schulz et al. found that glycolysis in C. elegans could be 
impaired by treatment with 2-deoxy-D-glucose (DOG) (Schulz, Zarse et al. 2007). 
The lifespan of the worms was then extended by the reduced glucose metabolism. 
Schulz et al. demonstrated that glucose restriction promotes mitochondrial 
metabolism, causing increased reactive oxygen species (ROS) formation (Schulz, 
Zarse et al. 2007). However, this idea that glucose shortens life span by inhibiting 
respiration is challenged by the work of Lee et al. who demonstrate that glucose 
shortens the life span of C. elegans by down-regulating DAF-16/FOXO activity and 
aquaporin gene expression (Lee, Murphy et al. 2009). Based on the findings that the 
AMPK subunit AAK-2 was inactivated by glucose treatment, and that DOG did not 
lengthen the life span of aak-2 null mutants, a model was proposed to suggest that 
glucose may shorten life span by inactivating the AMP-dependent kinase (AMPK) 
(Schulz, Zarse et al. 2007). This model predicted that glucose would not further 
decrease the life span of aak-2 null mutants. However, Lee et al. reported that the 
short life span of the worms caused by loss of aak-2 was further decreased by 
glucose feeding to the same extent as wild-type worms (Lee, Murphy et al. 2009). 
This finding, therefore, indicated that glucose does not shorten the life span of C. 
elegans by inactivating AMPK.  
Taken together, glucose loading shortens the life span of C. elegans, while glucose 
restriction can extend the life span of the worms. However, the mechanism by which 
increased glucose availability regulates the life span of C. elegans (either by 
inhibiting the respiration or through the IIS pathway) remains controversial and much 
work still needs to be done to unveil the mechanisms involved in this process.  
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The first step of the glucose metabolism is the transportation of glucose across the 
plasma membrane by the glucose transporters. In mammals, the low-level of basal 
glucose uptake required to sustain respiration in all cells is maintained by the 
facilitative glucose transporter, GLUT1. In the meantime, the glucose homeostasis is 
mainly regulated by two hormones: insulin and glucagon. The first step by which 
insulin regulates the blood glucose level involves the regulated transport of glucose 
into the cell, mediated by GLUT4. Insulin increases glucose uptake mainly by 
enriching the concentration of GLUT4 proteins on the plasma membrane (Chang, 
Chiang et al. 2004). C. elegans has orthologs for most of the key enzymes involved 
in eukaryotic intermediate metabolism, suggesting that the major metabolic pathways 
are probably present in the species (Braeckman, Houthoofd et al. 2009). However, 
the glucose transporter family in C. elegans is very poorly described. Furthermore, 
whether the similar insulin responsive glucose transport system is present in the 
worm is yet to be discovered. Thus, by investigating the relationships between the 
glucose transporters and the life expectancy of C. elegans, or the link of the glucose 
transporters to the IIS pathway in the worms may also provide threads to the 
understanding of how glucose effects the life span of C. elegans.  
5.1.2 Research objectives and experimental approach 
The identification of the first glucose transporter, H17B01.1 (H17), in C. elegans 
allows the study of whether this glucose transporter is related to the life span 
regulation in C. elegans. The availability of complete genome sequences provides 
the rapid approach of studying the individual gene’s function in C. elegans by RNA 
interference (RNAi). There are three ways of carrying out RNAi in C. elegans: 
injection (Fire, Xu et al. 1998), soaking (Tabara, Grishok et al. 1998), and feeding 
(Timmons and Fire 1998). RNAi by feeding is to feed the worms with bacteria 
producing the desired dsRNA and score the phenotype of the fed worms or their 
progeny. This method allows one to carry out RNAi on a large number of animals at 
once with least labour intensive and low cost. Thus, RNAi by feeding is used to study 
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the in vivo function of the gene H17 (Ahringer ed. 2006).  
Upon the above consideration, the aims of this chapter are: 1). to construct the 
bacteria producing H17 dsRNA; 2). to investigate the effect of H17 knockdown on the 
lifespan of C. elegans; 3). to study the glucose metabolism in the H17 knockdown 
worms; 4). to study the relationship of H17 and the IIS pathway in C. elegans.  
5.2   Results 
5.2.1 The construction of H17 RNAi bacteria strain and RNAi of H17 in       
C. elegans 
The first step of carrying out RNAi on C. elegans by feeding involves engineering 
bacteria to produce the dsRNA of the target gene (Timmons and Fire 1998). The 
cloning vector, L4440, containing two convergent T7 polymerase promoters in 
opposite orientation separated by a multiple cloning site (Timmons and Fire 1998) 
(Figure 5.1A) and bacteria strain, HT115 (Takiff, Chen et al. 1989; Dasgupta, 
Fernandez et al. 1998), was used for the engineering of H17 dsRNA producing 
bacteria (Timmons, Court et al. 2001). A ~ 400bp fragment (Figure 5.1B) was 
amplified with primers (Table 5.1) from pT7-H17a and pT7-H17b respectively. The 
amplified fragments were then ligated into the L4440 vector between the Acc65 I and 
Xba I restriction site (Figure 5.1C). The constructs of L4440-H17a and L4440-H17b 
were transformed into HT115 competent cells to form the desired H17 dsRNA 
producing bacteria. When induced with appropriate concentration of IPTG, the 
bacteria would be able to produce H17 dsRNA. 
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Table 5.1 The primers for amplifying the H17 a & b DNA template for RNAi constructs 
 
    
 
 
 
 
 
 
 
 
Primer Sequence Fragment size 
17aRNAifor CGG GGC CCC GAT AAA TGG 
417 bp 
17aRNAirev GCT CCA ATC TAG ACT TAG CC 
17bRNAifor CGG GGC CCC GAT ATG TCG 
395 bp 
17bRNAirev CCA CGT CTT CTA GAC CTT ATC G 
Figure 5.1 The construction of H17 RNAi bacteria strain. A. The map of L4440 (Adapted from Addgene 
[http://www.addgene.org/pgvec1?f=c&identifier=1654&atqx=L4440&cmd=findpl]). B. The Amplification of 
H17a and b fragments from pT7 H17 a/b. The PCR products were analyzed on a 1.5% agarose gel. C. Restriction 
enzyme digestion of the L4440 vector and H17 a /b fragments with Acc65 I and Xba I. The digestion products 
were analyzed on a 1% agarose gel. 
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In order to monitor the effectiveness of the RNAi of H17 in C. elegans, a positive 
control of unc-22 RNAi, which gave a noticeable “twitching” phenotype when the 
unc-22 RNAi worked (Timmons, Court et al. 2001), was used in parallel with each of 
the RNAi experiment. The “twitching” phenotype of unc-22 would give a direct way of 
examine whether the RNAi had worked or not. When 80% of the worms were 
showing the “twitching” phenotype, the parallel RNAi experiments were assumed to 
have work as well. And the subsequent experiments would then be carried out.  
NGM plates containing 50 μg/ml ampicillin and 1 mM IPTG were prepared and 
allowed to dry for 4-7 days before seeding the bacteria food source to give the best 
RNAi effect (Ahringer (ed.) 2006). LB liquid cultures of HT115 carrying L4440 
(negative control), L4440-H17a, L4440-H17b, and L4440-unc-22 (positive control) 
were prepared respectively by growing the single colony of each construct in LB 
medium containing 50 μg/ml ampicillin with shaking at 300 rpm, 37°C for 6~8 h. The 
cultures were then seeded on the NGM plates containing 50 μg/ml ampicillin and 1 
mM IPTG and allowed to induce overnight at RT. 
Synchronized and starved wild-type C. elegans L1 larvae were prepared (detailed in 
section 2.2.10) and seeded onto the NGM plates with RNAi bacteria food source. 
The worms were allowed to grow on the RNAi plates without exhausting the bacteria 
food until desired stage for subsequent experiments. The efficiency of the H17 
knockdown was examined by QPCR (detailed in section 2.2.11). The gene act-1 
(forward primer: ccaggaattgctgatcgtatgcagaa and reverse primer: tggagagggaagcga- 
ggataga) was used as housekeeping gene to normalize the RNA level of H17 (Li, 
Tewari et al. 2007). As shown in Figure 5.2, the RNA levels of both H17a and H17b 
were significantly and reliably knocked down by ~80% (H17a: 80.8±4.8%, H17b: 
79.7±6.0%) when treated with the engineered bacteria expressing H17 dsRNA. 
Therefore, the L4440-H17a and L4440-H17b constructs were used in the 
subsequent experiment.    
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5.2.2 The effect of H17 knockdown on the lifespan of C. elegans 
Glucose restriction is able to extend the life span of C. elegans (Schulz, Zarse et al. 
2007). Since H17 is reported to have a ubiquitously expression in C. elegans 
(described in section 4.2.5), the glucose uptake maybe restricted by knocking down 
the expression of H17 and the lifespan of the worms may, thus, be extended. 
Therefore, the wild-type (WT) worms were subjected to H17 RNAi and the lifespan of 
these worms were analyzed by lifespan assay (detailed in section 2.2.12). As shown 
in Figure 5.3 and Table 5.3, the worms subjected with H17a RNAi, H17b RNAi or 
L4440 vector exhibited similar survival curve and the same median survival of 15~16 
days. The results suggested that the life span of the WT worms was not significantly 
affected by the knock down of either H17a or H17b. In addition, unlike the food 
deprivation which can induce the dauer formation (Fielenbach and Antebi 2008), 
there was no noticeable increase of dauer phenotype in the H17 knocked-down WT 
worms. Moreover, the H17 knocked-down worms did not show any slow growth 
comparing with the control worms which were fed with bacteria carrying L4440 vector 
only.  
Figure 5.2 The RNAi of H17a and b in WT C. elegans. Total RNA was isolated from worms of all stages for 
each sample and quantified with UV-spectrophotometer. The cDNA from same amount of total RNA was then 
synthesized for each sample. The mRNA levels of H17a or b were then assessed respectively by Q-RCR using 
the primers listed in table 2.11. Each sample was analyzed in triplicates. The experiment was repeated three 
times. Each value is the mean ± SEM.   
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Meissner et al. reported that while the worm lifespan was not affected by the 
elimination of the worm intestinal peptide transporter, pep-2, the lifespan of the 
double mutant of pep-2 and daf-2 was extended by 60% compared to the daf-2 
single mutant (Meissner, Boll et al. 2004). The IIS pathway in worms is initiated by 
the activation of DAF-2 by the secreted insulin-like ligands, and is followed by the 
activation of AGE-1, production of second messenger PIP3 and the activation of the 
AKT family kinases (Paradis and Ruvkun 1998; Hertweck, Gobel et al. 2004) 
(detailed in section 1.1.1). Therefore, we decided to check whether the knockdown of 
H17 would have any effect on the life span of the IIS pathway mutant worms. Three 
IIS pathway mutant strains were chosen for the subsequent experiments. They are: 
daf-2 mutant (e1370, CB1370), age-1 mutant (hx546, TJ1052), and akt-1 mutant 
(mg144, GR1310) (Table 5.2). Among the three strains, e1370 is a temperature 
sensitive strain with 100% dauer formation at 25°C and 15% dauer formation at 20°C 
(Gems, Sutton et al. 1998). Hence, the strain is maintained at 15°C before being 
seeded on to the RNAi NGM plates. All of the three strains were then subjected to 
lifespan assay at 20°C.   
Figure 5.3 The lifespan assay in H17 RNAi WT C. elegans. WT young adult worms were allowed to lay eggs 
on the RNAi bacteria seeded NGM plates. The progeny were allowed to grow to L4 larvae stage at 20°C and 
then transferred to new RNAi bacteria seeded NGM plates containing 50 μM FUDR. The worms were allowed 
to grow till death without exhausting the RNAi bacteria food source. Day 0 of lifespan was the day that eggs 
were laid. Animals that failed to respond to a gentle prodding with a platinum wire were scored as dead. The 
data was analyzed with Kaplan-Meier method.   
- 127 - 
 
Table 5.2 Selected IIS pathway mutant worm strains for subsequent experiment 
Strain 
name 
Mutated 
gene 
Mammalian 
ortholog 
Phenotype 
CB1370 
(e1370) 
daf-2 
Insulin 
receptor 
Temperature sensitive dauer constitutive. Maintain at 15°C. 
100% dauer at 25°C. 15% dauer formation at 20°C.long lived, 
M-mating + low temperature only. 
TJ1052 
(hx546) 
age-1 PI3K Long live & stress resistance. Normal fertility. 
GR1310 
(mg144) 
akt-1 AKT/PKB 
No visible phenotype. Dominant suppressor of daf-c 
phenotype* of age-1 
* daf-c phenotype: dauer-constitutive phenotype. (worms inappropriately form dauer larvae under favorable 
conditions )  
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Figure 5.4 The lifespan assays in H17 RNAi IIS mutant worm strains. A. Lifespan assay for H17 RNAi 
daf-2 (e1370) mutants. B. Lifespan assay for H17 RNAi age-1 (hx546) mutants. C. Lifespan assay for H17 
RNAi akt-1 (mg144) mutants. D. Lifespan comparison of the controls (fed with bacteria carrying L4440) 
under different mutant gene background. Young adult worms were allowed to lay eggs on the RNAi bacteria 
seeded NGM plates. The progeny were allowed to grow to L4 larvae stage at 20°C and then transferred to 
new RNAi bacteria seeded NGM plates containing 50 μM FUDR. The worms were allowed to grow till death 
without exhausting the RNAi bacteria food source. Day 0 of lifespan was the day that eggs were laid. 
Animals that failed to respond to a gentle prodding with a platinum wire were scored as dead. The data was 
analyzed with Kaplan-Meier method.   
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As shown in Figure 5.4D, the median lifespan of the control mutant worms (worms 
fed with bacteria carrying L4440) was: 23.63 ± 1.56 days (daf-2, e1370), 20.16 ± 0.54 
days (age-1, hx546), and 14.96 ± 0.38 days (akt-1, mg144). These results were 
consistent with the median lifespan of the above mutants reported in other published 
literatures (Kenyon, Chang et al. 1993; Dorman, Albinder et al. 1995; Gems, Sutton 
et al. 1998; Paradis and Ruvkun 1998). However, the median lifespan of H17 RNAi 
mutant worms was not significantly different from that of the control mutants (Figure 
5.4A-C, Table 5.3). Hence, the lifespan of the IIS pathway mutants was not affected 
by the knockdown of H17. 
Table 5.3 Lifespan assays in the WT and IIS mutants under H17 RNAi condition 
Strain RNAi Mean lifespan days (±SD) Max lifespan N (censored)* 
WT 
Control 15.46 (0.33) 25 118 (2) 
H17a 15.48 (0.37) 25 102 (4) 
H17b 15.36 (0.35) 26 120 (3) 
daf-2 
(e1370) 
Control 23.63 (1.56) 44 163 (4) 
H17a 24.00 (0.50) 44 160 (2) 
H17b 22.00 (0.88) 43 156 (2) 
age-1 
(hx546) 
Control 20.16 (0.54) 39 105 (0) 
H17a 20.50 (0.44) 37 78 (2) 
H17b 20.12 (0.53) 39 82 (0) 
akt-1 
(mg144) 
Control 14.96 (0.38) 23 108 (2) 
H17a 15.38 (0.33) 26 94 (3) 
H17b 14.22 (0.39) 25 112 (3) 
XLSTAT-life statistical software (Addinsoft, New York, NY, USA) was used to plot survival data by the 
Kaplan–Meier method. 
* Total death scored (number of censored values) 
 
5.2.3 The effect of H17 knockdown on the glucose metabolism in C. elegans 
In C. elegans, glucose is oxidized to CO2 and water to provide ATP as the major 
energy source. Except from being stored as glycogen, excess glucose can be 
alternatively broken down to acetyl-CoA by glycolysis, and then converted to and 
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stored as fats (Ashrafi 2007). It was reported that loss of function of daf-2 caused fat 
accumulation in adults (Ashrafi 2007). Moreover, the global shifts in metabolic 
pathways were also reported to be associated with dauer larvae and daf-2 mutant 
adults (Holt and Riddle 2003; Burnell, Houthoofd et al. 2005; Ashrafi 2007). These 
shifts were found to be similar to the metabolic adjustments observed in nutrient 
deprived or fasting mammals. These adjustments favour energy conservation, fat 
storage, and utilization of stored reservoirs (Ashrafi 2007). Therefore, the influence of 
H17 knockdown on the glucose metabolism was also investigated by examining the 
CO2 release rate and the amount of fat converted from glucose metabolism in the WT 
and the IIS mutant worms.  
Both H17a and H17b were knocked down in the same worm so that the maximum 
effect could be observed in the experiments. Since the expression stage of H17a and 
H17b was unknown, in order to make sure that both H17a and H17b were knocked 
down in the same worm, equal volume of H17a and H17b cultures with similar OD600 
reading were mixed before seeding. The young adult worms which had being grown 
on the RNAi bacteria mixture plates were then allowed to lay eggs on the RNAi NGM 
plates until the L4 stage. In order to eliminate any influence from the glucose 
produced from digested bacteria, the L4 larvae were starved 18h to exhaust the 
ingested bacteria before being subjected to the subsequent experiments. A parallel 
plate of worms for each RNAi condition was also set up and starved. The worms on 
these parallel plates were collected for QPCR to examine the mRNA level of H17 
after the starvation. The mRNA level of H17 each of the mutants was knocked down 
to 32.63 ± 2.46% (WT), 42.26 ± 2.44% (daf-2, e1370), 41.30 ± 4.43% (age-1, hx546), 
and 28.37 ± 2.94% (akt-1, mg144) comparing with the controls for each group 
(Figure 5.5).   
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The glucose to fat conversion was examined by glucose uptake assays (detailed in 
2.2.13). Fats were extracted from the worm lysates with the organic solvent, heptane. 
If the radio-active U-[14C]-D-glucose taken up by the worms was converted to fat, the 
fat content would, therefore, be radio-active and the radioactivity could be detected 
by the scintillation counter. As shown in Figure 5.6, the rates of glucose converted to 
fat in the control worms (worms fed with bacteria carrying L4440) of each group (WT, 
daf-2 (e1370), age-1 (hx546), akt-1 (mg144)) were not significantly different from 
each other. The knockdown of H17 caused a small increase of glucose to fat 
conversion in the WT worms (P=0.0565) whereas the glucose to fat conversion in the 
H17 RNAi daf-2 mutant was significantly increased (P=0.0254) by ~64%. On the 
contrary, the knockdown of H17 in the akt-1 mutant led to a small decrease of the 
glucose to fat conversion. However, the conversion rate in the H17 RNAi age-1 
mutant was not significantly altered.     
Figure 5.5 The H17 mRNA levels in H17 RNAi WT and IIS mutant worms after 18 h starvation. H17a 
and H17b RNAi bacteria were mixed at 1:1 ratio before seeded to the NGM plates. Young adult worms 
grown on RNAi plates from eggs were washed with M9 buffer and transferred to new agarose plates 
containing 50 μg/ml ampicillin, 50 μM FUDR and without bacteria seeded. Worms were starved for 18 h. 
Total RNA was then extracted from starved worms for QPCR analysis of the H17 mRNA levels using the 
primers listed in table 2.11. Each sample was analyzed in triplicates. The experiment was repeated three 
times. Each value is the mean ± SEM.   
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The glucose oxidation rate was tested in both WT and IIS pathway mutants as 
described in section 2.2.14. In the control worms, the glucose oxidation rates were 
decreased in both daf-2 and age-1 mutants (Pdaf-2=0.0147, Page-1=0.0031) comparing 
to the rate of the WT worms. The H17 knockdown induced small decrease of the 
glucose oxidation rates in the WT, age-1, and akt-1 mutants (PWT=0.0471, 
Page-1=0.0478, Pakt-1=0.0057) (Figure 5.7). Whereas, in the daf-2 mutant, the glucose 
oxidation rate was greatly increased (P=0.0003) (about 2.7 fold increased than in the 
control mutant worms) by the knockdown of H17.  
Figure 5.6 Glucose to fat conversion assays in H17 RNAi WT and IIS mutant worm strains. 
Synchronized starved adult worms were incubated 1 h at 20°C in M9 buffer containing 50 μM D-glucose 
with 1μCi U-[C14]-D-glucose added for each assay. The fat content of each sample was extracted from worm 
lysates with heptane. The radio activity of the organic phase was counted using a scintillation counter. *A 
small increase of the glucose to fat conversion (P = 0.0565) in WT worms; ** a significant increase of 
glucose to fat conversion (P = 0.0254) in daf-2 (e1370) mutants. Each sample was analyzed in triplicates. The 
experiment was repeated three times. Each value is the mean ± SEM.  
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5.3  Discussion and conclusion 
In this chapter, the in vivo function of H17 was investigated under the condition of 
gene knockdown using RNAi. The studies described in this chapter were mainly 
focused on the effect of H17 knockdown on the lifespan and glucose metabolism in 
the WT and IIS pathway mutant worms.  
Being identified as a glucose transporter with almost ubiquitous expression in C. 
elegans of all stages (detailed in Chapter 4), H17 had the potential of being the major 
glucose transporter in C. elegans. Previous studies demonstrate that glucose 
shortens the lifespan of C. elegans while glucose restriction is able to extend the 
lifespan of the worms (Schulz, Zarse et al. 2007; Lee, Murphy et al. 2009; Schlotterer, 
Kukudov et al. 2009). If H17 were the major glucose transporter in the worms, the 
knockdown of H17 expression would decrease the glucose uptake level in the worms 
Figure 5.7 The glucose oxidation assays in H17 RNAi WT and IIS mutant worm strains. In an airtight 
sealed bijou tube (Figure 2.2), synchronized starved adult worms were incubated 1 h at 20°C in M9 buffer 
containing 50 μM D-glucose with 1μCi U-[14C]-D-glucose added for each assay. Released CO2 was absorbed 
by 0.1 M KOH. The radio activity of the KOH solution was counted using a scintillation counter. *Decreased 
glucose oxidation rates (PWT=0.0471, Page-1=0.0478, Pakt-1=0.0057). **Increased glucose oxidation rate 
(P=0.0003).  Each sample was analyzed in triplicates. The experiment was repeated three times. Each value 
is the mean ± SEM.  
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and establish the glucose restriction status in the worms. Thus, the lifespan of the 
worms would be extended when the expression of H17 was continuously suppressed 
during the lifespan assay.  
However, the lifespan assay results showed that the knockdown of H17 expression 
was not able to extend the lifespan either in the WT worms or in the IIS mutant 
worms. When maintained on 2-deoxy-D-glucose (DOG) plates (discussed in section 
5.1), the worms almost completely lost the ability to oxidize exogenous glucose 
(Schulz, Zarse et al. 2007). Both short term (treating the worms with DOG in the first 
6 days of early adult life) and continuous impairment of glucose metabolism were 
able to extend the C. elegans lifespan (Schulz, Zarse et al. 2007). These findings 
suggest that an almost completely impairment of either glucose metabolism or 
glucose uptake might be necessary for the lifespan extension effect being observed. 
Whereas in our case, the expression of H17 was knocked down by 80%, hence the 
glucose uptake in the worms was not completely disrupted. Moreover, the results of 
glucose uptake assays and glucose oxidation assays in WT worms also suggested 
that the exogenous glucose metabolism was not impaired by the H17 knockdown. 
Furthermore, when cultured on the bacteria seeded NGM plates, worms directly 
absorb lipid species (triglycerides, phospholipids, sphingolipids, etc.) from the 
bacterial food source (Braeckman, Houthoofd et al. 2009). Hence it is possible that 
the worms are more dependent on the bacteria food as the calorie source. Therefore 
the knockdown of H17 expression was not able to affect the lifespan of the worms. 
Finally, due to the poorly understood glucose transport system in C. elegans, a lot of 
the questions are still unknown, such as, whether H17 is the major glucose 
transporter in C. elegans, or if there is any other glucose transporter in C. elegans. 
Thus, although H17 knockdown did not affect either the WT or the IIS mutant worms’ 
lifespan this result is not sufficient to draw the conclusion that H17 could not affect 
the lifespan of C. elegans.   
Although the H17 knockdown did not affect the lifespan of the worms, the glucose 
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metabolism in both the WT and the IIS mutant worms was affected. The decreased 
level of 14C labelled CO2 release (Figure 5.7) indicated that the glucose uptake level 
in the WT worms was brought down by the H17 knockdown. Schulz et al. reported 
that when the glycolysis was impaired by the DOG treatment in worms the levels of 
transcripts encoding proteins involved in lipid storage were significantly upregulated 
(Schulz, Zarse et al. 2007). This was coincident with our finding that the glucose to 
fat conversion level was increased in the H17 RNAi WT worms.  
The long-lived daf-2 mutants are thought to have an enhanced mitochondrial 
efficiency by exhibiting low oxygen consumption and higher ATP levels but relatively 
low calorimetric/respirometric ratio (Braeckman, Houthoofd et al. 2002). In contrast, 
low metabolic rates for the IIS mutants were also reported (Van Voorhies and Ward 
1999). However, the analysis of transcriptional profiles of metabolism-related genes 
suggested that the citric acid cycle (TCA-cycle) and respiratory chain activities were 
not down-regulated in daf-2 mutants (McElwee, Schuster et al. 2006). It has also 
been reported that the daf-2 mutant worms have increased fat accumulation in 
intestinal and hypodermal cells (Kimura, Tissenbaum et al. 1997). Our results 
showed that the fat content derived from exogenous glucose (indicated as 14C 
labelled fat in our experiments) was not increased in the daf-2 mutant worms. 
Therefore, the increased fat storage in the daf-2 mutant might be synthesized from 
other source other than exogenous glucose. Whereas in the H17 RNAi daf-2 mutants, 
the level of 14C labelled fat was significantly increased. Moreover, the glucose 
oxidation level was also significantly increased in the daf-2 mutant worms. These 
increases observed in H17 RNAi daf-2 mutant were not found in either age-1 or akt-1 
mutants.  
There are two possible explanations for the above results. Firstly, carbohydrates are 
primarily stored as glycogen as well as trehalose in C. elegans (Cooper and Van 
Gundy 1970; Hanover, Forsythe et al. 2005). The daf-2 (e1370) animals were found 
to have an elevated fat storage (Kimura, Tissenbaum et al. 1997). Carissa et al. 
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reported that the daf-2 (e1370) mutation resulted in the >2 fold higher proportion of 
synthesized fatty acids than in the WT worms (Perez and Van Gilst 2008). Hence, the 
glycogen may have been greatly broken down and converted to fat storage in the 
daf-2 mutants. In the starving daf-2 mutants, with possibly reduced glycogen level, 
part of the exogenous glucose may be converted to either glycogen or trehalose so 
that the balance between carbohydrate breakdown and fat synthesis can be kept. 
Therefore, this may account for the observation that the exogenous glucose derived 
fat content is not increased in the control daf-2 mutants (daf-2 mutants fed with 
bacteria carrying L4440 vector only). Whereas, the knockdown of H17 may lead to 
reduced glucose availability, hence the exogenous glucose may be extensively used 
to fat and CO2 conversion rather than converted to glycogen. Thus the levels of 
exogenous glucose derived fat and CO2 conversion may have both been increased 
in the H17 knockdown daf-2 mutants.  
Secondly, the starving daf-2 mutant may enter an anaerobic metabolic status which 
is similar to the metabolic status of the dauer larvae since 15% of the worms enter 
dauer stage at 20°C for the e1370 temperature sensitive strain. The reduction of 
glucose availability caused by the H17 knockdown may trigger a compensatory 
glucose uptake process in the worms and induce an effect which is partially similar to 
the “Pasteur effect” found in anaerobic yeast (increased glucose consumption, faster 
glucose metabolic rate (Krebs 1972)). When worms enter the anaerobic metabolic 
status, the transcription of enzymes involved in the pathways of fatty acids 
β-oxidation, glycolysis, glycongenesis is found to be enhanced, indicating that the 
stored fat content is converted into sugars, such as trehalose (Ashrafi 2007; 
Braeckman, Houthoofd et al. 2009), rather than glucose, is assumed to be the 
transported sugar under such conditions (McElwee, Schuster et al. 2004). The 
transporting trehalose is broken down to glucose and then enters the TCA-cycle. 
With increased glucose consumption, accelerated glucose metabolic rate and 
enhanced mitochondrial efficiency of the daf-2 mutant background, the exogenous 
glucose to fat conversion and the production of CO2 is, therefore, increased (Figure 
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5.8). In contrast, the age-1 and akt-1 mutants are not able to induce the worms enter 
the anaerobic metabolic status and hence, the increased CO2 production is not 
observed in the H17 RNAi mutants. Further more, both the glucose to fat conversion 
and glucose oxidation are reduced in the akt-1 mutant suggesting that the akt-1 is 
also important in the glucose transport in C. elegans.    
 
 
 
To sum up, the knockdown of H17 was not able to affect the life span of either WT or 
IIS mutant worms. H17 may play an important role in the glucose metabolism in both 
WT and IIS mutant worms. However, more work is needed to investigate the further 
details of the in vivo function of the worm glucose transporter, H17.      
Figure 5.8 A hypothetic role of H17 in the glucose metabolism in daf-2 mutant worms. In the starved 
daf-2 (e1370) mutant worms, when H17 is expressed, the daf-2 mutant exhibits typical glucose metabolic 
effect (green arrows) as reported in other literatures, such as enhanced mitochondrial efficiency, reduced CO2 
production and increased lipid storage. When the H17 expression is knocked down, the glucose metabolism is 
shifted to the anaerobic status (blue arrows) where both the glucose consumption and glucose metabolism are 
increased. In the meantime, a compensate glucose uptake may also be induced to meet the need of the 
increased glucose consumption. Therefore, both the exogenous derived fat storage and CO2 production may 
be increased in response to this compensatory process.  
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Chapter 6 Final conclusion and discussion  
6.1 Final conclusion 
This thesis focused on the identification of glucose transporter in C. elegans and the 
primary investigation of the in vitro and in vivo function of the identified glucose 
transporter. 
In Chapter 3, nine putative worm glucose transporter genes (H17B01.1, R09B5.11, 
C35A11.4, F14E5.1, Y39E4B.5, F48E5.2, K09C4.5, K09C4.1, and T08B1.1) were 
selected for subsequent cloning based on the similarity of sequence motifs and 
membrane topology to the mammalian GLUT family, as well as the RNAi phenotype. 
Each of the putative glucose transporters was cloned into pT7-Blue vector to allow 
subsequent gene manipulation. The insertion of HA tag into the first exofacial loop of 
each protein allowed the in vitro detection of these putative transporters. The cloning 
of the putative transporters into the Xenopus translation vector, pT7TS, allowed the 
heterologous expression of the putative transporter in the Xenopus oocytes for the 
investigation of the glucose transport activity of these proteins.  
Upon successful cloning of the nine putative transporters into the pT7TS vector, the 
glucose and trehalose transport activities of these proteins were investigated with 
Xenopus oocytes expression system in Chapter 4. In vitro characteristic studies of 
the putative transporters suggested that the two transcripts of H17, H17a and H17b, 
were the only two proteins that were transporting glucose with high affinity out of all 
the cloned proteins. Trehalose can also be transported by the H17a and H17b when 
expressed in Xenopus oocytes. The fact that the insertion of HA tag in the first 
exofacial loop completely disrupted the glucose transport ability of the protein 
indicated that the first exofacial loop was essential for the glucose transport activity 
for H17. When expressed in CHO-T cells, the cellular localization of H17 was 
observed on plasma membrane as well as perinuclear region. The two transcripts 
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shared similar expression pattern in the CHO-T cells. Neither H17a nor H17b were 
insulin responsive when expressed in CHO-T cells or primary rat adipocytes. These 
results indicate that whether H17 is a downstream target of the IIS pathway or of 
another signal transduction pathway remains to be unveiled. 
The in vivo function of the H17 was investigated in Chapter 5. RNAi by feeding was 
used to knock down the expression of H17 in C. elegans. The effects of H17 
knockdown on the worm lifespan and glucose metabolism were examine in WT 
animals and IIS pathway mutants, including daf-2 (e1370), age-1 (hx546), and akt-1 
(mg144). The knockdown of H17 expression did not affect the lifespan of any of the 
tested strains. The fact that H17 knockdown led to increase in glucose to fat 
conversion as well as glucose oxidation rate in the daf-2 (e1370) suggested that this 
glucose transporter might play an important role in the insulin regulated glucose 
metabolism in C. elegans, particularly when the receptor for insulin-like peptides is 
non-functional. 
The studies outlined above provide novel background information on C. elegans 
dependence on glucose transport that will eventually lead to further studies on the 
relationship between nutrient supply via transporters and hormonal control of nutrient 
use. These studies could aim to test new ideas concerning the metabolic role and 
significance of H17 in worms that have a deficiency to the daf-2 pathway. Some 
approaches and new information that are needed for these further studies are 
suggested below.  
6.2 Discussion  
The initial goal of our study was to identify the GLUT4 ortholog in C. elegans. 
Because GLUT4 is the only insulin-regulated glucose transporter that is responsible 
for insulin-regulated glucose translocation into cells in mammals (Holman and 
Sandoval 2001). The identification of GLUT4 ortholog in C. elegans may provide 
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further understanding to the link between IIS- and CR-regulated lifespan extension in 
worm. However, the predicted GLUT4 ortholog in C. elegans, K09C4.1, did not have 
glucose affinity when being expressed in the Xenopus oocytes (detailed in section 
4.2.2). It is possible that the glucose homeostasis in the lower organism, C. elegans, 
is relatively simple, therefore, the insulin responsive GLUT4-mediated glucose 
transport may not be necessary for the worms. There is also the possibility that the 
correct GLUT4 ortholog is not selected since the initial selection of the candidate 
putative transporters is not only based on the similarity to the mammalian GLUT 
super family but also based on the growth or metabolic RNAi phenotype of the 
worms. If there were no obvious RNAi phenotype for the worm GLUT-4 ortholog, the 
putative protein would not be selected for subsequent cloning. Despite the 
unsuccessful search of C. elegans GLUT4-like protein, a GLUT3 ortholog, H17B01.1 
(H17) is identified. The two transcripts of H17 are high affinity glucose transporters 
and they are also capable of transporting trehalose. However, the affinity of H17 to 
trehalose still needs to be determined. 
The in vivo functional characterization of H17 was carried out via RNAi techniques 
that involve feeding the worms with bacteria carrying the RNAi. Although RNAi by 
feeding is widely used in the functional study of the C. elegans genes, the results of 
the lifespan assay on H17 RNAi worms indicate that the effect of H17 knockdown on 
the worms’ lifespan may be compromised either by the incomplete removal of the 
glucose supply, or by the presence of the bacteria food source (discussed in section 
5.3). Hence in order to further investigate whether H17 is affecting the lifespan of the 
worms or not, a transgenic H17 worm strain could be constructed so that the glucose 
transport activity of H17 could be completely depleted without exposing the worms to 
RNAi bacteria food source. Since the HA tag insertion into the first exofacial loop of 
H17 completely disrupts the H17 mediated-glucose transport (detailed in section 
4.2.2), it is possible to introduce the HA-tagged H17 into the C. elegans by 
microparticle bombardment method (Praitis 2006). Upon the successful introduction 
of the HA-tagged H17 into worm, the transgenic line could also be used in the study 
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of H17 mediated glucose metabolism in C. elegans, as well as the visualization of the 
in vivo expression and intracellular expression of H17 in C. elegans when combined 
with antibody labelling techniques.    
Similar to the mammalian nutrient metabolic system, the carbohydrates and lipid 
metabolism in C. elegans are also regulated by IIS pathway (Braeckman, Houthoofd 
et al. 2009). Two models (the increase of glucose metabolic efficiency vs. the 
presence of compensatory glucose uptake process) are suggested in Chapter 5 to 
interpret the effect of H17 knockdown on the glucose metabolism in daf-2 mutant 
worms (detailed in section 5.3). The major difference between the two models is 
whether the increase of the exogenous glucose derived fat content and glucose 
oxidation in daf-2 mutants are induced by more efficient usage of the available 
glucose source or the activation of compensatory glucose uptake process due to the 
knockdown of H17. To distinguish which of the two models fits the results better, the 
total amount of glucose taken up during the experiment should be determined. This 
would involve measuring the radioactivity of the extracted fat content, the released 
CO2, as well as the whole worm lysates. Decrease of total glucose uptake would not 
only indicate that the efficiency model accounts for the increased glucose 
metabolism caused by H17 knockdown in daf-2 mutants, but also would suggest that 
H17 could be the major glucose transporter in C. elegans; whereas, increase of the 
total glucose uptake would indicate the presence of other glucose transporter(s), as 
well as the presence of the compensatory glucose uptake process. Since the total 
glucose uptake would be limited in the efficiency model, a decrease of carbohydrate 
storage, such as glycogen and trehalose would be expected in the efficiency model. 
However, the total amount of fat content might not be necessarily increased 
comparing the same WT or IIS mutation background worms with/without H17 
knockdown. On the contrary, in the compensatory model, the glycogen level might 
not be significantly changed while the trehalose level would be increased as 
trehalose was the circulating sugar when the worms entered the anaerobic status 
(Braeckman, Houthoofd et al. 2009). An increase of total fat content level should also 
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be observed in this model. Moreover, an HA-tagged H17, daf-2 mutant line could also 
be constructed so that the function of H17 can be completely suppressed during the 
starvation of the worms before the glucose metabolism assays.               
To sum up, C. elegans is extensively used in the studies of the lifespan regulation 
mechanisms because of its completely sequenced genome, relatively short lifespan, 
as well as the conserved metabolic and signalling pathway, including the IIS pathway. 
The IIS pathway in C. elegans also plays an important role in the regulation of the 
nutrient homeostasis (Braeckman, Houthoofd et al. 2009) and, moreover, in the 
regulation of aging process (Porte, Baskin et al. 2005; Broughton and Partridge 2009) 
(detailed in section 1.1.1). Recent studies showed that glucose restriction extends 
the lifespan of C. elegans (Schulz, Zarse et al. 2007) while excessive glucose 
shortens the lifespan of the worms (Lee, Murphy et al. 2009) (detailed in section 
5.1.1). However, the mechanism of this process remains largely unknown. The first 
identification of the glucose transporter in C. elegans and its IIS- and age-related 
functional studies described in this thesis may provide the beginning of a course of 
investigation that eventually leads to further understanding of the IIS-regulated 
nutrient homeostasis in worms, as well as the link between IIS- and CR-related 
lifespan extensions in C. elegans.  
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Appendix 
1) Buffer compositions 
Name of buffer Composition 
General buffers 
PBS 154 mM NaCl, 12.5 mM Na2HPO4·12H2O, pH7.2 
TBS 10 mM Tris, pH 7.4, 154 mM NaCl 
TBS-Tween 20 10 mM Tris, pH 7.4, 154 mM NaCl, 0.1% (v/v) Tween-20 
SDS Sample buffer 
2% (w/v) SDS, 62.5 mM Tris HCl pH6.8, 0.01% (w/v) 
bromophenol blue, and 10% (v/v) glycerol 
Resolving gel buffer 1.5 M Tris-HCl, pH 8.9, 0.4 % (w/v) SDS 
Stacking gel buffer 0.5 M Tris-HCl, pH6.8, 0.4% (w/v) SDS 
Electrophoresis 
running buffer 
25 mM Tris-HCl, pH6.3, 0.1% (w/v) SDS, 0.2 M Glycine 
Transfer buffer 
48 mM Tris, 39 mM glycine, 0.0375% SDS (w/v), 20% (v/v) 
methanol, pH8.8 without adjusting 
Ponceau S stain 0.1% (w/v)Ponceau S, 3% (w/v) TCA 
BCA Reagent B 4% (w/v) CuSO4·5H2O 
TAE 40 mM Tris-acetate, 1 mM EDTA, pH 8.5 
TFB1 buffer 
100 mM RbCl, 50 mM MnCl2, 30 mM Potassium acetate, 10 
mM CaCl2, 15% glycerol (v/v), pH 5.8 
TFB2 buffer 
10 mM RbCl, 10 mM MOPS, 75 mM CaCl2, 15% glycerol 
(v/v), pH 6.5 
LB 
1% (w/v) Bacto
TM
 Tryptone, 0.5% (w/v) Bacto
TM
 Yeast Extract, 
0.5% NaCl, pH 7.5, autoclaved 
LB Agar plates 
1% (w/v) Bacto
TM
 Tryptone, 0.5% (w/v) Bacto
TM
 Yeast Extract, 
0.5% NaCl, pH 7.5, 1.5% agar, autoclaved 
Worm buffers 
M9 buffer 
22 mM KH2PO4, 22 mM Na2HPO4, 85 mM NaCl, 1 mM 
MgSO4 
NGM 
0.3% (w/v) NaCl, 0.25% (w/v) peptone, 1mM KPO4 buffer pH 
6.0, 1 mM MgSO4, autocalved; 5 μg/ml cholesterol (added after 
autoclave ) 
Xenopus oocyte buffers 
Ca
2+
 free  82.5 mM NaCl, 2.5 mM KCl, 1 mM NaHPO4, 1 mM MgCl2,
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OR-2 buffer 5 mM HEPES, pH 7.5 
ND96 buffer 
96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2,
 
5 mM 
HEPES pH 7.5, 2.5 pyruvic acid 
complete ND96 
buffer 
96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2,
 
5 mM 
HEPES pH 7.5, 2.5 pyruvic acid, 1% FBS 
Rat adipocytes buffers 
KRH buffer 
140 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.25 mM MgSO4, 
0.2 mM NaH2PO4, 10 mM HEPES, 200 nM adenosine, pH 7.4 
Adipocyte digestion 
buffer 
3.5% (w/v) BSA in KRH supplemented with 5 mM glucose and 
500 μg/ml Collagenase type 1 from Clostridium histolyticum 
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2) Sequence alignment of the putative glucose transporters with human GLUT1 and 
GLUT4 (T08 excepted) 
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